classification,report_date,termination_date,termination_speed,status,recall_reason,recall_category,manufacturer_name,product_type,route,notification_type
Class II,2017-06-21,2019-05-01,694,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2021-05-26,,,Ongoing,CMGP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,nan
Class II,2023-01-25,,,Ongoing,CGMP DEVIATIONS AND SUPERPOTENT DRUG,CGMP/GMP Issues,nan,nan,nan,Telephone
Class II,2018-08-15,2019-09-11,421,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-09-05,2018-10-10,51,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2018-12-05,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-03-27,2020-12-07,643,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-10-23,2020-02-12,161,Terminated,CGMP DEVIATION,CGMP/GMP Issues,Jubilant Cadista Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-11-27,2023-01-04,1153,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-10-07,2021-09-21,924,Terminated,CGMP DEVIATION,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2021-09-08,2022-11-04,463,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Casper Pharma , PRESCRIPTION DRUG,ORAL,Letter
Class II,2017-04-19,2018-07-03,466,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-04-17,2023-05-24,1542,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-06-26,2021-09-16,864,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Zydus Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-01-26,,,Ongoing,CGMP DEVIATION,CGMP/GMP Issues,Mayne Pharma, PRESCRIPTION DRUG,TOPICAL,Letter
Class II,2013-10-09,2014-11-20,469,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2014-02-12,2014-02-04,165,Terminated,CGMP DEVIATION,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class III,2017-10-11,2020-07-16,1100,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-10-31,2020-03-06,560,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-01-23,2020-03-27,1075,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-01-15,2021-03-10,440,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2022-02-02,2023-09-20,632,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Viona Pharmaceuticals , PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-04-20,2023-11-17,603,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2015-07-15,2017-02-22,632,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-02-13,2023-11-06,1795,Terminated,GMP DEVIATIONS,CGMP/GMP Issues,Walgreens, OTC DRUG,TOPICAL,Letter
Class II,2021-08-11,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Pfizer Laboratories Div Pfizer , PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-02-22,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class III,2016-09-14,2017-04-03,409,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2018-10-17,2020-05-08,596,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Greenstone , PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-01-29,2023-12-15,1439,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2020-03-18,2021-03-29,395,Terminated,CGMP DEVIATION,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2022-03-02,2023-10-31,634,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Professional Disposables International, OTC DRUG,TOPICAL,Letter
Class II,2022-06-01,2022-09-02,123,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class III,2016-04-06,2016-05-10,237,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-04-03,2020-04-29,407,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Allergan, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class II,2019-10-30,2020-12-01,419,Terminated,GMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-02-19,2021-10-26,634,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Zydus Pharmaceuticals USA ., PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2020-02-26,2022-08-04,909,Terminated,GMP DEVIATIONS,CGMP/GMP Issues,American Health Packaging, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-03-18,2022-09-17,1039,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2021-09-08,2023-02-16,554,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2022-01-19,2022-03-28,88,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2017-06-14,2019-02-21,679,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-07-18,2020-09-28,818,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,nan
Class II,2019-12-11,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-06-03,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2021-07-21,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,Cipla USA ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-06-08,2023-10-05,518,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Direct_Rx, PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-04-17,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Torrent Pharmaceuticals Limited, PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-10-02,2022-01-21,876,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-02-19,2020-11-03,281,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Actavis Pharma, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-03-25,2021-02-09,333,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-04-22,2020-07-24,101,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-06-24,2022-01-14,589,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2021-01-20,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2021-03-03,2022-12-28,769,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Areva Pharmaceuticals, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2020-11-04,2021-02-24,136,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2014-01-22,2017-08-07,1400,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class III,2015-04-22,2016-12-30,687,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-08-14,2020-06-05,326,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-08-05,2020-12-02,160,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2020-11-25,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2021-08-25,2022-09-07,448,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2022-04-27,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2023-08-02,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-03-14,2021-01-20,1106,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-11-14,2020-09-08,683,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,SC Johnson Professional USA, OTC DRUG,TOPICAL,Telephone
Class II,2019-02-20,2023-06-09,1634,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-09-26,2020-10-01,756,Terminated,CGMP DEVIATION,CGMP/GMP Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2019-05-22,2023-04-03,1434,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2019-05-29,2020-02-25,300,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2019-07-17,2020-09-09,489,Terminated,GMP DEVIATIONS,CGMP/GMP Issues,BluePoint Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-01-29,2020-07-23,225,Terminated,CGMP DEVIATION,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2021-03-24,2021-09-21,203,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2021-11-17,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Precision Dose, OTC DRUG,ORAL,Letter
Class II,2022-05-18,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2022-09-07,2023-09-07,380,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-03-15,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2018-02-07,2020-05-07,833,Terminated,CGMP DEVIATIONS.,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-03-18,2022-08-04,988,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2022-05-11,2022-09-09,137,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2022-06-22,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2023-07-05,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Pharmadel , OTC DRUG,AURICULAR (OTIC),Letter
Class II,2016-06-29,2017-01-24,258,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-12-19,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-03-25,2020-11-06,380,Terminated,CGMP DEVIATION,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2019-12-18,2023-05-09,1254,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2020-04-22,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,Aurolife Pharma, PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-03-09,2023-05-05,437,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2022-12-21,2023-09-20,282,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Atlantic Management Resources , OTC DRUG,TOPICAL,Telephone
Class II,2020-12-09,2022-02-01,439,Terminated,LACK OF CGMP,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2021-10-06,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2022-04-20,2023-05-04,407,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2022-07-20,2023-05-23,336,Terminated,CGMP,CGMP/GMP Issues,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,INTRAMUSCULAR,Letter
Class II,2023-01-18,,,Completed,CGMP DEVIATION,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-10-10,2020-08-31,731,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Telephone
Class II,2019-02-27,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Torrent Pharmaceuticals Limited, PRESCRIPTION DRUG,ORAL,Letter
Class II,2021-09-08,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,China-Gel, OTC DRUG,TOPICAL,Letter
Class II,2021-10-27,2023-04-21,577,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Telephone
Class II,2022-04-13,2023-08-14,511,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Eon Labs, PRESCRIPTION DRUG,ORAL,Press Release
Class II,2022-04-27,2023-10-25,580,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2019-06-05,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-07-01,2023-09-07,1189,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,TIME CAP LABORATORIES, PRESCRIPTION DRUG,ORAL,Press Release
Class II,2021-08-18,2022-12-02,491,Terminated,LACK OF CGMP,CGMP/GMP Issues,Pharmaceutical Associates, PRESCRIPTION DRUG,ORAL,Letter
Class II,2015-08-05,2016-10-13,462,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-05-08,2020-05-19,393,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-06-26,2023-04-03,1393,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2022-05-25,2023-10-05,531,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Parke-Davis Div of Pfizer , PRESCRIPTION DRUG,ORAL,Press Release
Class II,2022-11-23,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2023-02-01,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,Nephron SC ., PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2023-05-31,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,BluePoint Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-06-12,2013-06-06,104,Terminated,CGMP DEVIATION,CGMP/GMP Issues,nan,nan,nan,Telephone
Class II,2017-08-16,2018-04-24,348,Terminated,GMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Visit
Class II,2020-08-26,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2022-05-04,2022-09-22,163,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2023-11-08,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Safecor Health, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-07-01,2021-10-26,510,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-09-30,2023-10-04,1126,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2020-11-25,2023-01-04,817,Terminated,GMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-12-19,2020-02-27,468,Terminated,CGMP VIOLATIONS NOTED DURING THE FIRM'S MOST RECENT INSPECTION.,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-07-17,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2022-04-13,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Greenstone , PRESCRIPTION DRUG,ORAL,Press Release
Class II,2022-08-24,2023-02-19,219,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2012-10-03,2013-03-18,290,Terminated,GMP DEVIATION,CGMP/GMP Issues,Bracco Diagnostics , PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2018-10-17,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class III,2019-08-14,2020-09-09,568,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,BluePoint Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class II,2021-01-20,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2023-04-19,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Camber Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2012-06-27,2013-06-11,403,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Other
Class II,2015-01-28,2015-11-09,774,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-09-05,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-06-26,2020-09-30,510,Terminated,GMP DEVIATIONS,CGMP/GMP Issues,American Health Packaging, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-12-16,2022-03-11,458,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,CELLTRION USA, PRESCRIPTION DRUG,"INTRAVENOUS', 'SUBCUTANEOUS",Letter
Class II,2017-06-21,2018-05-31,409,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2019-01-23,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Aurobindo Pharma Limited, PRESCRIPTION DRUG,ORAL,Press Release
Class II,2019-06-26,2020-09-09,462,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,QUALITY CHOICE (Chain Drug Marketing Association), OTC DRUG,ORAL,Letter
Class II,2020-11-11,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-11-11,2021-10-22,381,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,PD-Rx Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-02-02,2023-06-07,548,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2022-03-09,2023-02-17,367,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Macleods Pharmaceuticals Limited, PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-06-29,2023-05-24,355,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,INTRAMUSCULAR,nan
Class II,2023-06-07,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2012-12-12,2013-11-14,493,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Telephone
Class II,2021-08-18,2023-07-29,760,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2022-03-16,2022-12-02,273,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2023-04-05,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2012-11-21,2016-07-25,1363,Terminated,GMP DEFICIENCIES,CGMP/GMP Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2017-11-29,2019-04-03,569,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-08-22,2023-03-25,1711,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2021-08-11,2022-07-20,385,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2021-08-04,2022-02-08,208,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2022-05-11,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2023-06-14,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2016-03-30,2017-12-13,745,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-05-22,2020-11-25,573,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-07-17,2021-10-26,859,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Macleods Pharmaceuticals Limited, PRESCRIPTION DRUG,ORAL,Letter
Class III,2019-11-06,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-07-22,2021-12-23,534,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-08-31,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Other
Class II,2023-01-04,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2016-12-07,2017-08-14,294,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2019-02-27,2020-06-04,486,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-11-20,2021-04-26,546,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Lannett Company, PRESCRIPTION DRUG,ORAL,Press Release
Class II,2020-05-13,2020-11-19,259,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'SUBCUTANEOUS",Letter
Class II,2020-10-14,2020-12-04,584,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2021-09-29,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Pfizer Laboratories Div Pfizer , PRESCRIPTION DRUG,ORAL,Press Release
Class II,2023-07-05,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,nan
Class II,2018-11-07,2020-03-27,520,Terminated,CGMP DEVIATION,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2021-11-10,2023-01-30,475,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-02-02,,,Ongoing,CGMP DEFICIENCIES,CGMP/GMP Issues,Meda Pharmaceuticals ., PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2022-06-15,2023-11-30,596,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Nephron Pharmaceuticals Corporation, PRESCRIPTION DRUG,RESPIRATORY (INHALATION),Letter
Class II,2022-05-11,2023-05-22,417,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-03-15,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2023-05-10,,,Ongoing,CGMP DEVIATIONS.,CGMP/GMP Issues,PD-Rx Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class III,2014-12-31,2015-10-26,326,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,AmerisourceBergen Drug Corporation, OTC DRUG,OPHTHALMIC,Letter
Class II,2018-10-24,2021-03-30,970,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-08-07,2023-06-05,1424,Terminated,CGMPS DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-11-11,2021-09-22,345,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,direct rx, PRESCRIPTION DRUG,ORAL,Letter
Class III,2013-06-12,2013-12-24,280,Terminated,CGMP DEVIATION,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-08-15,2021-04-22,997,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-10-14,,,Ongoing,CMGP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2022-06-22,2023-05-25,377,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class III,2012-09-05,2012-09-18,461,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Apotex Corp., PRESCRIPTION DRUG,NASAL,Letter
Class II,2017-03-08,2018-06-29,498,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2020-09-16,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2020-08-12,2022-01-21,546,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2021-01-20,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Nostrum Laboratories ., PRESCRIPTION DRUG,ORAL,Press Release
Class II,2023-07-19,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2016-01-13,2016-12-23,604,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2018-08-29,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,Camber Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class III,2019-08-07,2023-06-06,1527,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Telephone
Class II,2023-05-03,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,Methapharm, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2023-11-22,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2014-11-12,2015-03-16,175,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2023-08-09,,,Completed,CGMP DEVIATION,CGMP/GMP Issues,Ritedose Pharmaceuticals, PRESCRIPTION DRUG,ORAL,E-Mail
Class II,2014-05-21,2014-11-14,235,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2017-06-14,2021-09-24,1619,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class III,2019-02-27,2020-10-06,601,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-03-27,2020-09-09,553,Terminated,CGMP DEVIATION,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-08-28,2021-03-10,593,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2023-03-22,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,Breckenridge Pharmaceutical, PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-06-26,2015-05-07,699,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2017-01-11,2018-02-16,428,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2019-05-08,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Torrent Pharmaceuticals Limited, PRESCRIPTION DRUG,ORAL,Press Release
Class II,2020-01-08,2022-08-03,1006,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2022-03-02,2023-09-29,703,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Wal-Mart Stores , OTC DRUG,ORAL,Letter
Class III,2013-04-03,2013-03-28,280,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Telephone
Class II,2013-08-28,2014-04-15,349,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Telephone
Class II,2021-01-20,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2022-06-01,2022-12-02,205,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,DirectRx, PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-03-20,2013-03-25,62,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class III,2016-03-23,2016-11-23,292,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Telephone
Class II,2017-03-22,2017-05-25,78,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-11-20,2021-04-15,526,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-12-02,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2022-08-17,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,GERI-CARE PHARMACEUTICAL CORP, OTC DRUG,RECTAL,Letter
Class II,2017-07-12,2018-05-31,370,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2017-08-09,2019-01-14,551,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class III,2018-01-17,2019-04-10,481,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Akorn, PRESCRIPTION DRUG,ORAL,Letter
Class II,2018-10-10,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-12-18,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Amneal Pharmaceuticals of New York , PRESCRIPTION DRUG,ORAL,Press Release
Class II,2020-11-18,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2021-05-05,2021-06-16,831,Terminated,CGMP DEVIATION,CGMP/GMP Issues,PD-Rx Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-07-01,2021-11-08,521,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,PD-Rx Pharmaceuticals, PRESCRIPTION DRUG,ORAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2022-06-01,2022-09-02,121,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2023-04-12,,,Ongoing,CGMP DEVIATIONS FOR THE MANUFACTURING FIRM,CGMP/GMP Issues,Preferred Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2016-08-31,2018-04-24,1680,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class III,2016-09-28,2017-08-07,488,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,E-Mail
Class II,2017-02-08,2021-08-26,1681,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,VistaPharm, PRESCRIPTION DRUG,ORAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2018-11-28,2023-09-25,1792,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2019-03-27,2020-09-28,585,Terminated,CGMP DEVIATION,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-07-17,2020-02-19,250,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,nan
Class II,2023-03-15,2023-06-21,117,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2015-07-29,2018-05-09,1113,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Wockhardt USA ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-05-08,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-01-22,2020-08-31,230,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,INTRAMUSCULAR,Letter
Class II,2021-02-24,2022-12-02,679,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Ascend Laboratories, PRESCRIPTION DRUG,ORAL,E-Mail
Class II,2022-03-30,2023-08-23,531,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Other
Class II,2023-03-15,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2014-03-12,2014-10-08,257,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-11-26,2014-11-24,129,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class III,2015-10-21,2016-02-19,147,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,West-Ward Pharmaceuticals Corp., PRESCRIPTION DRUG,ORAL,nan
Class III,2018-02-21,2020-05-19,832,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2018-09-05,2019-10-30,435,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2019-10-23,2020-11-10,425,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2023-04-12,2023-12-04,292,Terminated,CGMP,CGMP/GMP Issues,Wilshire Pharmaceuticals, PRESCRIPTION DRUG,INTRAMUSCULAR,Letter
Class II,2013-08-21,2014-01-07,273,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2016-05-18,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2016-09-14,2017-02-07,235,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2016-10-05,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-08-22,2018-10-12,63,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-02-06,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,Solco Healthcare US, PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-08-14,2023-06-13,1432,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,nan
Class III,2019-10-16,2020-05-19,256,Terminated,GMP DEVIATION,CGMP/GMP Issues,Actavis Pharma, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-04-15,2021-03-08,347,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class III,2016-06-29,2016-07-26,69,Terminated,CGMP DEVIATION,CGMP/GMP Issues,nan,nan,nan,Telephone
Class III,2017-09-13,2018-03-28,330,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,E-Mail
Class II,2022-02-16,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2023-07-19,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Wal-Mart Stores, OTC DRUG,OPHTHALMIC,E-Mail
Class II,2023-11-29,,,Ongoing,CGMP DEVIATION,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class III,2015-07-22,2017-03-13,647,Terminated,CGMP DEVIATION,CGMP/GMP Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2017-01-04,2020-01-08,1146,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-05-29,2020-11-16,563,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2019-11-06,2020-10-21,370,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-01-29,2021-05-19,498,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2021-07-07,2023-03-08,666,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2018-01-31,2020-05-26,868,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,MARKSANS PHARMA LIMITED, PRESCRIPTION DRUG,ORAL,Letter
Class II,2018-08-01,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Solco Healthcare US, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-09-30,,,Ongoing,GMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Telephone
Class II,2023-08-30,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Aurobindo Pharma Limited, PRESCRIPTION DRUG,ORAL,Letter
Class II,2017-11-22,2018-05-11,198,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Telephone
Class II,2019-03-20,2019-05-01,133,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Telephone
Class II,2022-08-24,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2023-04-12,2023-10-24,211,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Preferred Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-08-27,2016-05-24,650,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Fresenius Kabi USA, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2020-01-15,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2020-02-12,2023-12-05,1421,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-03-25,2023-02-03,1065,Terminated,CGMP DEVIATION,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-07-01,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2022-03-09,2023-10-16,607,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Macleods Pharmaceuticals Limited, PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-09-21,2023-06-27,299,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-01-24,2021-06-24,1288,Terminated,GMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-07-18,2019-04-03,274,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-10-17,2020-11-06,772,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-11-07,2019-04-18,191,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2020-03-25,2020-10-19,269,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2021-02-10,2023-09-07,972,Terminated,CGMP DEVIATIONS.,CGMP/GMP Issues,Taro Pharmaceuticals U.S.A., PRESCRIPTION DRUG,ORAL,Letter
Class II,2021-05-05,2022-12-02,596,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2022-02-23,2022-10-25,252,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2022-05-04,2023-05-25,405,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Actavis Pharma, PRESCRIPTION DRUG,TOPICAL,nan
Class II,2016-01-06,2017-03-08,607,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2017-06-21,2019-05-02,714,Terminated,GMP DEVIATION,CGMP/GMP Issues,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2019-10-16,2023-07-14,1390,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Sandoz , PRESCRIPTION DRUG,ORAL,Press Release
Class II,2021-06-02,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,ViiV Healthcare Company, PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-01-26,2023-08-15,582,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-05-23,2019-06-20,422,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-06-20,2019-08-13,445,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2020-07-08,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-07-22,2021-01-08,182,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Akebia Therapeutics, PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-07-19,,,Ongoing,CGMP DEVIATION,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2023-07-26,2023-12-04,147,Terminated,CGMP VIOLATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2014-08-13,2015-03-09,256,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2019-02-06,2020-04-08,455,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2020-08-19,2021-09-10,402,Terminated,CGMP DEVIATIONS.,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2023-03-15,2023-12-06,287,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2023-04-26,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-09-09,2022-02-08,553,Terminated,CGMP DEVIATION,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2020-09-23,2023-11-08,1170,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2021-12-22,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,McKesson Corporation, PRESCRIPTION DRUG,TOPICAL,Press Release
Class II,2022-03-30,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2022-05-11,2023-07-25,470,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Torrent Pharmaceuticals Limited, PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-06-08,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2023-01-25,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2023-02-15,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2016-12-07,2018-05-17,566,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-07-03,2020-09-30,506,Terminated,GMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-06-19,2020-10-06,504,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-08-14,2021-10-26,826,Terminated,GMP DEVIATIONS,CGMP/GMP Issues,Glenmark Pharmaceuticals ., PRESCRIPTION DRUG,TOPICAL,Letter
Class II,2020-09-23,2022-05-27,673,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2013-06-12,2016-09-30,1339,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2017-09-27,2018-12-04,446,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-10-14,2020-12-07,327,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2022-03-02,2023-06-22,527,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Telephone
Class II,2017-04-19,2019-06-18,806,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-01-29,2023-12-14,1437,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Telephone
Class II,2022-06-01,2022-09-21,141,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2022-09-14,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2017-07-12,2020-07-20,1138,Terminated,GMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2018-08-08,2021-04-22,1000,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Bryant Ranch Prepack, PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-12-04,2021-10-27,713,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2012-07-11,2013-12-03,666,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2016-10-19,2018-02-05,556,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2017-12-06,2019-08-09,619,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2018-08-08,2018-10-17,92,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-09-05,2020-05-07,632,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,AvPAK, PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-06-07,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-01-16,,,Completed,GMP DEVIATIONS,CGMP/GMP Issues,Allergan, PRESCRIPTION DRUG,INTRAVITREAL,Letter
Class II,2020-02-12,2020-12-10,318,Terminated,GMP DEVIATIONS,CGMP/GMP Issues,Actavis Pharma, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-12-23,2022-08-16,610,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Cipla USA ., PRESCRIPTION DRUG,"INTRAVENOUS', 'SUBCUTANEOUS","Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2021-09-29,2021-10-22,38,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2022-03-09,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2023-01-25,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Akorn, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class III,2012-11-21,2014-03-25,543,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Telephone
Class II,2015-08-26,2017-04-12,623,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-03-14,2020-09-15,939,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Telephone
Class II,2018-06-20,2023-04-07,1796,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,SDA Laboratories, OTC DRUG,ORAL,Letter
Class II,2019-07-31,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-07-17,2023-02-19,1501,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,nan
Class II,2019-07-31,2023-04-24,1376,Terminated,CGMPS DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2020-07-01,2021-12-23,560,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Press Release
Class II,2020-11-11,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Nostrum Laboratories ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2015-06-24,2018-06-05,1120,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class III,2016-06-08,2017-08-14,521,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2022-05-04,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Glenmark Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-11-02,,,Ongoing,CHEMICAL CONTAMINATION AND CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2023-11-15,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Medline Industries, OTC DRUG,TOPICAL,Letter
Class II,2018-08-15,2018-12-10,139,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-09-26,2022-09-16,1477,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-03-27,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Camber Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Press Release
Class II,2019-12-04,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2021-02-03,2023-09-29,1010,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2021-09-15,2023-09-29,1122,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2022-12-28,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2023-03-08,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,Nephron Pharmaceuticals Corporation, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS', 'SUBCUTANEOUS",Letter
Class II,2018-10-17,2019-02-21,175,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-04-10,2023-09-29,1673,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2022-06-22,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2023-06-14,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,SUBLINGUAL,Letter
Class III,2017-01-04,2018-08-21,617,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-11-13,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,"[""Dr. Reddys Laboratories Limited""]", OTC DRUG,ORAL,Letter
Class III,2020-07-15,2021-02-11,233,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-10-07,2021-11-03,406,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class III,2016-06-15,2016-10-14,135,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,FAX
Class II,2019-03-27,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2021-11-24,2023-06-26,633,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Bayer Healthcare ., OTC DRUG,TOPICAL,Press Release
Class II,2022-02-09,2023-10-16,630,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,ADVANCED FIRST AID, OTC DRUG,ORAL,Letter
Class II,2014-10-22,2018-06-04,1426,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2018-02-28,2019-12-02,661,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-11-25,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2022-03-30,2022-12-02,274,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2022-05-04,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2022-05-04,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2012-06-27,2012-12-03,203,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,AbbVie ., PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2017-07-12,2018-02-19,263,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Xttrium Laboratories, PRESCRIPTION DRUG,ORAL,Telephone
Class II,2019-10-16,2021-03-23,547,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-01-15,2020-04-24,108,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2020-10-14,2021-11-05,414,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2022-08-24,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,Nephron SC ., PRESCRIPTION DRUG,INTRAMUSCULAR,Letter
Class II,2023-03-08,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Accord Healthcare, PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-10-25,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2013-11-13,2015-07-23,678,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2015-06-03,2016-01-15,238,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2018-07-18,2020-11-06,868,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Akorn, PRESCRIPTION DRUG,INTRAVENOUS,nan
Class II,2019-04-17,2019-04-11,28,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-09-09,2022-02-22,588,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2020-09-02,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2022-05-04,2022-05-27,51,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,REMEDYREPACK INC., PRESCRIPTION DRUG,ORAL,E-Mail
Class II,2023-10-25,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2019-08-21,2020-06-25,350,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Walgreens, OTC DRUG,RECTAL,Letter
Class II,2019-11-20,,,Completed,GGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2022-07-06,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,PD-Rx Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-05-03,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Northwind Pharmaceuticals, PRESCRIPTION DRUG,ORAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2012-11-28,2013-06-11,278,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-04-22,2020-10-08,188,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-04-22,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-07-01,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Amneal Pharmaceuticals , PRESCRIPTION DRUG,ORAL,Press Release
Class II,2021-10-06,2023-06-08,631,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,American Health Packaging, PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-01-26,2023-06-21,562,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2023-05-10,,,Ongoing,CGMP DEVIATION,CGMP/GMP Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2019-08-07,2020-07-16,449,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Major Pharmaceuticals, PRESCRIPTION DRUG,ORAL,nan
Class II,2020-03-25,2020-06-10,91,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Jubilant Cadista Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-07-13,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Golden State Medical Supply, PRESCRIPTION DRUG,ORAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2022-06-01,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2023-05-31,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2018-10-24,2020-05-07,618,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-10-07,2022-08-01,697,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,CVS Pharmacy, OTC DRUG,OPHTHALMIC,Letter
Class II,2020-09-30,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-12-30,2021-09-01,266,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Akebia Therapeutics, PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-10-05,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Novartis Pharmaceuticals Corporation, PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-09-21,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,Direct Rx, PRESCRIPTION DRUG,TOPICAL,Letter
Class II,2022-11-02,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,VistaPharm, PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-04-05,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Ascend Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-08-30,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2013-05-08,2013-12-23,315,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Jubilant Cadista Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,nan
Class II,2017-05-31,2018-02-16,303,Terminated,GMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2022-09-14,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Akorn, PRESCRIPTION DRUG,TOPICAL,Letter
Class II,2023-01-11,2023-05-04,133,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2013-05-08,2013-08-07,184,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,nan
Class III,2018-04-25,2020-01-14,644,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Telephone
Class II,2020-01-22,2020-11-06,358,Terminated,CGMP VIOLATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-06-24,2021-11-08,521,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2021-10-27,2022-12-06,427,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,LEADER/ Cardinal Health 110, OTC DRUG,ORAL,Letter
Class II,2015-04-15,2017-04-10,763,Terminated,LACK OF ASSURANCE OF STERILITY. A RECENT FDA INSPECTION REPORTED GMP VIOLATIONS POTENTIALLY IMPACTING PRODUCT QUALITY AND STERILITY.,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-08-29,2019-01-18,156,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-01-16,2020-06-26,541,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-01-23,2020-07-08,548,Terminated,CGMP DEVIATION,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-10-09,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Torrent Pharmaceuticals Limited, PRESCRIPTION DRUG,ORAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2020-09-09,2022-08-23,753,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2021-09-29,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Morton Grove Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2012-08-15,2013-08-02,407,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Visit
Class II,2021-04-14,2023-07-17,844,Terminated,CGMP DEVIAITONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2022-01-12,2023-02-24,452,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2023-05-24,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2016-12-28,2019-03-11,955,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Sage Products , OTC DRUG,TOPICAL,Letter
Class II,2018-11-28,2020-09-16,684,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-03-27,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2023-08-02,2023-09-21,63,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-02-14,2020-09-21,985,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Camber Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2018-06-20,2019-07-25,409,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-07-22,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Granules Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Press Release
Class II,2018-01-03,2018-09-19,379,Terminated,LACK OF ASSURANCE OF STERILITY AND CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2018-04-18,2020-12-15,993,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-09-12,2020-05-07,659,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-04-15,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2020-12-16,2023-05-17,995,Terminated,LACK OF CGMPS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2022-07-13,2023-05-25,356,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,INTRAMUSCULAR,nan
Class II,2022-11-02,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Aurobindo Pharma Limited, PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-03-13,2013-05-02,181,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Otsuka America Pharmaceutical, PRESCRIPTION DRUG,ORAL,Telephone
Class II,2016-07-06,2017-03-31,324,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-04-18,2019-01-24,301,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-01-29,2023-10-05,1385,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-06-24,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2023-02-08,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2017-03-01,2017-04-19,82,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Telephone
Class II,2018-02-21,2019-03-14,419,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,American Health Packaging, PRESCRIPTION DRUG,ORAL,Letter
Class II,2018-12-19,2021-10-26,1093,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-07-22,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-09-30,2023-05-17,1002,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2020-09-16,2021-12-16,479,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class II,2018-02-07,2018-10-03,317,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-05-30,2018-11-06,174,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-05-30,2021-03-10,1044,Terminated,GMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-10-31,2019-02-22,134,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Lannett Company, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-10-28,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2023-02-08,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2023-04-12,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Direct Rx, PRESCRIPTION DRUG,ORAL,Letter
Class III,2014-11-12,2015-06-11,234,Terminated,CGMP DEVIATION,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2017-11-29,2019-01-14,437,Terminated,GMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2019-07-31,2022-01-06,905,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Ascend Laboratories, PRESCRIPTION DRUG,ORAL,E-Mail
Class II,2017-05-31,2019-07-01,816,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2022-05-25,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2018-08-01,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2019-04-24,2020-06-25,441,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-02-12,2021-10-29,644,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Ascend Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-07-08,2022-09-24,834,Terminated,CGMP DEVIATION,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-09-02,2021-04-26,250,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Bayshore Pharmaceuticals , PRESCRIPTION DRUG,ORAL,Letter
Class II,2021-01-27,2022-09-28,677,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2021-09-08,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2022-08-24,2023-10-05,434,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2017-09-20,2020-05-07,981,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2018-04-25,2019-01-14,287,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-01-08,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Granules India Ltd, OTC DRUG,ORAL,Letter
Class II,2020-09-09,,,Completed,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2021-09-22,2023-10-17,1159,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Telephone
Class II,2022-03-23,2022-09-13,195,Terminated,CGMP DEVIATION,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2013-05-29,2014-05-08,402,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2017-10-11,2020-04-20,971,Terminated,GMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-08-29,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class III,2020-01-22,2021-06-03,510,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2022-06-08,2023-10-20,520,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Strides Pharma Science Limited, PRESCRIPTION DRUG,ORAL,nan
Class II,2023-04-12,2023-10-19,213,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2017-10-18,2018-03-29,183,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-05-30,2019-08-14,477,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-07-31,2021-10-27,859,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,KRAMER NOVIS, OTC DRUG,ORAL,Letter
Class II,2019-11-20,2021-03-17,509,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2020-11-11,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,TIME CAP LABORATORIES, PRESCRIPTION DRUG,ORAL,Press Release
Class II,2023-02-22,2023-11-17,281,Terminated,CGMP DEVIATION,CGMP/GMP Issues,Dermal Source, OTC DRUG,TOPICAL,Letter
Class II,2018-12-19,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Mylan Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Press Release
Class II,2019-10-02,2022-08-01,1049,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Akorn, PRESCRIPTION DRUG,TOPICAL,Letter
Class II,2020-04-15,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Other
Class II,2022-09-07,2023-09-28,407,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Padagis Israel Pharmaceuticals Ltd, PRESCRIPTION DRUG,TOPICAL,Letter
Class II,2023-06-07,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2023-08-30,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2017-06-21,2017-07-12,370,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-05-02,2021-01-20,1105,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,TIME CAP LABORATORIES, PRESCRIPTION DRUG,ORAL,Letter
Class II,2018-05-30,2019-02-14,290,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2018-12-19,2023-09-11,1844,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2020-04-01,2022-04-01,756,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Nostrum Laboratories, PRESCRIPTION DRUG,ORAL,E-Mail
Class II,2022-07-06,2023-06-23,359,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Northstar Rx , PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-08-13,2016-08-04,749,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Telephone
Class II,2018-08-01,2022-10-02,1537,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,nan
Class II,2019-03-27,2023-03-30,1485,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Telephone
Class II,2020-02-12,2021-03-23,438,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2022-07-06,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Macleods Pharmaceuticals Limited, PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-09-07,,,Ongoing,CGMP DEVIATION,CGMP/GMP Issues,nan,nan,nan,Other
Class II,2022-11-23,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2017-01-11,2022-06-15,2009,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class III,2017-03-22,2017-12-27,302,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,E-Mail
Class II,2018-10-31,2018-10-29,66,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2019-05-08,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Press Release
Class II,2020-05-06,2021-09-08,511,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Amneal Pharmaceuticals , PRESCRIPTION DRUG,ORAL,Press Release
Class II,2021-06-30,2023-05-31,729,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Viona Pharmaceuticals , PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-05-11,2023-10-13,546,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Macleods Pharmaceuticals Limited, PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-08-31,2023-08-15,372,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,Letter
Class II,2023-08-30,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2016-07-06,2017-06-01,423,Terminated,CGMP DEVIATIONS,CGMP/GMP Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,E-Mail
Class II,2021-02-10,,,Ongoing,CGMP DEVIATIONS,CGMP/GMP Issues,Nostrum Laboratories ., PRESCRIPTION DRUG,ORAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2013-04-03,2014-08-04,544,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2016-06-29,2018-08-21,830,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,E-Mail
Class II,2018-06-27,2020-12-14,929,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,"[""Dr. Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class I,2014-01-29,2015-02-10,530,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2014-02-05,2017-01-26,1157,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,E-Mail
Class II,2014-01-15,2014-08-04,224,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Actavis Pharma, PRESCRIPTION DRUG,ORAL,Letter
Class II,2015-03-18,2015-10-27,235,Terminated,MICROBIAL CONTAMINATION OF A NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2018-10-03,2019-08-19,349,Terminated,CROSS CONTAMINATION WITH OTHER PRODUCTS,Contamination/Foreign Matter,Boehringer Ingelheim Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class I,2020-09-23,,,Ongoing,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class I,2022-01-05,2022-07-25,234,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Gilead Sciences, PRESCRIPTION DRUG,INTRAVENOUS,Press Release
Class II,2012-10-03,2015-05-04,955,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2012-12-26,2014-05-08,581,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,"INFILTRATION', 'PERINEURAL",Letter
Class II,2013-11-27,2014-08-27,307,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Teva Neuroscience, PRESCRIPTION DRUG,SUBCUTANEOUS,Letter
Class II,2016-01-27,2016-12-23,410,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Telephone
Class II,2016-03-02,2016-05-25,107,Terminated,MICROBIAL CONTAMINATION OF A NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class III,2018-05-23,2019-12-04,603,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,nan,nan,nan,E-Mail
Class II,2021-06-09,,,Completed,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Oxford Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2021-06-30,2022-08-22,465,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2021-09-22,2023-07-12,677,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class II,2023-03-01,,,Ongoing,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,"[""Dr. Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class I,2013-02-13,2015-07-06,957,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2014-01-08,2014-08-27,320,Terminated,PRESENCE OF PRECIPITATE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2017-09-20,2020-09-14,1119,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class III,2018-02-28,2018-12-13,303,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Nostrum Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class III,2019-11-13,2021-03-04,489,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class III,2020-08-05,2023-06-08,1067,Terminated,CROSS CONTAMINATION WITH OTHER PRODUCTS,Contamination/Foreign Matter,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class I,2021-01-06,,,Ongoing,MICROBIAL CONTAMINATION OF A NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2014-03-05,2015-01-14,363,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Sun Pharmaceutical Industries ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2016-08-03,2017-09-22,466,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2016-09-21,2018-06-08,674,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2018-05-16,2020-12-14,966,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,"[""Dr. Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class I,2019-05-15,2023-06-20,1512,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Par Pharmaceutical, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class I,2020-06-17,2023-10-16,1274,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Fresenius Kabi USA, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS","Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2023-06-21,,,Completed,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2013-04-10,2013-10-01,228,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2021-11-17,2022-11-10,392,Terminated,FAILED EXCIPIENT SPECIFICATIONS AND PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2013-05-01,2014-02-26,314,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Sandoz , PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-04-16,2014-07-30,149,Terminated,PENICILLIN CROSS CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,E-Mail
Class II,2018-05-23,2019-06-26,418,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2019-01-16,2020-08-18,607,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2021-03-10,2023-10-12,995,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Aurobindo Pharma Limited, PRESCRIPTION DRUG,ORAL,Letter
Class III,2019-10-16,2021-03-04,527,Terminated,PRESENCE OF FOREIGN TABLET,Contamination/Foreign Matter,Amneal Pharmaceuticals , PRESCRIPTION DRUG,ORAL,Letter
Class I,2023-11-29,,,Ongoing,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Exela Pharma Sciences, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class I,2014-01-22,2015-08-21,721,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class I,2014-02-12,2014-12-04,415,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,B. Braun Medical ., PRESCRIPTION DRUG,INTRAVENOUS,Press Release
Class II,2014-01-22,2014-01-17,414,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,E-Mail
Class I,2019-07-24,2022-09-20,1180,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Fresenius Kabi USA, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2021-05-19,2023-06-27,784,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class II,2021-08-25,2023-04-03,598,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Zydus Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class I,2018-02-07,2018-08-29,292,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2018-01-24,2018-02-28,280,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2019-03-20,2020-06-19,504,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2012-06-27,2012-07-05,148,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,FAX
Class II,2012-12-26,2013-05-07,946,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,FAX
Class I,2014-08-13,2015-05-29,361,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Alexion Pharmaceuticals ., PRESCRIPTION DRUG,INTRAVENOUS,Press Release
Class II,2014-10-15,2016-09-20,810,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Mylan Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,E-Mail
Class III,2016-04-27,2016-06-03,99,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2016-12-28,2017-04-06,255,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2017-11-22,2019-09-10,740,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Amneal Pharmaceuticals , PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class I,2019-03-20,2022-01-19,1279,Terminated,MICROBIAL CONTAMINATION,Contamination/Foreign Matter,King Bio ., OTC DRUG,ORAL,Press Release
Class II,2022-09-21,,,Completed,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-07-16,2017-03-16,1035,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Press Release
Class III,2015-11-18,2015-12-24,64,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Breckenridge Pharmaceutical, PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-12-28,2023-09-13,286,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,nan
Class I,2014-12-31,2016-01-04,480,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class I,2015-08-26,2016-05-20,424,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2018-01-31,2019-05-01,474,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2019-04-10,2021-01-27,684,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class III,2022-10-12,,,Ongoing,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,AuroMedics Pharma , PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2014-08-06,2015-02-05,195,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Sandoz , PRESCRIPTION DRUG,ORAL,Letter
Class I,2015-08-19,2016-06-29,469,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class III,2018-01-03,2018-10-01,293,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Akebia Therapeutics, PRESCRIPTION DRUG,ORAL,Letter
Class II,2018-06-20,2020-10-23,891,Terminated,MICROBIAL CONTAMINATION OF NONSTERILE PRODUCT,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2020-06-17,2022-01-13,594,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Roerig, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2022-01-19,2022-11-04,308,Terminated,COMPLAINT RECEIVED OF FOREIGN MATTER,Contamination/Foreign Matter,TruPharma , PRESCRIPTION DRUG,ORAL,Letter
Class II,2012-09-26,2013-06-21,372,Terminated,MICROBIAL CONTAMINATION OF NON STERILE PRODUCT,Contamination/Foreign Matter,nan,nan,nan,E-Mail
Class I,2016-07-13,,,Ongoing,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2019-04-10,2021-07-23,1236,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class III,2020-01-22,2022-08-12,948,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2020-02-19,2022-11-17,1014,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Aurobindo Pharma Limited, PRESCRIPTION DRUG,ORAL,Letter
Class I,2021-02-24,,,Ongoing,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class II,2012-06-20,2013-06-27,442,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2015-04-29,2015-10-07,327,Terminated,PENICILLIN CROSS CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2015-03-25,2016-12-30,693,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2017-08-16,2018-09-05,476,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2020-03-18,,,Ongoing,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2021-10-27,2023-04-13,560,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2013-08-21,2017-04-06,1339,Terminated,MICROBIAL CONTAMINATION OF A NON,Contamination/Foreign Matter,nan,nan,nan,Telephone
Class I,2015-02-11,2017-11-07,1299,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,"INFILTRATION', 'PERINEURAL",Press Release
Class I,2015-09-02,2016-11-02,467,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class III,2017-05-24,2021-08-24,1621,Terminated,CROSS CONTAMINATION WITH OTHER PRODUCTS,Contamination/Foreign Matter,Taro Pharmaceuticals U.S.A., PRESCRIPTION DRUG,TOPICAL,Letter
Class I,2017-05-31,,,Ongoing,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Press Release
Class I,2019-03-13,2023-02-14,1462,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Telephone
Class I,2019-04-17,,,Ongoing,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Asclemed USA, PRESCRIPTION DRUG,"EPIDURAL', 'INFILTRATION', 'INTRA-ARTICULAR', 'INTRALESIONAL', 'INTRAMUSCULAR', 'TOPICAL",Letter
Class I,2020-08-12,2023-01-27,934,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Mylan Institutional , PRESCRIPTION DRUG,INTRAVENOUS,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2020-11-25,2023-02-17,844,Terminated,PRESENCE OF FOREIGN TABLET,Contamination/Foreign Matter,Camber Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-11-13,2014-07-07,271,Terminated,CROSS CONTAMINATION WITH OTHER PRODUCTS,Contamination/Foreign Matter,Sandoz , PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-05-14,2016-04-29,854,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Telephone
Class II,2016-11-02,2017-11-29,419,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2017-01-25,2017-08-22,237,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,Padagis Israel Pharmaceuticals Ltd, PRESCRIPTION DRUG,TOPICAL,Letter
Class II,2021-04-21,2022-04-14,379,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class II,2021-08-18,2023-10-18,833,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Aurobindo Pharma Limited, PRESCRIPTION DRUG,ORAL,nan
Class II,2023-11-15,,,Ongoing,PRESENCE OF FOREIGN TABLET,Contamination/Foreign Matter,"[""Dr.Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-11-08,,,Completed,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,GlaxoSmithKline Consumer Healthcare Holdings (US) , OTC DRUG,ORAL,Letter
Class II,2012-08-08,2013-01-24,290,Terminated,ADULTERATED PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,"[""Dr.Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class II,2012-11-07,2014-08-01,683,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2014-01-29,2014-11-04,504,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,GlaxoSmithKline Consumer Healthcare Holdings (US) , OTC DRUG,ORAL,Letter
Class II,2014-03-12,2015-11-20,686,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2014-08-27,2015-07-14,550,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2014-09-10,2014-09-23,183,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,Apotex Corp, PRESCRIPTION DRUG,ORAL,Letter
Class II,2017-08-30,,,Ongoing,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class II,2019-07-03,2023-05-24,1430,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,nan
Class I,2021-03-03,,,Ongoing,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,E-Mail
Class I,2023-10-18,,,Ongoing,CROSS CONTAMINATION WITH OTHER PRODUCTS,Contamination/Foreign Matter,SCYNEXIS, PRESCRIPTION DRUG,ORAL,E-Mail
Class II,2013-02-20,2013-08-22,244,Terminated,MICROBIAL CONTAMINATION OF A NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class III,2014-06-04,2015-09-15,508,Terminated,PRESENCE OF PRECIPITATE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2017-03-29,2019-08-23,899,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2017-05-31,2017-06-01,122,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,Mylan Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,E-Mail
Class I,2017-07-19,2018-04-24,334,Terminated,PRESENCE OF FORIEGN TABLETS,Contamination/Foreign Matter,AstraZeneca Pharmaceuticals LP, PRESCRIPTION DRUG,ORAL,Press Release
Class II,2020-03-25,2023-06-02,1397,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2019-09-18,2020-11-04,432,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2020-09-02,2023-05-19,1023,Terminated,DISCOLORATION AND PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Ecolab ., OTC DRUG,TOPICAL,E-Mail
Class II,2023-08-09,,,Ongoing,LACK OF ASSURANCE OF STERILITY. VALIDATION DATA FOR DECONTAMINATION CYCLES IS LACKING.,Contamination/Foreign Matter,nan,nan,nan,Letter
Class III,2015-04-22,2016-12-30,645,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2016-06-15,2022-04-15,2313,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class I,2016-10-19,2017-03-27,255,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class I,2017-04-12,2018-04-26,457,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2021-10-13,2022-08-17,317,Terminated,MICROBIAL CONTAMINATION OF STERILE PRODUCTS,Contamination/Foreign Matter,Akorn, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class II,2013-08-21,2014-03-19,229,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,Walmart Stores ., OTC DRUG,ORAL,Letter
Class II,2014-03-05,2014-09-29,244,Terminated,PRESENCE OF FOREIGN TABLET,Contamination/Foreign Matter,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,E-Mail
Class III,2015-10-21,2017-10-27,757,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2017-04-05,2019-03-15,724,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,Mylan Institutional ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-11-06,2023-08-31,1434,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Taro Pharmaceuticals U.S.A., PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-12-02,,,Completed,PRESENCE OF FOREIGN TABLET,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2020-12-09,2022-09-08,660,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,MPM Medical , OTC DRUG,TOPICAL,Letter
Class I,2022-07-13,,,Completed,MICROBIAL CONTAMINATION OF A NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2012-07-18,2014-09-04,822,Terminated,ADULTERATED PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,ViiV Healthcare Company, PRESCRIPTION DRUG,ORAL,Letter
Class I,2013-01-30,2013-03-25,238,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,E-Mail
Class II,2013-04-24,2013-07-05,212,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Teva Neuroscience, PRESCRIPTION DRUG,SUBCUTANEOUS,Letter
Class II,2017-03-15,,,Completed,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,McKesson Corporation dba SKY Packaging, OTC DRUG,ORAL,Letter
Class III,2017-04-19,2019-09-09,927,Terminated,PRESENCE OF FOREIGN TABLET,Contamination/Foreign Matter,Rising Health, PRESCRIPTION DRUG,ORAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2018-10-31,2020-10-22,735,Terminated,PRESENCE OF PRECIPITATE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2019-04-03,2022-08-11,1282,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,Ecolab ., OTC DRUG,TOPICAL,Letter
Class II,2020-01-22,2021-06-09,540,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class I,2013-02-13,2013-11-14,331,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,Matrixx Initiatives, OTC DRUG,NASAL,Press Release
Class I,2013-09-04,2016-03-10,1020,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2013-10-09,2014-07-25,315,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2018-02-14,2020-03-17,834,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Eugia US , PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2020-03-25,2021-02-09,337,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Sun Pharmaceutical Industries ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2021-12-29,2022-12-08,471,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,EFFICIENT LABORATORIES INC, OTC DRUG,ORAL,Letter
Class I,2013-09-04,2015-05-28,1000,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2013-08-14,2015-07-20,843,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class II,2013-08-21,2014-09-18,481,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2015-02-18,2017-11-30,1037,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2018-12-05,2020-05-07,534,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2019-04-10,2023-04-27,1708,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Telephone
Class I,2020-08-19,,,Ongoing,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,E-Mail
Class III,2012-08-01,2015-11-30,1271,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2013-08-21,2015-01-23,581,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Bracco Diagnostics , PRESCRIPTION DRUG,"ORAL', 'RECTAL",Letter
Class III,2017-04-12,2017-12-15,283,Terminated,CROSS CONTAMINATION WITH ANOTHER PRODUCT,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2019-12-04,2023-05-11,1267,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Telephone
Class II,2020-04-22,2022-01-14,666,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2022-05-18,,,Completed,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2022-07-06,2022-09-26,110,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class I,2014-03-26,2015-12-18,791,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,"EPIDURAL', 'INFILTRATION', 'INTRACAUDAL', 'PERINEURAL",Letter
Class I,2013-08-14,2014-01-29,254,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class II,2018-08-15,2019-08-15,386,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Meda Pharmaceuticals ., PRESCRIPTION DRUG,NASAL,Letter
Class II,2019-04-24,2022-08-16,1243,Terminated,PRESENCE OF PARTICULATE MATTER.,Contamination/Foreign Matter,Cipla USA ., PRESCRIPTION DRUG,INTRAMUSCULAR,Letter
Class II,2019-09-25,2023-07-12,1433,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class I,2020-12-02,,,Ongoing,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2020-12-23,,,Completed,CROSS CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2022-08-17,2023-06-21,337,Terminated,PRESENCE OF FOREIGN TABLET,Contamination/Foreign Matter,Strides Pharma Science Limited, PRESCRIPTION DRUG,ORAL,Letter
Class II,2012-08-08,2015-01-16,1008,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,West-Ward Pharmaceuticals Corp, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2013-11-27,2014-10-06,377,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2018-03-07,2019-09-10,578,Terminated,PRESENCE OF FOREIGN TABLET,Contamination/Foreign Matter,AvPAK, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-08-05,2021-08-26,405,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,BluePoint Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class I,2022-03-30,2023-09-29,574,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Fresenius Kabi USA, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2013-12-11,2014-04-03,191,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2014-11-05,2015-08-12,313,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Telephone
Class II,2016-02-17,2016-02-25,196,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2019-12-18,2021-10-14,682,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2023-07-12,,,Ongoing,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Strides Pharma Science Limited, PRESCRIPTION DRUG,ORAL,Letter
Class II,2012-09-05,2013-09-18,432,Terminated,MICROBIAL CONTAMINATION OF NON STERILE PRODUCT,Contamination/Foreign Matter,nan,nan,nan,E-Mail
Class II,2014-05-28,2015-08-13,486,Terminated,CROSS CONTAMINATION WITH OTHER PRODUCTS,Contamination/Foreign Matter,Sandoz , PRESCRIPTION DRUG,ORAL,Letter
Class III,2014-05-07,2015-02-13,308,Terminated,PRESENCE OF PRECIPITATE,Contamination/Foreign Matter,nan,nan,nan,Telephone
Class II,2016-01-27,2016-10-13,370,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2016-12-28,,,Ongoing,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,"EPIDURAL', 'INFILTRATION', 'INTRACAUDAL', 'PERINEURAL",Letter
Class II,2018-04-25,2019-01-15,291,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class III,2019-05-01,2021-01-14,633,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Zydus Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2021-03-31,2022-09-28,568,Terminated,PRESENCE OF PARTICULATE MATTER.ONE CONFIRMED  CUSTOMER REPORT OF PARTICULATE MATTER WITHIN TWO SEMI,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2013-08-07,2013-08-15,59,Terminated,PRESENCE OF FORIEGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,FAX
Class II,2014-07-09,2017-04-10,1029,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2017-04-05,2018-01-26,312,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,Mylan Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Telephone
Class I,2020-07-29,,,Completed,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2022-09-21,2022-11-16,62,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class III,2013-03-13,2013-11-01,287,Terminated,PRESENCE OF PRECIPITATE,Contamination/Foreign Matter,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2013-08-21,2014-06-23,328,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2014-09-24,2016-09-21,803,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class I,2015-04-15,2017-04-14,862,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2016-01-27,2017-03-10,444,Terminated,MICROBIAL CONTAMINATION OF NON STERILE PRODUCTS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2018-12-26,2021-02-09,798,Terminated,PRESENCE OF FOREIGN TABLET,Contamination/Foreign Matter,EPIC PHARMA, PRESCRIPTION DRUG,ORAL,Letter
Class III,2020-12-02,2022-08-25,646,Terminated,CROSS CONTAMINATION WITH OTHER PRODUCTS,Contamination/Foreign Matter,Fresenius Kabi USA, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class I,2013-05-22,2014-01-06,340,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,E-Mail
Class II,2014-04-16,2015-01-21,309,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2014-05-07,2015-02-24,309,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Baxter Healthcare Corporation, PRESCRIPTION DRUG,IRRIGATION,Letter
Class I,2015-07-15,2016-01-26,278,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,"EPIDURAL', 'INFILTRATION', 'INTRACAUDAL', 'PERINEURAL","Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2022-10-26,,,Ongoing,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Eugia US , PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2015-09-16,2017-03-16,588,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2021-08-18,2023-06-08,679,Terminated,PRESENCE OF FOREIN TABLETS,Contamination/Foreign Matter,Northstar Rx , PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-12-25,2014-08-14,280,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2016-06-22,2018-09-24,871,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2017-08-23,2018-03-29,237,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Janssen Products, PRESCRIPTION DRUG,"INTRAVENOUS', 'SUBCUTANEOUS",Letter
Class II,2017-12-27,2018-12-13,400,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2020-02-19,,,Completed,CROSS CONTAMINATION,Contamination/Foreign Matter,Taro Pharmaceuticals U.S.A., PRESCRIPTION DRUG,ORAL,Letter
Class I,2020-09-02,2021-05-21,296,Terminated,CROSS CONTAMINATION WITH OTHER PRODUCT,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2021-05-26,2023-07-29,817,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS', 'SUBCUTANEOUS",Letter
Class I,2022-10-12,,,Ongoing,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Letter
Class III,2013-03-13,2014-10-09,603,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2020-02-19,2020-10-22,265,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class I,2022-03-30,2022-08-01,188,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,Blaine Labs ., OTC DRUG,TOPICAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2023-02-01,,,Completed,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Press Release
Class I,2014-03-26,2016-09-20,1037,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2014-04-30,2015-06-30,460,Terminated,PRESENCE OF PARTICULATE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2015-03-04,2015-10-23,275,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2016-08-17,2017-01-26,218,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2022-04-20,2023-06-20,448,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Teva Parenteral Medicines, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2013-03-06,2015-01-21,744,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2014-01-29,2014-10-16,308,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2015-04-01,2016-11-23,712,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Telephone
Class II,2017-02-01,2017-03-09,1024,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,nan
Class II,2019-12-04,2020-11-17,372,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Asclemed USA, PRESCRIPTION DRUG,"EPIDURAL', 'INFILTRATION', 'INTRA-ARTICULAR', 'TOPICAL",Letter
Class II,2013-02-13,2013-12-23,327,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Mylan Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2015-08-19,2017-04-19,644,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,GlaxoSmithKline Consumer Healthcare Holdings (US) , OTC DRUG,ORAL,Letter
Class II,2016-03-09,2016-11-16,285,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Baxter Healthcare Corporation, PRESCRIPTION DRUG,IRRIGATION,Letter
Class II,2016-05-11,2016-09-13,159,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2018-01-24,2018-09-12,267,Terminated,CROSS CONTAMINATION WITH OTHER PRODUCTS,Contamination/Foreign Matter,Unichem Pharmaceuticals (USA), PRESCRIPTION DRUG,ORAL,Letter
Class II,2018-05-02,2020-11-24,964,Terminated,PRESENCE OF PARTICULATE MATTER. RECALL DUE TO PRESENCE OF UNKNOWN PARTICULATE MATTER.,Contamination/Foreign Matter,nan,nan,nan,E-Mail
Class I,2018-09-19,2021-01-27,888,Terminated,MICROBIAL CONTAMINATION OF NON STERILE PRODUCTS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2014-05-07,2014-12-04,378,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,B. Braun Medical ., PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2015-08-19,2016-05-26,329,Terminated,PRESENCE OF PARTICULATE MATTER AND LACK OF ASSURANCE OF STERILITY,Contamination/Foreign Matter,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2017-08-09,2020-05-29,1078,Terminated,PRESENCE OF  FOREIGN TABLETS,Contamination/Foreign Matter,TIME CAP LABORATORIES, PRESCRIPTION DRUG,ORAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2017-11-29,2019-03-15,483,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class I,2023-10-25,,,Ongoing,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2012-10-31,2013-11-21,398,Terminated,CROSS CONTAMINATION WITH OTHER PRODUCTS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2013-11-13,2014-06-02,258,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Amgen , PRESCRIPTION DRUG,SUBCUTANEOUS,Letter
Class II,2014-12-17,2015-06-16,418,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class I,2014-10-08,2017-04-28,995,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAPERITONEAL,Letter
Class III,2016-11-30,2017-05-08,214,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2018-04-04,2020-08-03,962,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Amneal Pharmaceuticals , PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class I,2018-09-05,,,Ongoing,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2021-07-14,2022-04-04,290,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2023-07-19,,,Ongoing,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Accord Healthcare ., PRESCRIPTION DRUG,"ENDOTRACHEAL', 'INTRAMEDULLARY', 'INTRAMUSCULAR', 'INTRAVENOUS', 'SUBCUTANEOUS",Letter
Class II,2014-01-01,2014-07-10,261,Terminated,CROSS CONTAMINATION WITH OTHER PRODUCTS,Contamination/Foreign Matter,Sandoz , PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-10-22,2017-09-20,1101,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Zydus Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2015-03-04,2017-05-02,810,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Par Pharmaceutical, PRESCRIPTION DRUG,TOPICAL,Letter
Class I,2015-08-26,2016-12-01,503,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2016-01-20,2016-06-24,472,Terminated,PENICILLIN CROSS CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2018-08-08,2022-08-25,1519,Terminated,MICROBIAL CONTAMINATION OF STERILE PRODUCTS,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class II,2019-07-31,2023-08-14,1487,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2020-02-19,2020-08-18,235,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class III,2020-07-22,2022-07-28,945,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,Akorn, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class II,2022-02-23,,,Ongoing,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Telephone
Class III,2014-05-07,2015-03-28,347,Terminated,PRESENCE OF PRECIPITATE,Contamination/Foreign Matter,nan,nan,nan,Telephone
Class II,2014-05-28,2015-03-16,328,Terminated,CROSS CONTAMINATION WITH OTHER PRODUCTS,Contamination/Foreign Matter,SIGMAPHARM LABORATORIES, PRESCRIPTION DRUG,ORAL,Letter
Class I,2015-04-29,2017-01-17,728,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class II,2015-05-06,2016-10-27,563,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class II,2015-10-21,2016-08-02,315,Terminated,CROSS CONTAMINATION WITH OTHER PRODUCTS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2016-12-07,2017-06-07,217,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Ascend Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-12-18,2020-02-07,73,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2020-08-12,2023-10-16,1202,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,E-Mail
Class II,2021-09-22,2023-03-07,565,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Rhodes Pharmaceuticals L.P., PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-04-06,,,Ongoing,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Aurolife Pharma , PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-09-24,2015-07-23,322,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,"EPIDURAL', 'INFILTRATION', 'INTRACAUDAL', 'PERINEURAL",Letter
Class II,2015-05-20,2017-01-26,637,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2016-03-30,2017-09-22,570,Terminated,CROSS CONTAMINATION WITH OTHER PRODUCTS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2017-12-06,2020-09-01,1016,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Zydus Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-01-30,2020-03-03,413,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2020-02-12,2022-11-29,1036,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Biocon Pharma ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-06-26,2014-04-17,317,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Pharmacia & Upjohn Company , PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2015-06-24,2016-09-27,475,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class III,2017-07-12,2019-01-14,577,Terminated,CROSS CONTAMINATION WITH OTHER PRODUCT,Contamination/Foreign Matter,Sandoz , PRESCRIPTION DRUG,ORAL,Letter
Class II,2018-08-01,2019-03-11,242,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,INTRAMUSCULAR,Letter
Class II,2022-10-12,,,Ongoing,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2013-05-22,2014-10-09,552,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,Glenmark Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2013-05-08,2013-05-17,725,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,nan,nan,nan,FAX
Class I,2014-05-28,2017-05-10,1161,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Wyeth Pharmaceuticals , PRESCRIPTION DRUG,ORAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2014-12-10,2017-06-21,1001,Terminated,PRESENCE OF FOREIGN CAPSULES,Contamination/Foreign Matter,nan,nan,nan,Letter
Class III,2020-03-04,2022-07-28,888,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Akorn, OTC DRUG,OPHTHALMIC,Letter
Class I,2020-08-12,,,Completed,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,E-Mail
Class II,2012-10-03,2013-05-21,298,Terminated,ADULTERATED PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Mylan Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2012-12-12,2013-07-12,249,Terminated,ADULTERATED PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2013-08-14,2014-10-28,526,Terminated,PRESENCE OF PARTICULATE,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2014-06-11,2014-07-09,86,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,E-Mail
Class III,2016-11-30,2017-09-28,350,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2020-12-16,2022-09-12,664,Terminated,CROSS CONTAMINATION WITH OTHER PRODUCTS,Contamination/Foreign Matter,Fresenius Kabi USA, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2012-08-08,2012-12-18,224,Terminated,CROSS CONTAMINATION W,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2014-04-30,2016-08-31,901,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Takeda Pharmaceuticals America, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2015-01-07,2017-05-04,869,Terminated,MICROBIAL CONTAMINATION OF NON STERILE PRODUCT,Contamination/Foreign Matter,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2015-11-25,2015-11-27,158,Terminated,PENICILLIN CROSS CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Telephone
Class II,2017-11-29,2018-06-19,238,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,American Health Packaging, PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-11-20,2020-04-16,167,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,KVK-Tech, PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-12-25,2023-04-04,1232,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2023-02-08,,,Ongoing,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class II,2012-11-14,2013-11-21,622,Terminated,ADULTERATED PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,nan,nan,nan,FAX
Class II,2014-06-04,2015-02-05,259,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Sandoz , PRESCRIPTION DRUG,ORAL,Letter
Class I,2015-09-30,2017-01-27,730,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,E-Mail
Class II,2017-04-19,,,Ongoing,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Telephone
Class III,2021-01-20,2021-11-05,317,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Genus Lifesciences ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-02-22,2023-04-27,140,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2013-07-17,2014-10-28,544,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2017-04-12,2021-05-25,1530,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Takeda Pharmaceuticals America, PRESCRIPTION DRUG,SUBCUTANEOUS,Letter
Class II,2017-09-20,2020-01-06,871,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Zydus Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2020-06-10,2021-10-22,512,Terminated,PRESENCE OF FOREIGN SUBSTANCE CONSISTENT WITH GRANULES FROM DESICCANT PACKS USED DURING STORAGE,Contamination/Foreign Matter,AvKARE, PRESCRIPTION DRUG,ORAL,Letter
Class II,2016-01-27,2017-03-22,504,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2018-05-16,,,Ongoing,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Eugia US , PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class III,2019-10-23,2020-04-20,199,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2012-11-28,2014-03-06,562,Terminated,ADULTERATED PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Sun Pharmaceutical Industries ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-05-01,2014-11-03,574,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2013-09-04,2016-02-08,921,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2014-03-12,2017-02-01,1087,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,"EPIDURAL', 'INFILTRATION', 'INTRACAUDAL', 'PERINEURAL",Letter
Class III,2015-09-16,2015-11-27,108,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Golden State Medical Supply, PRESCRIPTION DRUG,ORAL,Letter
Class II,2018-01-31,2019-12-18,720,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2018-11-21,2020-10-02,700,Terminated,CROSS CONTAMINATION WITH OTHER PRODUCTS,Contamination/Foreign Matter,Sandoz ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2018-11-28,2020-09-28,692,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2018-12-05,2020-03-30,502,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Ascend Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-09-04,2023-06-20,1406,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,ROERIG, PRESCRIPTION DRUG,ORAL,Press Release
Class I,2023-05-17,,,Ongoing,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,Camber Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class III,2012-09-05,2014-01-10,532,Terminated,MICROBIAL CONTAMINATION OF A NON,Contamination/Foreign Matter,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2019-05-29,2023-11-28,1662,Terminated,CROSS CONTAMINATION WITH OTHER PRODUCTS,Contamination/Foreign Matter,Novartis Pharmaceuticals Corporation, PRESCRIPTION DRUG,ORAL,Press Release
Class II,2023-08-02,,,Ongoing,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-04-08,2021-06-30,455,Terminated,PRESENCE OF FOREIGN TABLET,Contamination/Foreign Matter,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class I,2020-09-23,2021-01-27,163,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class II,2013-02-20,2014-02-27,469,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2013-05-08,2014-06-09,479,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2013-07-17,2015-10-27,848,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Fresenius Kabi USA, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class I,2014-05-07,2014-10-07,288,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,"EPIDURAL', 'INFILTRATION', 'INTRACAUDAL', 'PERINEURAL",Press Release
Class II,2014-03-26,2017-09-26,1351,Terminated,PRESENCE OF FOREIGN MATTER,Contamination/Foreign Matter,nan,nan,nan,Telephone
Class II,2016-06-22,2016-10-20,178,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Fresenius Kabi USA, PRESCRIPTION DRUG,"INFILTRATION', 'PERINEURAL",Letter
Class II,2017-08-09,2020-01-24,921,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2018-08-22,2019-10-15,428,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class I,2020-08-05,2023-11-28,1254,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Letter
Class III,2013-09-25,2014-06-16,290,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Boehringer Ingelheim Pharmaceuticals, PRESCRIPTION DRUG,"ORAL', 'RESPIRATORY (INHALATION)",Letter
Class II,2014-02-12,2014-08-27,292,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class III,2014-03-05,2015-05-11,446,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Gilead Sciences, PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-04-30,2017-04-24,1112,Terminated,PRESENCE OF FORIEGN TABLETS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2015-08-26,2016-05-19,428,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2019-12-11,2020-06-05,206,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2022-04-13,2023-08-15,502,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Merck Sharp & Dohme , PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-01-11,,,Ongoing,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Eugia US , PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2013-05-08,2013-06-25,101,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2014-03-12,2014-10-29,267,Terminated,PRESENCE OF PRECIPITATE,Contamination/Foreign Matter,nan,nan,nan,Telephone
Class II,2015-04-29,2016-12-09,654,Terminated,PRESENCE OF PARTICULATE.,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2015-09-30,,,Ongoing,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,"INFILTRATION', 'PERINEURAL",Letter
Class I,2017-04-12,2017-10-19,258,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2017-04-12,2020-06-10,1218,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,XGen Pharmaceuticals DJB, PRESCRIPTION DRUG,INTRAVENOUS,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2017-08-16,2018-05-11,289,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Teva Parenteral Medicines, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS', 'SUBCUTANEOUS",Telephone
Class II,2018-03-07,2020-01-23,706,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,B. Braun Medical ., PRESCRIPTION DRUG,IRRIGATION,Letter
Class II,2019-02-06,2021-05-06,931,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2021-09-08,2022-12-02,487,Terminated,PRESENCE OF FOREIGN MATTER,Contamination/Foreign Matter,Macleods Pharmaceuticals Limited, PRESCRIPTION DRUG,ORAL,Letter
Class III,2013-05-29,2013-11-01,211,Terminated,PRESENCE OF PRECIPITATE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2012-09-05,2013-03-28,244,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2013-02-06,2014-01-29,397,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,Hillyard GMP, OTC DRUG,TOPICAL,E-Mail
Class II,2016-04-27,2017-12-06,638,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2017-09-27,2018-03-29,197,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Janssen Products, PRESCRIPTION DRUG,"INTRAVENOUS', 'SUBCUTANEOUS",Letter
Class II,2023-02-01,,,Ongoing,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Accord Healthcare ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2017-06-28,2020-01-24,956,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2013-07-24,2015-06-30,749,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2014-04-16,2015-12-03,657,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2015-09-02,2017-01-23,651,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,E-Mail
Class III,2015-09-23,2017-02-13,522,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2015-11-25,2016-11-16,406,Terminated,PRESENCE OF PARTICULATE MATTER.,Contamination/Foreign Matter,nan,nan,nan,Letter
Class III,2017-01-25,2018-06-01,546,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Takeda Pharmaceuticals America, PRESCRIPTION DRUG,ORAL,nan
Class III,2017-04-19,2019-08-19,908,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,Lupin Pharmaceuticals, PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2017-09-20,2018-04-25,355,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Ascend Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class I,2020-09-02,2022-09-12,782,Terminated,CROSS CONTAMINATION WITH OTHER PRODUCTS,Contamination/Foreign Matter,Fresenius Kabi USA, PRESCRIPTION DRUG,INTRAVENOUS,Press Release
Class II,2013-12-04,2014-08-04,383,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2015-02-11,2018-06-04,1252,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Taro Pharmaceuticals U.S.A., OTC DRUG,ORAL,Letter
Class II,2019-12-11,2020-11-06,372,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class III,2023-03-08,,,Ongoing,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,ScieGen Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-05-17,,,Ongoing,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class III,2023-11-29,,,Ongoing,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,NCS HealthCare of KY, PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-08-06,2016-09-15,797,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,JUBILANT CADISTA PHARMACEUTICALS INC., PRESCRIPTION DRUG,ORAL,Telephone
Class II,2015-09-16,2016-11-17,440,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2016-06-01,,,Ongoing,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2013-03-06,2013-05-24,296,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,"[""Dr. Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-01-30,2014-05-16,527,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2014-06-25,2015-08-06,465,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2018-03-07,2020-04-01,810,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,AuroMedics Pharma , PRESCRIPTION DRUG,INTRAVENOUS,Press Release
Class II,2020-02-05,2023-11-20,1740,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Telephone
Class II,2020-02-05,2020-11-06,295,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2023-03-15,,,Ongoing,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2014-05-07,2017-11-27,1382,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Telephone
Class II,2014-08-06,2014-10-21,89,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2014-10-22,2014-10-16,136,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2015-03-18,2016-07-12,505,Terminated,PRESENCE OF FORIEGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2018-08-15,,,Ongoing,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,nan
Class II,2013-04-03,2013-05-17,452,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2013-12-18,2015-12-21,865,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2014-06-11,2017-03-16,1060,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,"EPIDURAL', 'INFILTRATION', 'INTRACAUDAL', 'PERINEURAL",Press Release
Class I,2014-10-08,2016-06-29,698,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Merck Sharp & Dohme , PRESCRIPTION DRUG,INTRAVENOUS,Press Release
Class II,2016-05-25,2016-05-25,51,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2017-03-08,2018-06-29,540,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class II,2017-04-05,2018-05-31,451,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,GlaxoSmithKline Consumer Healthcare Holdings (US) , OTC DRUG,ORAL,Letter
Class II,2018-01-24,2023-01-04,1967,Terminated,MICROBIAL CONTAMINATION OF NON STERILE PRODUCT,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2018-01-17,2020-01-24,773,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class III,2018-02-28,2021-02-18,1112,Terminated,PRESENCE OF FOREIGN TABLET,Contamination/Foreign Matter,Aurobindo Pharma Limited, PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-12-18,2021-01-27,429,Terminated,CROSS CONTAMINATION WITH OTHER PRODUCTS,Contamination/Foreign Matter,nan,nan,nan,E-Mail
Class I,2022-01-19,2023-12-04,719,Completed,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,Taro Pharmaceuticals U.S.A., PRESCRIPTION DRUG,TOPICAL,Letter
Class II,2013-01-30,2014-08-04,605,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class III,2013-07-31,2013-10-17,140,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2013-10-23,2014-12-02,452,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2014-11-05,2016-07-29,721,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Merck Sharp & Dohme , PRESCRIPTION DRUG,INTRAVENOUS,Press Release
Class II,2014-07-16,2016-02-16,733,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2016-01-20,2017-01-11,440,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class III,2019-07-31,2020-04-22,279,Terminated,PRESENCE OF FOREIGN TABLET,Contamination/Foreign Matter,nan,nan,nan,Letter
Class III,2020-04-01,2021-07-07,471,Terminated,PRESENCE OF FOREIGN TABLET,Contamination/Foreign Matter,Mylan Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class I,2022-07-06,2023-04-14,309,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,Green Pharmaceuticals ., OTC DRUG,NASAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2012-12-26,2013-09-06,388,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Bracco Diagnostics , PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2013-04-17,2013-09-03,176,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2013-10-09,2014-11-10,438,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2013-12-25,2015-02-03,571,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,"EPIDURAL', 'INFILTRATION', 'INTRACAUDAL', 'PERINEURAL",Letter
Class I,2014-06-18,2016-07-22,827,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Merck Sharp & Dohme , PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class I,2018-11-14,2019-08-25,326,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class III,2018-11-28,2020-09-30,691,Terminated,CROSS CONTAMINATION WITH OTHER PRODUCTS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class III,2020-10-07,2022-11-08,775,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Legacy Pharmaceutical Packaging, PRESCRIPTION DRUG,ORAL,E-Mail
Class II,2013-11-13,2014-10-28,382,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class I,2020-12-09,2022-03-15,503,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2014-05-07,2014-12-15,306,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class III,2018-01-24,2018-03-23,91,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Camber Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-07-31,2020-03-05,233,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,Bionpharma ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-09-02,,,Ongoing,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Aurobindo Pharma Limited, PRESCRIPTION DRUG,ORAL,Letter
Class I,2021-10-06,2022-02-18,162,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2023-11-15,,,Ongoing,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2012-12-05,2014-04-28,535,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Sun Pharmaceutical Industries ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-02-13,2014-12-18,741,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2017-09-06,2018-09-13,399,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Morton Grove Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2018-01-17,2020-05-11,957,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2018-02-14,2019-09-10,616,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Eugia US , PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2018-09-26,2022-03-01,1274,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,"[""Dr. Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-04-17,2020-09-14,539,Terminated,PRESENCE OF  FOREIGN TABLET,Contamination/Foreign Matter,Glenmark Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-01-22,2023-11-20,1775,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Telephone
Class I,2021-02-03,2023-06-09,898,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Fresenius Kabi USA, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class I,2022-08-03,,,Completed,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2013-03-20,2014-04-03,435,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class III,2013-05-15,2013-07-01,874,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,FAX
Class II,2015-09-09,2016-05-31,404,Terminated,PENICILLIN CROSS CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2012-08-15,2013-04-11,328,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Teva Neuroscience, PRESCRIPTION DRUG,SUBCUTANEOUS,Letter
Class II,2016-03-09,2017-03-02,380,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Genzyme Corporation, PRESCRIPTION DRUG,INTRAMUSCULAR,Telephone
Class II,2018-05-23,2019-02-28,315,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class II,2018-06-13,2022-09-28,1581,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class I,2021-07-28,2022-12-02,584,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class II,2014-03-26,2014-09-18,191,Terminated,PRESENCE OF PARTICULATE MATTER PERRIGO IS RECALLING SEVEN LOTS OF CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION 75MG,Contamination/Foreign Matter,Padagis US , PRESCRIPTION DRUG,ORAL,Letter
Class I,2014-10-22,2017-03-17,962,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,"EPIDURAL', 'INFILTRATION', 'INTRACAUDAL', 'PERINEURAL",Press Release
Class II,2015-10-14,2016-05-04,264,Terminated,PRESENCE OF FOREIGN TABLET,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2016-11-30,2021-09-24,1780,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,VistaPharm, PRESCRIPTION DRUG,ORAL,E-Mail
Class II,2019-08-07,2023-06-09,1430,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,Wal-Mart Stores , OTC DRUG,ORAL,Letter
Class II,2019-10-16,2023-05-31,1343,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,EPIC PHARMA, PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-02-23,2023-07-17,525,Terminated,FOREIGN MATTER IDENTIFIED AS STAINLESS STEEL MICROSCOPIC WEAR PARTICLES MIXED WITH PUNCH LUBRICANT OIL AND SILICONE PARTICLES FROM THE DUST CUP,Contamination/Foreign Matter,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class II,2012-08-08,2013-12-17,643,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,E-Mail
Class II,2014-07-16,2016-05-24,753,Terminated,PRESENCE OF PARTICULAR MATTER,Contamination/Foreign Matter,Fresenius Kabi USA, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2016-12-07,2017-06-29,293,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,E-Mail
Class II,2018-03-07,2019-09-10,573,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2019-11-13,2022-01-20,818,Terminated,PRESENCE OF PARTICULATE MATTER.,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2021-03-10,2021-08-26,192,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,Teva Parenteral Medicines, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2023-11-01,,,Ongoing,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class I,2023-12-06,,,Ongoing,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,Bayer HealthCare Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2015-01-14,2017-05-01,889,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2015-02-04,2015-07-30,219,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class I,2015-07-15,2016-11-04,556,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class III,2016-10-12,2019-03-08,917,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Takeda Pharmaceuticals America, PRESCRIPTION DRUG,ORAL,Letter
Class II,2017-05-17,2018-02-02,284,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2017-08-23,2019-03-11,593,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class II,2020-02-19,,,Ongoing,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Major Pharmaceuticals, OTC DRUG,ORAL,Letter
Class I,2022-01-26,2022-11-15,329,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class III,2012-07-18,2013-04-11,283,Terminated,ADULTERATED PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,AstraZeneca Pharmaceuticals LP, PRESCRIPTION DRUG,ORAL,Letter
Class I,2014-05-28,2015-06-29,500,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2014-10-29,2014-11-06,168,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2018-02-14,2019-06-24,551,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Eugia US , PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2018-04-25,2019-04-08,367,Terminated,CROSS CONTAMINATION WITH OTHER PRODUCTS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2021-01-06,2023-06-20,915,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Fresenius Kabi USA, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class I,2022-09-21,,,Ongoing,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,TOPCO ASSOC, OTC DRUG,ORAL,Press Release
Class II,2013-07-31,2015-06-04,707,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS', 'SUBCUTANEOUS",Letter
Class II,2014-02-12,2014-01-31,268,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2017-03-29,2018-04-23,404,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,INTRAMUSCULAR,Letter
Class II,2019-02-06,2022-06-15,1346,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Akorn, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class II,2019-05-08,2022-09-17,1241,Terminated,PRESENCE OF PRECIPITATE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class III,2023-09-06,,,Ongoing,CROSS CONTAMINATION WITH OTHER PRODUCTS,Contamination/Foreign Matter,Lundbeck Pharmaceuticals , PRESCRIPTION DRUG,ORAL,Letter
Class I,2023-10-25,,,Ongoing,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,VistaPharm, PRESCRIPTION DRUG,ORAL,Letter
Class II,2012-10-03,2013-08-08,344,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2013-08-14,2016-05-18,1035,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,GlaxoSmithKline Consumer Healthcare Holdings (US) , OTC DRUG,ORAL,Letter
Class I,2014-03-26,2016-09-21,1035,Terminated,PRESENCE OF PATICULATE MATTER,Contamination/Foreign Matter,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class I,2014-06-18,2017-05-10,1161,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2015-08-19,2016-06-29,433,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class II,2012-07-25,2017-04-11,1813,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2012-10-31,2014-10-07,763,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,E-Mail
Class II,2012-11-28,2012-11-28,68,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2013-09-18,2014-09-18,400,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2015-12-09,2018-06-11,1099,Terminated,PENICILLIN CROSS CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Telephone
Class II,2015-09-02,2018-10-19,1177,Terminated,PRESENCE OF FOREIGN TABLET,Contamination/Foreign Matter,Unichem Pharmaceuticals (USA), PRESCRIPTION DRUG,ORAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2018-07-18,2022-01-26,1316,Terminated,MICROBAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class II,2019-11-27,2020-11-17,379,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Actavis Pharma, PRESCRIPTION DRUG,ORAL,Letter
Class I,2021-11-10,2023-07-25,644,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Merck Sharp & Dohme , PRESCRIPTION DRUG,INTRAVENOUS,Press Release
Class II,2014-02-12,2014-06-09,199,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,Sheffield Pharmaceuticals , OTC DRUG,TOPICAL,Letter
Class III,2014-04-09,2014-08-21,191,Terminated,CROSS CONTAMINATION WITH OTHER PRODUCTS,Contamination/Foreign Matter,ViiV Healthcare Company, PRESCRIPTION DRUG,ORAL,Letter
Class I,2014-09-24,2015-05-29,382,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2015-02-25,2015-12-29,439,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,"INFILTRATION', 'PERINEURAL",Letter
Class II,2016-02-17,2017-08-22,650,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2017-03-15,2019-03-15,777,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Mylan Institutional ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-11-09,2023-09-07,324,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,SUBLINGUAL,Letter
Class II,2014-08-13,2017-04-27,1002,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2015-11-18,2016-05-19,436,Terminated,RECALLED PRODUCTS WERE MADE USING AN ACTIVE INGREDIENT THAT WAS RECALLED BY A SUPPLIER DUE TO PENICILLIN CROSS CONTAMINATION.,Contamination/Foreign Matter,nan,nan,nan,Telephone
Class III,2015-09-16,2017-06-13,712,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,nan,nan,nan,E-Mail
Class III,2019-11-06,,,Completed,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Apotex Corp., PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-01-25,,,Ongoing,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Ascend Laboratories, PRESCRIPTION DRUG,ORAL,E-Mail
Class III,2012-06-20,2013-06-21,410,Terminated,ADULTERATED PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2014-01-29,2016-01-07,798,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Fresenius Kabi USA, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2017-12-06,2020-09-03,1057,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Camber Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class I,2018-07-18,,,Ongoing,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Eugia US , PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class I,2020-05-20,2023-09-07,1241,Terminated,CROSS CONTAMINATION WITH OTHER PRODUCTS,Contamination/Foreign Matter,nan,nan,nan,Telephone
Class II,2013-02-13,2015-03-18,833,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2013-04-24,,,Ongoing,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,Pfizer Laboratories Div Pfizer , PRESCRIPTION DRUG,ORAL,Letter
Class II,2017-12-27,2018-10-18,307,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,B. Braun Medical ., PRESCRIPTION DRUG,IRRIGATION,Letter
Class II,2020-11-18,2023-05-22,957,Terminated,PRESENCE OF PARTICULATE MATTER IN SOLUTION,Contamination/Foreign Matter,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRASPINAL,Letter
Class II,2023-02-01,2023-04-14,88,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2023-10-25,,,Ongoing,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,KVK-TECH, PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-07-31,2014-06-23,403,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2016-02-17,2020-08-31,1712,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2016-07-27,2018-03-06,670,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,E-Mail
Class I,2018-06-13,2020-03-27,662,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS', 'SUBCUTANEOUS",Press Release
Class II,2019-08-21,2020-09-14,425,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class I,2022-11-16,,,Ongoing,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Mylan Institutional , PRESCRIPTION DRUG,"INTRAVENOUS', 'SUBCUTANEOUS",Letter
Class I,2014-04-23,2014-11-04,414,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,"INFILTRATION', 'PERINEURAL",Letter
Class II,2014-08-13,2014-11-06,92,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2014-08-27,2015-06-10,310,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2014-10-08,2016-06-22,646,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,AbbVie ., PRESCRIPTION DRUG,ORAL,Letter
Class I,2018-05-23,2023-06-21,1877,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Eugia US , PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2018-06-20,2022-10-18,1610,Terminated,MICROBIAL CONTAMINATION OF A NON,Contamination/Foreign Matter,Medline Industries, OTC DRUG,TOPICAL,Letter
Class II,2012-10-31,2013-03-27,232,Terminated,CROSS CONTAMINATION W,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2014-09-10,2016-02-08,530,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,Sage Products , OTC DRUG,TOPICAL,Letter
Class II,2017-03-29,2019-11-05,974,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Zydus Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2017-12-20,2018-05-30,407,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-03-13,2020-05-08,443,Terminated,CROSS CONTAMINATION,Contamination/Foreign Matter,Discount Drug Mart, OTC DRUG,TOPICAL,Letter
Class I,2021-04-21,2023-10-16,931,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,Spartan Chemical Company, OTC DRUG,TOPICAL,Letter
Class II,2023-05-03,2023-12-13,238,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Ferring Pharmaceuticals ., PRESCRIPTION DRUG,SUBCUTANEOUS,nan
Class I,2015-07-15,2017-02-07,686,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2019-02-27,2021-04-12,1978,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,E-Mail
Class II,2021-06-30,2022-09-28,495,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Royal Pharmaceuticals, PRESCRIPTION DRUG,AURICULAR (OTIC),Letter
Class I,2021-09-29,2022-03-11,196,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2022-09-21,,,Ongoing,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Press Release
Class I,2012-10-03,2014-02-03,587,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2014-07-02,2016-09-20,888,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Wyeth Pharmaceuticals , PRESCRIPTION DRUG,ORAL,Letter
Class III,2018-10-03,2018-11-29,78,Terminated,PRESENCE OF FOREIGN TABLET,Contamination/Foreign Matter,Camber Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class I,2021-07-21,2022-01-19,315,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2013-01-30,2014-07-09,586,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2013-04-03,2014-10-08,590,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2013-08-14,2015-01-29,587,Terminated,PRESENCE OF PRECIPITATE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2014-10-08,2017-04-03,1021,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,"EPIDURAL', 'INFILTRATION', 'INTRACAUDAL', 'PERINEURAL",Press Release
Class I,2015-05-13,2016-06-09,462,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2018-12-05,2019-04-01,145,Terminated,CROSS CONTAMINATION WITH OTHER PRODUCTS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2019-11-13,2020-12-10,414,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2012-08-08,2013-09-19,507,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class III,2013-07-31,2014-06-17,334,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2014-02-12,2014-09-15,301,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Baxter Healthcare Company, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2018-11-14,2020-09-04,718,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,Medline Industries, OTC DRUG,DENTAL,Letter
Class I,2020-09-02,2021-04-09,289,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2014-08-27,2015-05-29,422,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2015-09-02,2017-03-21,586,Terminated,PENICILLIN CROSS CONTAMINATION AND PRESENCE OF FOREIGN SUBSTANCE.  PRODUCT WAS CONTAMINATED WITH PENICILLIN AND FOREIGN SUBSTANCES DURING MANUFACTURING PROCESS.,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2015-09-30,2017-04-19,604,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Allergan, OTC DRUG,OPHTHALMIC,nan
Class III,2017-06-14,2017-12-13,230,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Camber Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class I,2017-12-27,2018-11-08,435,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Press Release
Class I,2020-08-12,2022-01-19,644,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Telephone
Class II,2023-10-11,,,Ongoing,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,AuroMedics Pharma , PRESCRIPTION DRUG,"INTRA-ARTICULAR', 'INTRAMUSCULAR', 'SOFT TISSUE",nan
Class I,2016-06-01,2017-02-07,335,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2018-08-22,2019-01-18,177,Terminated,MICROBIAL CONTAMINATION OF A NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2020-09-30,,,Ongoing,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class II,2012-09-05,2014-05-06,641,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2014-10-15,2016-10-11,755,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class III,2015-09-16,2016-10-13,455,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class I,2016-06-01,2018-02-26,767,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2018-02-21,2018-12-13,478,Terminated,CROSS CONTAMINATION WITH OTHER PRODUCTS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2018-07-25,2019-11-05,490,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class III,2019-04-17,2020-11-06,591,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Telephone
Class I,2019-12-25,2020-07-13,220,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2021-03-03,2022-09-29,814,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,CareFusion 213 , OTC DRUG,TOPICAL,Letter
Class III,2021-06-02,2023-02-17,659,Terminated,PRESENCE OF FOREIGN TABLET,Contamination/Foreign Matter,Ascend Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-01-09,2014-10-15,720,Terminated,PRESENCE OF PARTICULATES,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2014-05-28,2016-02-26,659,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Zydus Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2014-10-15,2015-05-11,223,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Gilead Sciences, PRESCRIPTION DRUG,ORAL,Letter
Class II,2016-07-27,2017-08-09,387,Terminated,PENICILLIN CROSS CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2017-03-08,2017-07-20,182,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,nan,nan,nan,E-Mail
Class II,2017-07-19,2019-03-15,640,Terminated,MICROBIAL CONTAMINATION OF NON STERILE PRODUCTS,Contamination/Foreign Matter,nan,nan,nan,E-Mail
Class II,2022-06-15,2023-06-08,380,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,Walgreen Company, OTC DRUG,AURICULAR (OTIC),Letter
Class II,2014-01-01,2016-03-02,831,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,FAX
Class II,2017-03-15,2017-07-12,174,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Mylan Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,E-Mail
Class II,2017-08-09,2019-04-03,646,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,VistaPharm, PRESCRIPTION DRUG,ORAL,Letter
Class III,2020-06-03,2022-11-15,903,Terminated,PRESENCE OF FOREIGN SUBSTANCE VISUALLY CONSISTENT WITH THE SILICA GRANULES PRESENT IN THE DESICCANT PACKS UTILIZED DURING STORAGE OF THE PRODUCT.,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2022-07-27,,,Completed,CROSS CONTAMINATION WITH OTHER PRODUCTS,Contamination/Foreign Matter,Better Living Brands , OTC DRUG,TOPICAL,Letter
Class II,2022-10-05,2023-10-31,405,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Mylan Institutional , PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2012-06-20,2018-06-28,2662,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class II,2012-07-18,2013-04-09,299,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2012-10-31,2012-10-30,628,Terminated,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2013-01-23,2014-01-06,385,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2013-03-20,2017-01-26,1470,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2017-07-12,2020-02-07,954,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,GlaxoSmithKline Consumer Healthcare Holdings (US) , OTC DRUG,DENTAL,Letter
Class I,2019-01-16,2021-11-03,1035,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2019-07-31,2020-09-09,418,Terminated,PRESENCE OF FOREIGN TABLETS,Contamination/Foreign Matter,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class III,2013-02-27,2014-06-03,496,Terminated,CROSS CONTAMINATION WITH OTHER PRODUCTS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2014-08-27,2015-06-29,413,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class I,2018-09-19,2020-06-02,645,Terminated,PRESENCE OF PRECIPITATE,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2019-10-16,2021-02-05,506,Terminated,MICROBIAL CONTAMINATION OF NON,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2021-04-14,,,Ongoing,CROSS CONTAMINATION WITH OTHER PRODUCT,Contamination/Foreign Matter,Apotex Corp., PRESCRIPTION DRUG,ORAL,Press Release
Class II,2012-11-07,2013-08-30,421,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2014-02-05,2015-03-02,483,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Alexion Pharmaceuticals ., PRESCRIPTION DRUG,INTRAVENOUS,E-Mail
Class II,2014-01-01,2014-01-13,58,Terminated,MICROBIAL CONTAMINATION OF NON STERILE PRODUCTS,Contamination/Foreign Matter,nan,nan,nan,Letter
Class III,2017-11-01,2020-09-10,1086,Terminated,CROSS CONTAMINATION WITH OTHER PRODUCTS,Contamination/Foreign Matter,Taro Pharmaceuticals U.S.A., PRESCRIPTION DRUG,TOPICAL,Letter
Class I,2020-05-27,2021-11-10,551,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class II,2021-09-29,2023-10-31,782,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Aurobindo Pharma Limited, PRESCRIPTION DRUG,ORAL,Letter
Class I,2022-02-16,,,Ongoing,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,Eugia US , PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRATHECAL', 'INTRAVENOUS', 'OPHTHALMIC",Letter
Class III,2022-05-18,2023-09-25,514,Terminated,PRESENCE OF FOREIGN SUBSTANCE,Contamination/Foreign Matter,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class II,2012-08-08,2013-11-04,468,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2020-03-25,2021-05-26,443,Terminated,PRESENCE OF PARTICULATE MATTER. PRESENCE OF METAL PARTICLES.,Contamination/Foreign Matter,nan,nan,nan,Letter
Class III,2020-07-01,2021-01-13,265,Terminated,PRESENCE OF PARTICULATE MATTER,Contamination/Foreign Matter,nan,nan,nan,Letter
Class II,2020-07-01,2022-12-21,922,Terminated,PRESENCE OF FOREIGN TABLET,Contamination/Foreign Matter,Aurobindo Pharma Limited, PRESCRIPTION DRUG,ORAL,Letter
Class I,2022-05-11,,,Ongoing,CHEMICAL CONTAMINATION,Contamination/Foreign Matter,nan,nan,nan,Press Release
Class III,2012-07-18,2013-02-01,210,Terminated,IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2014-02-05,2016-05-09,903,Terminated,FAILED IMPURITIES,Impurity Issues,E. Fougera & Co. a division of Fougera Pharmaceuticals ., PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2023-08-23,,,Ongoing,FAILED IMPURITIES,Impurity Issues,Alembic Pharmaceuticals ., PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class II,2023-01-18,2023-03-03,73,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2017-03-22,2018-02-16,374,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2023-04-12,2023-08-23,149,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2013-08-07,2015-11-30,927,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2015-08-12,2016-08-17,420,Terminated,FAILED IMPURITIES,Impurity Issues,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class II,2017-02-22,2018-02-06,369,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2016-01-20,2016-11-01,355,Terminated,FAILED IMPURITIES,Impurity Issues,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class III,2017-04-19,2017-04-17,374,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,E-Mail
Class II,2021-03-31,2021-07-28,131,Terminated,FAILED IMPURITIES,Impurity Issues,Golden State Medical Supply, PRESCRIPTION DRUG,ORAL,Letter
Class II,2015-03-25,2016-07-15,493,Terminated,FAILED IMPURITIES,Impurity Issues,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class III,2018-09-26,2022-10-14,1513,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2021-11-24,2023-02-27,487,Terminated,FAILED IMPURITIES,Impurity Issues,Actavis Pharma, PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class III,2022-06-15,,,Ongoing,FAILED IMPURITIES,Impurity Issues,Novartis Pharmaceuticals Corporation, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class II,2022-12-28,,,Ongoing,FAILED IMPURITIES,Impurity Issues,Aurolife Pharma , PRESCRIPTION DRUG,ORAL,nan
Class III,2016-03-02,2020-12-18,1800,Terminated,FAILED IMPURITIES,Impurity Issues,Zydus Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-09-25,2022-06-15,1010,Terminated,FAILED IMPURITIES,Impurity Issues,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2021-12-29,2023-07-16,712,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2012-09-26,2013-04-10,210,Terminated,IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2014-08-06,2015-06-03,349,Terminated,FAILED IMPURITIES,Impurity Issues,Roerig, PRESCRIPTION DRUG,ORAL,Letter
Class III,2017-05-03,2020-02-05,1050,Terminated,FAILED IMPURITIES,Impurity Issues,Sandoz , PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class III,2018-08-22,2020-04-15,622,Terminated,FAILED IMPURITIES,Impurity Issues,"[""Dr. Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-09-25,2022-08-16,1089,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2016-06-29,2017-08-17,472,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2017-11-29,2020-04-01,877,Terminated,FAILED IMPURITIES,Impurity Issues,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2018-03-21,2020-04-15,772,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2018-10-31,2022-11-08,1495,Terminated,FAILED IMPURITIES,Impurity Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2015-03-11,2017-07-29,884,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2015-11-25,2017-04-20,542,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2019-03-06,2020-06-22,482,Terminated,FAILED IMPURITIES,Impurity Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class II,2020-06-10,2023-06-01,1112,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2020-12-09,2023-06-20,951,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2023-01-04,,,Completed,FAILED IMPURITIES,Impurity Issues,AvPAK, PRESCRIPTION DRUG,ORAL,Letter
Class II,2018-11-21,2020-11-03,746,Terminated,FAILED IMPURITIES,Impurity Issues,Publix Super Markets , OTC DRUG,ORAL,Letter
Class II,2019-06-19,,,Ongoing,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2020-12-30,2022-09-24,654,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2013-08-28,2014-08-04,396,Terminated,FAILED IMPURITES,Impurity Issues,VistaPharm, PRESCRIPTION DRUG,ORAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2015-12-16,2016-06-07,195,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,E-Mail
Class III,2018-02-14,2018-09-05,219,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2019-11-20,2020-11-09,390,Terminated,FAILED IMPURITIES,Impurity Issues,Amneal Pharmaceuticals NY , PRESCRIPTION DRUG,ORAL,Letter
Class III,2022-09-07,,,Ongoing,IDENTIFICATION OF AN UNKNOWN IMPURITY AT THE 12,Impurity Issues,Akorn, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class III,2012-07-25,2013-12-09,521,Terminated,IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2013-07-17,2015-05-11,720,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2016-07-13,2017-04-07,308,Terminated,FAILED IMPURITIES,Impurity Issues,"[""Dr. Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class III,2017-07-12,2017-12-06,202,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Telephone
Class III,2015-04-15,2015-10-09,212,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,E-Mail
Class III,2019-04-24,2020-01-10,283,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,E-Mail
Class II,2020-09-02,2021-06-07,301,Terminated,FAILED IMPURITY,Impurity Issues,nan,nan,nan,Letter
Class II,2022-08-17,2023-09-14,430,Terminated,FAILED IMPURITIES,Impurity Issues,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2014-07-02,2014-12-09,222,Terminated,FAILED IMPURITIES,Impurity Issues,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class III,2017-10-18,2019-03-15,528,Terminated,FAILED IMPURITIES,Impurity Issues,Dr.Reddys Laboratories Limited, OTC DRUG,ORAL,Letter
Class III,2023-04-19,2023-10-31,216,Terminated,FAILED IMPURITIES,Impurity Issues,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,INTRAVENOUS,E-Mail
Class III,2014-07-23,2016-07-26,754,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2016-03-23,2017-01-13,343,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2017-02-01,2017-09-17,244,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2018-09-12,2020-11-06,805,Terminated,FAILED IMPURITIES,Impurity Issues,Akorn, PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-03-09,2023-10-04,594,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2016-02-10,2016-12-21,328,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2019-05-01,2022-07-28,1192,Terminated,FAILED IMPURITIES,Impurity Issues,Akorn, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2019-10-16,2023-03-09,1249,Terminated,FAILED IMPURITIES,Impurity Issues,Mylan Institutional , PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2020-08-19,2022-01-21,549,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2021-05-26,2022-10-05,526,Terminated,FAILED IMPURITIES,Impurity Issues,KVK-Tech, PRESCRIPTION DRUG,ORAL,Letter
Class II,2021-09-01,2022-09-26,409,Terminated,FAILED IMPURITIES SPECIFICATIONS,Impurity Issues,Sigmapharm Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class II,2015-04-15,2017-05-15,782,Terminated,FAILED IMPURITIES,Impurity Issues,Heritage Pharmaceuticals . d/b/a Avet Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2018-01-31,2018-06-14,223,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2018-05-16,2020-12-14,976,Terminated,FAILED IMPURITIES,Impurity Issues,Septodont, PRESCRIPTION DRUG,SUBMUCOSAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2018-09-26,2020-10-22,777,Terminated,FAILED IMPURITIES,Impurity Issues,CIPLA USA INC., PRESCRIPTION DRUG,ORAL,Letter
Class III,2020-02-26,2023-03-08,1125,Terminated,FAILED IMPURITIES,Impurity Issues,AuroMedics Pharma , PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2022-11-23,2023-08-18,281,Terminated,FAILED IMPURITIES,Impurity Issues,Par Pharmaceutical, PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-08-07,2014-05-15,365,Terminated,FAILED IMPURITY,Impurity Issues,nan,nan,nan,Letter
Class III,2023-09-13,,,Ongoing,FAILED IMPURITIES,Impurity Issues,Ascend Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class III,2016-11-16,2018-08-28,699,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2019-01-30,2023-02-17,1494,Terminated,FAILED IMPURITIES,Impurity Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2020-11-11,2022-08-22,693,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2014-05-28,2014-11-20,227,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2016-04-13,2017-05-08,508,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2017-11-01,2019-02-27,554,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2021-10-06,2022-09-26,370,Terminated,FAILED IMPURITIES,Impurity Issues,Sigmapharm Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-02-08,2023-10-27,287,Terminated,FAILED IMPURITY,Impurity Issues,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class III,2021-09-22,2022-04-28,227,Terminated,FAILED IMPURITIES,Impurity Issues,Mylan Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2013-04-10,2015-12-10,1240,Terminated,FAILED IMPURITIES,Impurity Issues,E. Fougera & Co. a division of Fougera Pharmaceuticals ., PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2016-01-13,2016-12-19,416,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2022-03-23,2023-07-16,507,Terminated,FAILED IMPURITIES,Impurity Issues,Major Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class III,2015-03-18,2018-04-25,1238,Terminated,FAILED IMPURITIES,Impurity Issues,Micro Labs Limited, PRESCRIPTION DRUG,ORAL,E-Mail
Class III,2016-10-26,2017-05-05,225,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2018-10-03,2020-03-03,538,Terminated,FAILED IMPURITIES,Impurity Issues,"[""Dr.Reddys Laboratories ""]", PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2023-05-03,,,Ongoing,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2022-01-12,2022-04-14,106,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2012-12-26,2013-12-04,356,Terminated,IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2017-03-01,2022-06-15,1958,Terminated,FAILED IMPURITIES,Impurity Issues,Apotex Corp., PRESCRIPTION DRUG,ORAL,Letter
Class III,2018-03-28,2020-08-31,906,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2018-09-19,2019-12-06,456,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2019-04-17,2020-07-01,457,Terminated,FAILED IMPURITIES,Impurity Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-01-15,2023-08-09,1339,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Telephone
Class II,2021-04-14,2023-06-06,813,Terminated,FAILED IMPURITIES,Impurity Issues,FERRING PHARMACEUTICALS INC., PRESCRIPTION DRUG,SUBCUTANEOUS,Letter
Class III,2012-10-17,2013-06-27,317,Terminated,IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2013-03-27,2014-01-31,357,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2013-07-17,2014-01-15,306,Terminated,FAILED IMPURITY,Impurity Issues,nan,nan,nan,Letter
Class III,2015-01-14,2016-02-01,406,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2019-06-26,2021-01-08,583,Terminated,TESTING OF FEXOFENADINE HCL AND PSEUDOEPHEDRINE FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2020-05-27,2020-08-31,109,Terminated,FAILED IMPURITIES,Impurity Issues,Exelan Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2013-06-19,2014-04-09,310,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2014-10-01,2015-05-21,289,Terminated,FAILED IMPURITY,Impurity Issues,Akorn, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2017-02-08,2018-06-22,553,Terminated,FAILED IMPURITIES,Impurity Issues,Fresenius Kabi USA, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class III,2022-06-15,2023-12-08,569,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2022-08-24,,,Ongoing,FAILED IMPURITIES,Impurity Issues,Zydus Pharmaceuticals USA ., PRESCRIPTION DRUG,INTRAMUSCULAR,Letter
Class II,2023-03-22,2023-11-28,278,Terminated,FAILED IMPURITIES SPECIFICATION,Impurity Issues,Prestige Brands Holdings, OTC DRUG,OPHTHALMIC,Letter
Class III,2017-04-19,2019-05-01,776,Terminated,FAILED IMPURITIES,Impurity Issues,Allergan, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class III,2018-04-18,2021-01-20,1052,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2018-06-27,2019-11-08,514,Terminated,FAILED IMPURITIES,Impurity Issues,"[""Dr. Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class III,2020-03-04,2020-08-31,189,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2023-05-24,2023-12-12,215,Terminated,FAILED IMPURITIES,Impurity Issues,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class III,2015-12-30,2016-03-22,176,Terminated,FAILED IMPURITY,Impurity Issues,United Natural Foods, OTC DRUG,ORAL,Letter
Class III,2018-12-26,2020-11-25,726,Terminated,FAILED IMPURITIES,Impurity Issues,VistaPharm, PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-08-21,2020-09-30,579,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2013-02-06,2015-06-16,907,Terminated,FAILED IMPURITY,Impurity Issues,nan,nan,nan,Letter
Class III,2013-06-05,2014-01-15,307,Terminated,FAILED IMPURITY,Impurity Issues,nan,nan,nan,Letter
Class III,2017-06-07,2020-01-13,971,Terminated,FAILED IMPURITIES,Impurity Issues,VistaPharm, PRESCRIPTION DRUG,ORAL,Letter
Class III,2020-10-14,2022-02-22,531,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2022-04-27,2023-05-23,411,Terminated,FAILED IMPURITIES,Impurity Issues,Mylan Institutional , PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2014-01-22,2014-11-04,538,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2018-07-18,2020-04-13,664,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,nan
Class II,2020-02-26,2021-02-19,388,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2023-02-15,,,Ongoing,FAILED IMPURITIES,Impurity Issues,Biocon Phama ., PRESCRIPTION DRUG,ORAL,E-Mail
Class III,2013-06-05,2013-08-15,150,Terminated,FAILED IMPURITY,Impurity Issues,nan,nan,nan,FAX
Class III,2015-09-02,2017-01-13,549,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2020-06-24,2023-01-10,959,Terminated,FAILED IMPURITIES,Impurity Issues,Prasco Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class III,2015-04-15,2016-07-12,475,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2016-03-16,2016-06-28,153,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2017-07-26,2019-09-10,796,Terminated,FAILED IMPURITIES,Impurity Issues,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2017-11-01,2017-12-01,87,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,E-Mail
Class III,2014-09-24,2019-10-02,1868,Terminated,FAILED IMPURITY,Impurity Issues,nan,nan,nan,Letter
Class III,2016-07-06,2016-10-14,135,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2021-09-22,2022-08-17,369,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2018-08-01,2019-04-10,288,Terminated,FAILED IMPURITIES,Impurity Issues,Major Pharmaceuticals, PRESCRIPTION DRUG,ORAL,nan
Class II,2018-08-15,2020-11-06,828,Terminated,FAILED IMPURITIES,Impurity Issues,Akorn, PRESCRIPTION DRUG,TOPICAL,Letter
Class II,2015-07-22,2016-05-19,350,Terminated,FAILED IMPURITIES,Impurity Issues,Fresenius Kabi USA, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2015-11-25,2016-12-21,415,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2016-10-19,2017-05-05,234,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2018-12-05,2022-08-09,1380,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2023-12-13,,,Ongoing,FAILED IMPURITIES,Impurity Issues,KinderFarms, OTC DRUG,ORAL,E-Mail
Class III,2017-07-12,2018-05-09,341,Terminated,FAILED IMPURITIES,Impurity Issues,Cosette Pharmaceuticals, PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2020-01-08,2020-10-19,311,Terminated,FAILED IMPURITIES,Impurity Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class II,2023-07-19,2023-09-11,214,Terminated,FAILED IMPURITIES,Impurity Issues,Costco Wholesale Company, OTC DRUG,ORAL,Letter
Class III,2023-10-11,,,Ongoing,FAILED IMPURITIES,Impurity Issues,American Health Packaging, PRESCRIPTION DRUG,ORAL,Letter
Class III,2015-05-20,2017-02-14,662,Terminated,FAILED IMPURITIES,Impurity Issues,Dr. Reddys Laboratories, PRESCRIPTION DRUG,RESPIRATORY (INHALATION),"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2016-02-17,2017-04-12,468,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2022-03-09,,,Ongoing,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2023-03-22,,,Ongoing,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2023-12-06,,,Ongoing,FAILED IMPURITIES,Impurity Issues,Golden State Medical Supply, PRESCRIPTION DRUG,ORAL,Letter
Class III,2013-01-23,2013-12-18,603,Terminated,IMPURITIES,Impurity Issues,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class II,2017-07-05,2019-05-01,730,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2017-11-22,2019-10-30,741,Terminated,FAILED IMPURITIES,Impurity Issues,Allergan, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class III,2014-01-22,2016-03-14,802,Terminated,FAILED IMPURITIES,Impurity Issues,Pfizer Laboratories Div Pfizer , PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2014-07-23,2015-03-09,265,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2017-01-18,2017-08-18,343,Terminated,FAILED IMPURITIES,Impurity Issues,Pfizer Laboratories Div Pfizer , PRESCRIPTION DRUG,ORAL,Letter
Class III,2017-02-01,2018-03-05,417,Terminated,FAILED IMPURITIES,Impurity Issues,Actavis Pharma, PRESCRIPTION DRUG,INTRABRONCHIAL,Letter
Class III,2017-03-08,2017-09-26,225,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2018-07-18,2020-04-29,674,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,nan
Class III,2019-02-27,2019-09-12,211,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2021-07-28,,,Ongoing,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2022-02-23,2023-05-01,446,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2016-09-28,2018-03-26,637,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2017-04-12,2017-04-10,490,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,E-Mail
Class II,2021-04-28,,,Ongoing,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2023-06-21,,,Ongoing,FAILED IMPURITIES,Impurity Issues,Amring Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2012-07-04,2013-04-10,343,Terminated,IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2014-05-07,2014-10-07,181,Terminated,FAILED IMPURITIES,Impurity Issues,Sun Pharmaceutical Industries, OTC DRUG,ORAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2014-11-05,2015-09-21,348,Terminated,FAILED IMPURITIES,Impurity Issues,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class III,2015-06-10,2016-10-05,539,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2018-11-21,2020-10-06,740,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2021-03-10,2023-09-07,930,Terminated,FAILED IMPURITIES,Impurity Issues,"[""Dr. Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-01-12,2022-11-08,469,Terminated,FAILED IMPURITIES,Impurity Issues,L. Perrigo Company, OTC DRUG,ORAL,Letter
Class II,2023-04-05,,,Ongoing,FAILED IMPURITIES,Impurity Issues,Par Pharmaceutical, PRESCRIPTION DRUG,NASAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2012-07-04,2013-02-22,707,Terminated,IMPURITIES,Impurity Issues,nan,nan,nan,FAX
Class III,2014-09-03,2015-07-23,399,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Telephone
Class III,2020-05-27,2022-10-02,872,Terminated,FAILED IMPURITIES,Impurity Issues,West-Ward Pharmaceuticals Corp., PRESCRIPTION DRUG,ORAL,Letter
Class III,2012-08-29,2013-03-01,297,Terminated,IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2013-12-25,2015-05-21,531,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2016-05-18,2017-04-10,376,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2017-05-17,2018-07-11,476,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2018-08-08,2019-01-18,176,Terminated,CARCINOGEN IMPURITY DETECTED IN API USED TO MANUFACTURE DRUG PRODUCT.,Impurity Issues,nan,nan,nan,Letter
Class II,2019-08-07,2021-02-16,595,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2016-02-17,2017-01-11,351,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2018-09-19,2019-08-14,372,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2019-02-06,2019-10-09,264,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2021-05-05,,,Ongoing,FAILED IMPURITIES,Impurity Issues,Preferred Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-03-01,,,Ongoing,FAILED IMPURITIES,Impurity Issues,Rising Health, PRESCRIPTION DRUG,ORAL,Letter
Class III,2016-06-22,2017-03-03,279,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2017-03-15,2018-01-09,336,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2020-02-12,2021-01-08,345,Terminated,FAILED IMPURITIES,Impurity Issues,Unichem Pharmaceuticals (USA), PRESCRIPTION DRUG,ORAL,Letter
Class III,2021-03-24,2022-05-19,441,Terminated,FAILED IMPURITY,Impurity Issues,Teva Parenteral Medicines, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2016-10-19,2017-06-29,272,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2018-02-07,2019-09-17,609,Terminated,FAILED IMPURITIES,Impurity Issues,Fresenius Kabi USA, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2018-08-29,2020-06-26,682,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2016-07-06,2018-06-13,819,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2017-12-13,2019-03-15,487,Terminated,FAILED IMPURITIES,Impurity Issues,Epic Pharma, PRESCRIPTION DRUG,ORAL,E-Mail
Class II,2017-08-23,2019-02-27,587,Terminated,FAILED IMPURITIES,Impurity Issues,Camber Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class III,2018-11-21,2019-06-20,226,Terminated,FAILED IMPURITIES,Impurity Issues,Takeda Pharmaceuticals America, PRESCRIPTION DRUG,ORAL,Letter
Class III,2019-06-19,2021-01-28,617,Terminated,FAILED IMPURITIES,Impurity Issues,Fresenius Kabi USA, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class III,2021-09-29,2022-08-25,470,Terminated,FAILED IMPURITIES,Impurity Issues,American Health Packaging, PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-01-25,,,Completed,FAILED IMPURITIES,Impurity Issues,American Health Packaging, PRESCRIPTION DRUG,ORAL,Letter
Class II,2012-06-20,2013-03-22,346,Terminated,IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2015-05-27,2015-08-31,158,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2019-04-03,2020-07-01,467,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2021-04-21,2022-12-13,631,Terminated,FAILED IMPURITIES,Impurity Issues,Macleods Pharmaceuticals Limited, PRESCRIPTION DRUG,ORAL,Letter
Class III,2016-07-20,2017-02-02,259,Terminated,FAILED IMPURITIES,Impurity Issues,Hikma Pharmceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2016-11-30,2017-08-01,271,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,E-Mail
Class III,2019-02-20,2020-06-26,511,Terminated,FAILED IMPURITIES,Impurity Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class II,2020-01-22,2020-10-22,301,Terminated,FAILED IMPURITIES,Impurity Issues,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-02-23,,,Ongoing,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2014-09-03,2015-06-29,374,Terminated,FAILED IMPURITY,Impurity Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-11-12,2017-06-14,972,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2018-02-21,2019-04-30,449,Terminated,FAILED IMPURITIES,Impurity Issues,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class III,2019-05-01,2022-10-14,1283,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2017-08-09,2019-04-01,629,Terminated,FAILED IMPURITIES,Impurity Issues,"[""Dr.Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class III,2017-08-30,2020-01-29,901,Terminated,FAILED IMPURITIES,Impurity Issues,PD-Rx Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class III,2020-12-02,2022-01-28,462,Terminated,FAILED IMPURITIES,Impurity Issues,Heritage Pharmaceuticals . d/b/a Avet Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2021-01-06,2023-05-03,867,Terminated,FAILED IMPURITY,Impurity Issues,Ascend Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class II,2012-06-20,2013-08-05,425,Terminated,IMPURITIES,Impurity Issues,Meridian Medical Technologies , PRESCRIPTION DRUG,INTRAMUSCULAR,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2017-10-25,2018-09-13,346,Terminated,FAILED IMPURITIES,Impurity Issues,Unichem Pharmaceuticals (USA), PRESCRIPTION DRUG,ORAL,Letter
Class III,2018-08-08,2019-12-06,498,Terminated,FAILED IMPURITIES,Impurity Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class III,2014-04-09,2015-05-12,470,Terminated,FAILED IMPURITIES,Impurity Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class III,2015-04-01,2016-07-26,526,Terminated,FAILED IMPURITIES,Impurity Issues,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2022-08-10,2023-06-22,346,Terminated,FAILED IMPURITIES,Impurity Issues,Amneal Pharmaceuticals of New York , PRESCRIPTION DRUG,TOPICAL,Letter
Class II,2022-10-05,,,Ongoing,FAILED IMPURITIES,Impurity Issues,Akorn, PRESCRIPTION DRUG,ORAL,Letter
Class III,2014-08-27,2015-10-09,476,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,E-Mail
Class III,2015-06-03,2016-11-15,558,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2017-02-15,2017-07-24,284,Terminated,FAILED IMPURITIES,Impurity Issues,"[""Dr. Reddys Laboratories Ltd.""]", PRESCRIPTION DRUG,ORAL,Letter
Class II,2017-11-08,2019-03-11,521,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2018-01-17,2018-10-01,291,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2021-09-22,,,Ongoing,FAILED IMPURITIES,Impurity Issues,Meitheal Pharmaceuticals ., PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class III,2023-03-08,,,Ongoing,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2012-08-08,2013-03-18,286,Terminated,IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2014-11-12,2016-09-30,715,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2019-10-16,2022-09-24,1097,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2020-06-17,2021-01-08,227,Terminated,FAILED IMPURITIES,Impurity Issues,Unichem Pharmaceuticals (USA), PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-02-22,2023-08-04,220,Terminated,FAILED IMPURITIES,Impurity Issues,American Health Packaging, PRESCRIPTION DRUG,ORAL,Letter
Class III,2013-12-18,2013-12-30,311,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2023-01-18,,,Ongoing,FAILED IMPURITIES,Impurity Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-05-31,,,Ongoing,FAILED IMPURITIES,Impurity Issues,WALGREEN CO., OTC DRUG,ORAL,Letter
Class III,2014-05-07,2014-12-23,278,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2014-11-19,2016-03-08,694,Terminated,FAILED IMPURITIES,Impurity Issues,Fresenius Kabi USA, PRESCRIPTION DRUG,INTRAMUSCULAR,Letter
Class II,2016-06-01,2017-11-30,617,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2017-03-08,2017-10-17,251,Terminated,FAILED IMPURITIES,Impurity Issues,American Health Packaging, PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-03-27,2020-04-29,467,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2021-06-02,2023-02-16,653,Terminated,FAILED IMPURITIES,Impurity Issues,"[""Dr. Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class III,2014-08-13,2015-01-12,182,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2016-04-27,2018-02-09,697,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2016-08-31,2017-02-08,190,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2020-03-11,2021-06-03,470,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2023-03-22,,,Ongoing,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2023-06-21,,,Ongoing,FAILED IMPURITIES,Impurity Issues,AvPAK, PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-01-22,2016-05-11,967,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2017-03-08,2018-06-18,496,Terminated,FAILED  IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2012-12-05,2014-09-11,703,Terminated,IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2013-01-23,2014-06-16,551,Terminated,IMPURITIES,Impurity Issues,West-Ward Pharmaceuticals Corp., PRESCRIPTION DRUG,ORAL,Letter
Class III,2014-01-08,2014-10-07,295,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2014-03-19,2015-06-19,507,Terminated,FAILED IMPURITY,Impurity Issues,nan,nan,nan,Letter
Class III,2016-01-27,2016-12-23,521,Terminated,FAILED IMPURITIES,Impurity Issues,PD-Rx Pharmaceuticals, PRESCRIPTION DRUG,ORAL,E-Mail
Class II,2017-10-25,2020-04-29,946,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2018-03-14,2019-02-26,368,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2013-05-15,2013-07-24,134,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2022-05-18,2023-06-09,434,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2016-06-15,2016-10-14,135,Terminated,FAILED IMPURITY,Impurity Issues,nan,nan,nan,FAX
Class III,2019-04-10,2022-08-11,1245,Terminated,FAILED IMPURITIES,Impurity Issues,Pharmacia & Upjohn Company , PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class III,2021-05-05,,,Ongoing,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2023-07-19,,,Ongoing,FAILED IMPURITIES,Impurity Issues,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class III,2013-07-17,2015-03-17,673,Terminated,FAILED IMPURITY,Impurity Issues,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2017-10-11,2020-01-16,855,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2019-09-04,2022-07-28,1087,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2021-06-23,2023-02-16,622,Terminated,FAILED IMPURITIES,Impurity Issues,"[""Dr. Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class III,2023-01-25,2023-06-08,211,Terminated,FAILED IMPURITY,Impurity Issues,Lannett Company, PRESCRIPTION DRUG,ORAL,Letter
Class III,2023-11-29,,,Ongoing,FAILED IMPURITIES,Impurity Issues,Glenmark Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-11-05,2016-09-21,904,Terminated,FAILED IMPURITY,Impurity Issues,nan,nan,nan,Letter
Class III,2015-09-02,2017-04-03,607,Terminated,FAILED IMPURITIES,Impurity Issues,Taro Pharmaceuticals U.S.A., PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2019-09-18,2020-07-16,314,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2020-04-08,2022-07-28,855,Terminated,FAILED IMPURITIES,Impurity Issues,Akorn, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class III,2021-12-01,2023-08-23,646,Terminated,FAILED IMPURITIES,Impurity Issues,Aurobindo Pharma Limited, PRESCRIPTION DRUG,ORAL,Letter
Class III,2014-12-10,2015-07-23,294,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2018-03-21,2020-06-08,826,Terminated,FAILED IMPURITIES,Impurity Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class III,2016-10-12,2017-03-13,220,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2017-08-23,2019-03-11,600,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2016-06-22,2017-06-13,787,Terminated,FAILED IMPURITIES,Impurity Issues,Bausch Health US, PRESCRIPTION DRUG,ORAL,Letter
Class III,2016-07-06,2017-04-26,369,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2017-07-26,2018-04-26,301,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2015-06-17,2017-11-29,967,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2015-10-28,,,Ongoing,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2016-04-20,2016-11-07,214,Terminated,FAILED IMPURITIES,Impurity Issues,Fresenius Kabi USA, PRESCRIPTION DRUG,INTRAMUSCULAR,Letter
Class II,2018-10-31,2020-09-30,742,Terminated,FAILED IMPURITIES,Impurity Issues,Upsher-Smith Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class III,2021-06-23,2023-06-02,723,Terminated,FAILED IMPURITIES SPECIFICATION,Impurity Issues,nan,nan,nan,Letter
Class II,2013-02-06,2014-01-03,387,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2021-02-10,2021-12-16,329,Terminated,FAILED IMPURITIES,Impurity Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-11-08,,,Ongoing,FAILED IMPURITIES,Impurity Issues,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class III,2013-07-17,2014-04-10,391,Terminated,FAILED IMPURITY,Impurity Issues,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class III,2015-01-14,2017-01-26,779,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2015-11-25,2017-01-26,525,Terminated,FAILED IMPURITY,Impurity Issues,Akorn, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2020-01-22,2021-07-14,554,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2022-04-06,2023-11-13,607,Terminated,FAILED IMPURITIES,Impurity Issues,"[""Dr. Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class III,2016-08-31,2017-07-21,359,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2018-09-05,2020-11-03,818,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2020-04-08,2021-11-02,582,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2014-11-19,2016-04-19,609,Terminated,FAILED IMPURITIES,Impurity Issues,Micro Labs Limited, PRESCRIPTION DRUG,ORAL,Letter
Class III,2018-09-19,2020-06-26,668,Terminated,FAILED IMPURITIES,Impurity Issues,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2014-02-12,2014-10-22,308,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2017-09-20,2019-12-04,820,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,E-Mail
Class II,2019-12-25,2021-03-17,478,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2021-03-24,2022-08-09,519,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2019-06-26,,,Ongoing,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2015-04-01,2015-04-17,38,Terminated,FAILED IMPURITIES,Impurity Issues,Matheson Tri-Gas, PRESCRIPTION DRUG,RESPIRATORY (INHALATION),"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2020-07-15,2023-06-30,1121,Terminated,FAILED IMPURITIES,Impurity Issues,Somerset Therapeutics, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class II,2015-07-22,2016-02-12,220,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2016-08-03,2017-05-08,342,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2021-11-17,2022-12-21,413,Terminated,FAILED IMPURITIES,Impurity Issues,Ascend Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class II,2012-07-18,2013-05-22,357,Terminated,IMPURITIES,Impurity Issues,VistaPharm, PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-08-06,2014-11-20,233,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2019-04-17,2020-05-07,400,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2021-01-13,2023-06-01,920,Terminated,FAILED IMPURITY,Impurity Issues,Ascend Laboratories, PRESCRIPTION DRUG,ORAL,E-Mail
Class II,2013-08-14,2014-06-03,308,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2014-04-09,2014-11-14,276,Terminated,FAILED IMPURITY,Impurity Issues,nan,nan,nan,Telephone
Class III,2019-02-13,2020-06-22,511,Terminated,FAILED IMPURITIES,Impurity Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class III,2021-02-17,2021-11-03,271,Terminated,FAILED IMPURITY,Impurity Issues,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2021-06-30,2023-02-16,618,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2017-12-20,2018-07-03,217,Terminated,FAILED IMPURITIES,Impurity Issues,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class III,2021-01-20,2021-03-19,91,Terminated,FAILED IMPURITIES,Impurity Issues,KVK-Tech, PRESCRIPTION DRUG,ORAL,Letter
Class III,2021-02-03,2022-02-11,400,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2013-02-13,2013-05-10,344,Terminated,IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class III,2016-01-13,2016-12-21,419,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,E-Mail
Class III,2018-02-07,2018-12-07,312,Terminated,FAILED IMPURITIES,Impurity Issues,"[""Dr. Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class II,2016-09-14,2018-05-01,722,Terminated,FAILED IMPURITIES,Impurity Issues,Zydus Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2020-07-15,2022-09-28,827,Terminated,FAILED IMPURITIES,Impurity Issues,VistaPharm, PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-07-16,2015-04-01,335,Terminated,FAILED IMPURITY,Impurity Issues,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,nan
Class II,2016-04-13,2017-09-22,584,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2019-10-02,2023-04-24,1334,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Telephone
Class II,2022-01-12,2023-04-13,478,Terminated,FAILED IMPURITIES,Impurity Issues,Ascend Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-10-26,,,Ongoing,FAILED IMPURITIES,Impurity Issues,Golden State Medical Supply, PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-12-06,,,Ongoing,FAILED IMPURITIES,Impurity Issues,Apotex Corp., PRESCRIPTION DRUG,ORAL,E-Mail
Class III,2015-06-24,2016-04-06,329,Terminated,FAILED IMPURITIES,Impurity Issues,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2016-03-09,2017-05-23,467,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,E-Mail
Class II,2019-09-25,2020-11-03,424,Terminated,FAILED IMPURITIES,Impurity Issues,Torrent Pharmaceuticals Limited, PRESCRIPTION DRUG,ORAL,Letter
Class III,2023-11-08,,,Ongoing,FAILED IMPURITIES,Impurity Issues,GLENMARK PHARMACEUTICALS INC., PRESCRIPTION DRUG,ORAL,Letter
Class III,2012-10-24,2013-01-14,116,Terminated,IMPURITY,Impurity Issues,Sandoz , OTC DRUG,ORAL,Letter
Class II,2014-10-01,2017-03-17,920,Terminated,FAILED IMPURITIES,Impurity Issues,Hospira, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",nan
Class III,2017-06-21,2018-02-14,281,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2022-02-23,,,Ongoing,FAILED IMPURITIES,Impurity Issues,Aurobindo Pharma Limited, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class III,2017-08-09,2018-04-26,275,Terminated,FAILED IMPURITIES,Impurity Issues,Actavis Pharma, PRESCRIPTION DRUG,INTRABRONCHIAL,Letter
Class III,2019-04-10,2020-04-22,391,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2020-12-23,,,Ongoing,FAILED IMPURITIES,Impurity Issues,Wal-Mart Stores, OTC DRUG,TOPICAL,Letter
Class II,2022-03-16,2023-07-16,509,Terminated,IMPURITY FAILURE AT 0,Impurity Issues,American Health Packaging, PRESCRIPTION DRUG,ORAL,Letter
Class III,2012-10-10,2013-03-29,274,Terminated,IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2013-07-31,2014-11-04,699,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Visit
Class II,2019-08-07,2021-03-09,610,Terminated,FAILED IMPURITIES,Impurity Issues,Piramal Critical Care , PRESCRIPTION DRUG,INTRATHECAL,Letter
Class II,2021-03-24,2022-03-23,377,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2017-03-29,2022-06-01,1932,Terminated,FAILED IMPURITIES,Impurity Issues,nan,nan,nan,Letter
Class II,2019-03-20,2022-08-09,1264,Terminated,FAILED IMPURITIES,Impurity Issues,Akorn, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class III,2023-06-28,,,Ongoing,FAILED IMPURITIES,Impurity Issues,Aurolife Pharma , PRESCRIPTION DRUG,ORAL,nan
Class III,2023-09-13,,,Ongoing,FAILED IMPURITIES,Impurity Issues,Armas Pharmaceuticals ., PRESCRIPTION DRUG,INTRAVENOUS,E-Mail
Class III,2023-11-15,,,Ongoing,FAILED IMPURITIES,Impurity Issues,Taro Pharmaceuticals U.S.A., PRESCRIPTION DRUG,AURICULAR (OTIC),Letter
Class III,2017-08-23,2018-12-04,488,Terminated,FAILED IMPURITIES,Impurity Issues,KVK-Tech, PRESCRIPTION DRUG,ORAL,Letter
Class III,2012-07-25,2012-07-19,132,Terminated,LABELING ILLEGIBLE,Labeling Issues,Rising Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2015-12-16,2016-11-01,356,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2019-02-27,2020-03-23,410,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2019-05-29,2020-11-19,567,Terminated,LABELING,Labeling Issues,Dentsply Pharmaceutical, PRESCRIPTION DRUG,SUBCUTANEOUS,Letter
Class III,2021-01-20,2021-11-05,324,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2021-09-22,2023-06-21,650,Terminated,LABELING,Labeling Issues,Kroger CO, OTC DRUG,TOPICAL,Letter
Class II,2015-11-18,2016-07-25,336,Terminated,LABELING,Labeling Issues,PURACAP LABORATORIES  DBA BLU PHARMACEUTICALS, PRESCRIPTION DRUG,ORAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2016-02-10,2016-06-20,154,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2018-11-14,2019-08-21,327,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2019-01-30,2019-05-01,106,Terminated,LABELING,Labeling Issues,nan,nan,nan,Telephone
Class II,2019-04-17,2023-06-20,1548,Terminated,LABELING,Labeling Issues,Lohxa, PRESCRIPTION DRUG,ORAL,Letter
Class III,2015-08-26,2015-08-21,8,Terminated,LABELING,Labeling Issues,nan,nan,nan,Telephone
Class II,2017-11-01,2018-06-27,285,Terminated,LABELING,Labeling Issues,CareFusion 213 , OTC DRUG,TOPICAL,Letter
Class III,2020-05-20,2021-10-26,554,Terminated,LABELING,Labeling Issues,GlaxoSmithKline Consumer Healthcare Holdings (US) , OTC DRUG,TOPICAL,Letter
Class III,2012-07-11,2013-01-15,201,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2016-06-29,2017-06-09,375,Terminated,LABELING,Labeling Issues,Solco Healthcare US, PRESCRIPTION DRUG,ORAL,Letter
Class III,2017-01-04,2017-12-05,392,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2018-08-15,2020-01-30,553,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2019-09-04,2021-10-28,822,Terminated,LABELING,Labeling Issues,Aurobindo Pharma Limited, PRESCRIPTION DRUG,ORAL,Letter
Class II,2017-03-29,2018-07-02,487,Terminated,LABELING,Labeling Issues,E. Fougera & Co. a division of Fougera Pharmaceuticals ., PRESCRIPTION DRUG,TOPICAL,Letter
Class II,2017-08-09,2018-03-28,266,Terminated,LABELING ERROR,Labeling Issues,nan,nan,nan,Telephone
Class I,2017-12-13,2019-05-02,633,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2019-10-16,2021-10-25,773,Terminated,LABELING,Labeling Issues,Liebel-Flarsheim Company , PRESCRIPTION DRUG,"INTRA-ARTERIAL', 'INTRAVENOUS",Letter
Class II,2021-09-01,2021-12-23,133,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2013-05-29,2014-11-04,564,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2014-05-21,2016-05-26,786,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2016-05-04,2017-03-17,339,Terminated,LABELING,Labeling Issues,McKesson Corporation dba SKY Packaging, OTC DRUG,ORAL,Letter
Class II,2018-05-30,2020-06-04,776,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2020-08-19,2021-07-07,358,Terminated,LABELING,Labeling Issues,V2 Pharma, PRESCRIPTION DRUG,nan,Letter
Class III,2020-09-02,2022-05-20,658,Terminated,LABELING,Labeling Issues,The Mentholatum Company, OTC DRUG,TOPICAL,Letter
Class II,2020-09-09,2022-02-22,568,Terminated,LABELING NOT ELSEWHERE CLASSIFIED,Labeling Issues,nan,nan,nan,Telephone
Class II,2022-04-13,,,Ongoing,LABELING,Labeling Issues,nan,nan,nan,Letter
Class I,2016-02-24,2016-06-29,278,Terminated,LABELING,Labeling Issues,Medline Industries, OTC DRUG,ORAL,Letter
Class III,2015-12-23,2016-11-01,378,Terminated,LABELING,Labeling Issues,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-05-22,2014-02-13,297,Terminated,LABELING,Labeling Issues,nan,nan,nan,Telephone
Class III,2014-03-19,2015-12-08,678,Terminated,LABELING,Labeling Issues,E. Fougera & Co. a division of Fougera Pharmaceuticals ., PRESCRIPTION DRUG,TOPICAL,Letter
Class II,2015-01-07,2015-06-01,167,Terminated,LABELING,Labeling Issues,nan,nan,nan,E-Mail
Class III,2016-01-20,2016-05-03,137,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2018-01-17,2019-05-01,510,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2017-11-22,2020-09-10,1064,Terminated,LABELING,Labeling Issues,Sanofi-Aventis U.S. , PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class I,2019-06-19,2021-02-10,624,Terminated,LABELING,Labeling Issues,KRAMER NOVIS, OTC DRUG,ORAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2014-10-22,2015-08-04,440,Terminated,LABELING,Labeling Issues,Bausch Health US, PRESCRIPTION DRUG,ORAL,Letter
Class III,2016-10-05,2017-08-09,328,Terminated,LABELING,Labeling Issues,Wyeth Pharmaceuticals , PRESCRIPTION DRUG,ORAL,Letter
Class III,2016-11-02,2018-05-14,572,Terminated,LABELING,Labeling Issues,Janssen Pharmaceuticals, PRESCRIPTION DRUG,ORAL,nan
Class III,2017-10-18,2018-04-18,208,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2022-02-09,2023-06-01,510,Terminated,MISLABELING,Labeling Issues,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-08-14,2014-08-27,400,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2016-03-23,2016-11-15,362,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2016-03-02,,,Ongoing,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2016-05-11,2016-08-29,157,Terminated,LABELING,Labeling Issues,Bryant Ranch Prepack, PRESCRIPTION DRUG,ORAL,Letter
Class III,2017-03-01,2018-08-28,572,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2018-02-14,2019-05-01,464,Terminated,LABELING,Labeling Issues,Astellas Pharma US, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2014-01-29,2015-11-24,749,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2016-03-02,2016-05-03,91,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class I,2016-12-28,2017-06-01,286,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2019-02-27,2019-10-30,266,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2023-08-23,,,Ongoing,LABELING,Labeling Issues,Advanced Accelerator Applications USA, PRESCRIPTION DRUG,INTRAVENOUS,nan
Class II,2013-09-25,2014-03-20,203,Terminated,LABELING,Labeling Issues,"[""Dr. Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class III,2014-12-17,2015-06-24,201,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2014-12-24,2015-05-21,167,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2015-03-25,2016-02-09,363,Terminated,CORRECT LABELED PRODUCT MISPACK,Labeling Issues,nan,nan,nan,Letter
Class II,2017-08-30,2018-09-11,509,Terminated,LABELING,Labeling Issues,nan,nan,nan,Press Release
Class III,2018-11-21,2020-04-22,531,Terminated,LABELING,Labeling Issues,ImClone , PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2022-04-13,2023-02-16,342,Terminated,LABELING,Labeling Issues,Natco Pharma USA , PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-03-20,2013-04-02,1128,Terminated,LABELING,Labeling Issues,nan,nan,nan,E-Mail
Class III,2012-08-01,2013-01-31,192,Terminated,LABELING,Labeling Issues,nan,nan,nan,E-Mail
Class III,2013-06-12,2014-11-26,645,Terminated,LABELING,Labeling Issues,GlaxoSmithKline Consumer Healthcare Holdings (US) , OTC DRUG,TOPICAL,Letter
Class II,2021-06-02,2021-08-11,90,Terminated,LABELING,Labeling Issues,The Procter & Gamble Manufacturing Company, OTC DRUG,DENTAL,E-Mail
Class I,2022-05-04,2023-10-18,554,Terminated,LABELING,Labeling Issues,Mylan Specialty L.P., PRESCRIPTION DRUG,SUBCUTANEOUS,Press Release
Class III,2023-05-31,,,Ongoing,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2023-09-13,,,Ongoing,CASES OF SODIUM FLUORIDE 1.1% PRESCRIPTION DENTAL TOOTHPASTE MAY CONTAIN CARTONS LABELED AS CAPSAICIN CREAM 0.025% BUT CONTAIN CORRECTLY LABELED TUBES OF SODIUM FLUORIDE 1.1% PRESCRIPTION DENTAL TOOTHPASTE,Labeling Issues,AvKARE, PRESCRIPTION DRUG,DENTAL,Letter
Class III,2013-03-27,2014-11-26,629,Terminated,LABELING,Labeling Issues,GlaxoSmithKline Consumer Healthcare Holdings (US) , OTC DRUG,NASAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2013-12-04,2015-05-12,550,Terminated,LABELING,Labeling Issues,Fresenius Kabi USA, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2014-04-30,2014-07-01,78,Terminated,LABELING,Labeling Issues,Upsher-Smith Laboratories, PRESCRIPTION DRUG,ORAL,Telephone
Class I,2015-05-20,2016-10-19,593,Terminated,LABELING,Labeling Issues,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Press Release
Class II,2017-10-04,2018-06-21,289,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2018-02-07,2018-04-23,91,Terminated,LABELING,Labeling Issues,Camber Pharmaceuticals , PRESCRIPTION DRUG,ORAL,Letter
Class III,2018-09-05,2020-05-19,637,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2021-02-24,2022-09-23,625,Terminated,LABELING,Labeling Issues,nan,nan,nan,E-Mail
Class II,2021-12-29,2022-07-12,225,Terminated,LABELING,Labeling Issues,nan,nan,nan,Telephone
Class III,2022-08-03,,,Completed,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2023-01-04,2023-12-06,355,Terminated,LABELING,Labeling Issues,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,INTRAVENOUS,nan
Class II,2014-10-01,2016-09-27,750,Terminated,CORRECT LABELED PRODUCT MISPACK,Labeling Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2015-10-28,2016-06-30,261,Terminated,LABELING,Labeling Issues,Concordia Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,E-Mail
Class III,2016-04-13,2016-08-22,192,Terminated,LABELING,Labeling Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2018-10-17,2019-03-26,189,Terminated,LABELING,Labeling Issues,Xiromed, PRESCRIPTION DRUG,nan,Letter
Class II,2019-09-04,2020-11-06,456,Terminated,LABELING,Labeling Issues,Alkermes, PRESCRIPTION DRUG,nan,Letter
Class I,2022-04-06,2022-11-15,252,Terminated,LABELING,Labeling Issues,JUBILANT CADISTA PHARMACEUTICALS INC., PRESCRIPTION DRUG,ORAL,E-Mail
Class III,2023-04-19,,,Ongoing,LABELING,Labeling Issues,Focus Health Group, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'SUBCUTANEOUS",Letter
Class II,2018-09-05,2021-02-11,903,Terminated,LABELING ERROR,Labeling Issues,GlaxoSmithKline Consumer Healthcare Holdings (US) , OTC DRUG,ORAL,Letter
Class II,2018-10-17,2020-10-02,730,Terminated,CORRECT LABELED PRODUCT MISPACK,Labeling Issues,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2020-12-16,2021-05-13,174,Terminated,LABELING,Labeling Issues,Septodont, PRESCRIPTION DRUG,SUBCUTANEOUS,Letter
Class III,2022-04-13,2022-12-02,245,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2023-08-16,,,Ongoing,LABELING,Labeling Issues,B. Braun Medical ., PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2015-06-10,2018-06-06,1112,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class I,2022-01-26,,,Completed,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2012-10-31,2013-07-10,400,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2017-01-18,2017-05-11,211,Terminated,LABELING,Labeling Issues,nan,nan,nan,E-Mail
Class III,2017-07-26,2018-01-16,202,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2013-04-10,2013-07-10,159,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2017-09-20,2019-03-11,571,Terminated,LABELING,Labeling Issues,VistaPharm, PRESCRIPTION DRUG,ORAL,Letter
Class III,2020-07-01,2022-08-03,784,Terminated,LABELING NOT ELSEWHERE CLASSIFIED,Labeling Issues,nan,nan,nan,Letter
Class III,2023-12-06,,,Ongoing,LABELING,Labeling Issues,nan,nan,nan,Telephone
Class II,2019-01-30,2020-06-05,581,Terminated,LABELING INCORRECT INSTRUCTIONS,Labeling Issues,nan,nan,nan,Letter
Class II,2020-04-01,2021-10-28,591,Terminated,LABELING,Labeling Issues,GlaxoSmithKline Consumer Healthcare Holdings (US) , OTC DRUG,ORAL,Letter
Class III,2023-11-15,,,Ongoing,LABELING,Labeling Issues,AbbVie ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2012-09-05,2012-08-30,589,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2020-11-25,2022-10-18,761,Terminated,LABELING,Labeling Issues,Deseret Biologicals, OTC DRUG,ORAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2020-07-22,2022-08-19,767,Terminated,LABELING ERROR,Labeling Issues,Fresenius Kabi USA, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2014-01-29,2014-02-07,220,Terminated,LABELING,Labeling Issues,nan,nan,nan,Telephone
Class II,2014-05-07,2014-05-01,45,Terminated,LABELING,Labeling Issues,nan,nan,nan,Telephone
Class III,2016-04-20,2017-01-11,286,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2021-09-01,2023-08-07,718,Terminated,LABELING,Labeling Issues,Eli Lilly  Company, PRESCRIPTION DRUG,SUBCUTANEOUS,Letter
Class I,2022-02-23,2022-09-16,225,Terminated,LABELING,Labeling Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2014-01-22,2015-06-05,581,Terminated,LABELING,Labeling Issues,nan,nan,nan,Telephone
Class III,2014-04-16,2014-12-02,274,Terminated,LABELING,Labeling Issues,Novartis Pharmaceuticals Corporation, PRESCRIPTION DRUG,ORAL,Letter
Class III,2014-08-27,2017-07-26,1196,Terminated,LABELING,Labeling Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2017-03-22,2017-03-16,48,Terminated,LABELING,Labeling Issues,nan,nan,nan,Telephone
Class I,2017-07-19,2022-03-15,1744,Terminated,LABELING,Labeling Issues,E.R. Squibb & Sons, PRESCRIPTION DRUG,ORAL,E-Mail
Class III,2018-02-21,2019-02-07,370,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2018-04-04,2019-12-16,637,Terminated,LABELING,Labeling Issues,Glenmark Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2019-06-26,2022-07-28,1147,Terminated,LABELING,Labeling Issues,Akorn Operating Company , PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-12-03,2016-11-03,724,Terminated,LABELING,Labeling Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2021-09-01,,,Ongoing,LABELING,Labeling Issues,Xellia Pharmaceuticals USA , PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2023-06-14,,,Ongoing,LABELING,Labeling Issues,HF Acquisition Co , PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2012-10-03,2015-08-13,1133,Terminated,LABELING,Labeling Issues,Glenmark Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2013-12-25,2014-06-16,360,Terminated,LABELING,Labeling Issues,nan,nan,nan,E-Mail
Class III,2017-07-05,2017-12-07,185,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2019-02-20,2020-01-24,365,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2019-05-15,2021-06-29,796,Terminated,LABELING,Labeling Issues,Zydus Pharmaceuticals (USA) ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2021-01-06,2021-11-05,345,Terminated,LABELLING,Labeling Issues,nan,nan,nan,Letter
Class III,2013-04-10,2014-02-06,324,Terminated,LABELING ILLEGIBLE,Labeling Issues,"[""Dr. Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class I,2016-02-24,2016-02-17,733,Terminated,LABELING,Labeling Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2022-09-07,,,Ongoing,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2012-10-03,2012-11-16,109,Terminated,LABELING,Labeling Issues,nan,nan,nan,FAX
Class III,2013-08-28,2014-11-04,455,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2016-05-11,2016-10-20,181,Terminated,LABELING,Labeling Issues,nan,nan,nan,Telephone
Class III,2017-03-29,2018-01-03,316,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2018-05-23,2019-01-23,274,Terminated,LABELING,Labeling Issues,Aurolife Pharma, PRESCRIPTION DRUG,ORAL,Letter
Class I,2021-03-03,2023-10-16,992,Terminated,LABELING,Labeling Issues,Meitheal Pharmaceuticals ., PRESCRIPTION DRUG,INTRAVENOUS,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2021-04-14,2022-12-05,628,Terminated,LABELING,Labeling Issues,Alembic Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2016-04-20,2016-10-27,224,Terminated,LABELING,Labeling Issues,Amneal Pharmaceuticals of New York , PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-02-19,2023-03-09,1172,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2022-09-21,2023-08-14,350,Terminated,LABELING,Labeling Issues,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class III,2018-06-06,2021-01-26,978,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class I,2021-06-09,2023-04-04,701,Terminated,LABELING,Labeling Issues,Hospira, PRESCRIPTION DRUG,"EPIDURAL', 'INFILTRATION', 'INTRACAUDAL', 'PERINEURAL",Letter
Class III,2023-04-19,2023-06-01,66,Terminated,LABELING,Labeling Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2017-03-22,2017-06-13,120,Terminated,LABEL MIX UP,Labeling Issues,Colgate Oral Pharmaceuticals, PRESCRIPTION DRUG,DENTAL,Letter
Class II,2018-01-17,2019-02-25,448,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2018-03-28,2018-04-23,49,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2019-05-29,2023-07-17,1526,Terminated,LABELING,Labeling Issues,Takeda Pharmaceuticals America, PRESCRIPTION DRUG,ORAL,Letter
Class III,2019-11-27,2022-08-16,1040,Terminated,LABELING,Labeling Issues,XGen Pharmaceuticals DJB, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2023-05-31,,,Ongoing,LABELING,Labeling Issues,Mayne Pharma, PRESCRIPTION DRUG,"BUCCAL', 'SUBLINGUAL",Letter
Class II,2013-09-18,2014-04-24,259,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2014-04-16,2015-12-18,633,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2017-06-21,2017-06-13,116,Terminated,LABELING,Labeling Issues,nan,nan,nan,Telephone
Class III,2013-03-06,2014-04-01,480,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2014-11-12,2015-04-29,194,Terminated,LABELING,Labeling Issues,Obagi Cosmeceuticals , PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2021-06-23,2021-09-21,105,Terminated,LABELING,Labeling Issues,nan,nan,nan,E-Mail
Class III,2022-01-19,2022-08-19,259,Terminated,LABELING,Labeling Issues,Akorn, PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-03-15,,,Ongoing,LABELING,Labeling Issues,Sagent Pharmaceuticals, PRESCRIPTION DRUG,"INTRAVENOUS', 'SUBCUTANEOUS",Letter
Class II,2015-06-17,2016-12-09,591,Terminated,LABELING,Labeling Issues,nan,nan,nan,Telephone
Class III,2016-04-13,2017-08-07,514,Terminated,LABELING,Labeling Issues,Jubilant DraxImage ., PRESCRIPTION DRUG,ORAL,E-Mail
Class II,2019-01-23,2020-01-24,449,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2019-04-17,2021-06-02,796,Terminated,LABELING,Labeling Issues,XGen Pharmaceuticals DJB, PRESCRIPTION DRUG,EPIDURAL,Letter
Class III,2019-11-06,2021-02-02,494,Terminated,LABELING,Labeling Issues,Asclemed USA, PRESCRIPTION DRUG,nan,E-Mail
Class I,2018-02-07,2020-05-07,854,Terminated,LABELING,Labeling Issues,nan,nan,nan,E-Mail
Class II,2019-10-09,2021-02-19,512,Terminated,LABELING,Labeling Issues,Alkermes, PRESCRIPTION DRUG,nan,Letter
Class III,2013-01-23,2013-11-19,344,Terminated,LABELING,Labeling Issues,nan,nan,nan,Telephone
Class II,2017-09-13,2020-11-24,1208,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2021-06-09,2022-10-18,533,Terminated,LABELING,Labeling Issues,Mylan Institutional , PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2017-12-27,2018-06-21,213,Terminated,LABELING,Labeling Issues,Actavis Pharma, PRESCRIPTION DRUG,ORAL,Letter
Class III,2021-03-10,2022-11-15,634,Terminated,LABELING,Labeling Issues,JUBILANT CADISTA PHARMACEUTICALS INC., PRESCRIPTION DRUG,ORAL,Letter
Class II,2012-10-03,2012-11-01,65,Terminated,LABEL MIX UP,Labeling Issues,nan,nan,nan,Letter
Class II,2015-12-16,2016-07-07,254,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2021-05-12,2022-06-09,414,Terminated,LABELING,Labeling Issues,Heritage Pharmaceuticals . d/b/a Avet Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-01-22,2014-02-07,220,Terminated,LABELING,Labeling Issues,nan,nan,nan,Telephone
Class III,2016-09-28,2017-09-01,379,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class I,2020-09-09,2022-12-28,863,Terminated,LABELING,Labeling Issues,Mylan Institutional , PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2013-08-21,2014-06-23,374,Terminated,LABELING,Labeling Issues,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2015-04-22,2015-09-30,728,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2021-02-03,2021-11-02,295,Terminated,INCORRECT LABELING,Labeling Issues,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,INTRAMUSCULAR,Letter
Class II,2022-01-19,,,Ongoing,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2013-07-03,2015-05-11,803,Terminated,LABELING WRONG BARCODE,Labeling Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2022-09-07,2023-03-03,211,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2023-05-10,,,Ongoing,LABELING,Labeling Issues,Bryant Ranch Prepack, PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2018-01-17,2019-10-11,675,Terminated,LABELING,Labeling Issues,Winthrop U.S, PRESCRIPTION DRUG,SUBCUTANEOUS,Letter
Class III,2012-07-11,2013-03-18,335,Terminated,LABELING,Labeling Issues,Actavis Pharma, PRESCRIPTION DRUG,ORAL,Letter
Class III,2015-12-09,2017-03-29,505,Terminated,LABELING,Labeling Issues,nan,nan,nan,E-Mail
Class III,2021-12-01,,,Ongoing,LABELING,Labeling Issues,nan,nan,nan,Letter
Class I,2013-09-04,2016-05-19,1067,Terminated,LABELING,Labeling Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2016-04-06,2016-03-30,258,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2016-10-05,2017-05-03,237,Terminated,LABELING,Labeling Issues,nan,nan,nan,E-Mail
Class III,2018-10-10,2022-03-09,1269,Terminated,LABELING NOT ELSEWHERE CLASSIFIED,Labeling Issues,nan,nan,nan,Letter
Class II,2019-03-27,2020-12-02,686,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class I,2019-10-02,2021-02-05,518,Terminated,LABEL MIX,Labeling Issues,nan,nan,nan,Letter
Class I,2021-02-17,,,Ongoing,LABELING,Labeling Issues,Apotex Corp., PRESCRIPTION DRUG,SUBCUTANEOUS,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2022-03-09,2023-08-15,531,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2015-05-13,2015-10-14,197,Terminated,LABELING,Labeling Issues,nan,nan,nan,E-Mail
Class I,2018-01-10,2020-10-05,1074,Terminated,LABELING,Labeling Issues,Fresenius Kabi USA, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class III,2020-11-11,2023-04-04,894,Terminated,LABELING NOT ELSEWHERE CLASSIFIED,Labeling Issues,Chalkboard Health, OTC DRUG,ORAL,Letter
Class III,2016-12-21,2017-07-12,394,Terminated,LABELING,Labeling Issues,JUBILANT CADISTA PHARMACEUTICALS INC., PRESCRIPTION DRUG,ORAL,E-Mail
Class II,2017-05-31,2019-06-18,806,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class I,2018-02-21,2019-12-06,688,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2019-09-18,2020-09-09,379,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2012-11-21,2013-01-31,161,Terminated,LABELING,Labeling Issues,nan,nan,nan,E-Mail
Class III,2013-06-12,2014-02-13,323,Terminated,LABELING,Labeling Issues,Major Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class I,2016-02-24,2017-09-28,632,Terminated,LABELING,Labeling Issues,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Press Release
Class II,2017-11-29,2020-09-21,1089,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2020-03-18,2022-09-24,940,Terminated,LABELING,Labeling Issues,Major Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class III,2023-08-30,,,Ongoing,LABELING,Labeling Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2018-01-03,2020-05-19,966,Terminated,LABELING,Labeling Issues,nan,nan,nan,Telephone
Class II,2019-02-20,2020-02-25,382,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2021-02-17,2022-02-08,376,Terminated,LABELING,Labeling Issues,Accord Healthcare, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class III,2021-03-24,2021-06-10,170,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2021-09-01,2023-06-08,672,Terminated,LABELING,Labeling Issues,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAPLEURAL', 'INTRAVENOUS', 'SUBCUTANEOUS",Letter
Class III,2014-01-15,2014-04-01,398,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2021-05-26,2022-04-05,356,Terminated,LABELING,Labeling Issues,Fresenius Medical Care North America, PRESCRIPTION DRUG,INTRAPERITONEAL,Letter
Class II,2021-10-13,,,Ongoing,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2019-01-30,2020-04-02,463,Terminated,LABELING NOT ELSEWHERE CLASSIFIED,Labeling Issues,Discount Drug Mart, OTC DRUG,ORAL,Letter
Class III,2020-01-15,2022-09-28,1043,Terminated,LABELING PRODUCT CONTAINS UNDECLARED API,Labeling Issues,Idelle Labs, OTC DRUG,TOPICAL,Letter
Class I,2020-10-21,,,Ongoing,LABELING,Labeling Issues,nan,nan,nan,Press Release
Class I,2021-05-12,,,Ongoing,LABELING,Labeling Issues,A-S Medication Solutions, OTC DRUG,ORAL,nan
Class II,2023-03-29,2023-12-04,270,Terminated,LABELING,Labeling Issues,Boehringer Ingelheim Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-12-06,,,Ongoing,LABELING,Labeling Issues,Glenmark Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2016-04-06,2016-08-01,237,Terminated,LABELING,Labeling Issues,Genzyme Corporation, PRESCRIPTION DRUG,INTRAVENOUS,E-Mail
Class III,2016-09-28,2018-03-05,579,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2017-10-04,2019-04-08,560,Terminated,LABELING,Labeling Issues,Sandoz , PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2018-02-07,2020-06-04,875,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2021-04-14,2021-09-21,232,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2013-03-20,2013-11-18,290,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2013-08-28,2013-11-07,98,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class I,2014-09-24,2015-08-03,398,Terminated,LABELING,Labeling Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2018-04-18,2020-09-03,899,Terminated,LABELING,Labeling Issues,nan,nan,nan,Telephone
Class I,2012-06-27,2012-07-24,622,Terminated,LABELING,Labeling Issues,nan,nan,nan,FAX
Class I,2018-10-10,2020-02-04,505,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class I,2019-01-02,2019-05-02,154,Terminated,LABELING,Labeling Issues,nan,nan,nan,Telephone
Class III,2019-11-06,2020-05-07,199,Terminated,INCORRECT LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2013-02-13,2013-06-06,129,Terminated,LABELING,Labeling Issues,nan,nan,nan,Telephone
Class II,2013-05-01,2013-08-22,132,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2016-10-05,2017-05-03,230,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2018-03-14,2019-02-26,369,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2016-06-22,2016-12-23,218,Terminated,LABELING,Labeling Issues,Prasco Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class II,2017-07-05,2018-05-31,364,Terminated,LABELING,Labeling Issues,nan,nan,nan,Telephone
Class III,2018-11-21,2020-10-13,749,Terminated,LABELING NOT ELSEWHERE CLASSIFIED,Labeling Issues,nan,nan,nan,Letter
Class II,2013-01-09,2015-07-10,948,Terminated,LABELING,Labeling Issues,AbbVie ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2016-06-22,2017-04-25,335,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2016-11-09,,,Ongoing,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2016-11-23,2017-09-12,327,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2017-05-10,2017-08-11,116,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2018-10-24,2019-07-26,333,Terminated,LABELING,Labeling Issues,Mylan Pharmaceuticals ., PRESCRIPTION DRUG,nan,Letter
Class II,2021-01-27,2023-06-21,903,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class I,2021-07-21,,,Ongoing,LABELING NOT ELSEWHERE CLASSIFIED,Labeling Issues,nan,nan,nan,Letter
Class II,2012-12-05,2013-12-23,410,Terminated,LABELING ILLEGIBLE,Labeling Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2015-01-21,2015-04-22,110,Terminated,LABELING,Labeling Issues,nan,nan,nan,Telephone
Class III,2016-09-28,2017-03-15,356,Terminated,LABELING,Labeling Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,E-Mail
Class I,2018-05-02,2020-01-14,670,Terminated,LABELING,Labeling Issues,nan,nan,nan,Press Release
Class III,2020-02-19,2020-11-17,281,Terminated,LABELING,Labeling Issues,Par Pharmaceutical, PRESCRIPTION DRUG,ORAL,Letter
Class III,2020-03-25,2021-04-09,401,Terminated,LABELING,Labeling Issues,Par Pharmaceutical, PRESCRIPTION DRUG,ORAL,Letter
Class III,2013-12-04,2014-03-24,185,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2014-02-19,2014-08-04,238,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2016-11-30,2017-06-16,224,Terminated,LABELING,Labeling Issues,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2020-02-26,2021-05-19,477,Terminated,LABELING,Labeling Issues,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-09-16,2023-06-07,1070,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2015-01-28,2015-04-14,116,Terminated,LABELING,Labeling Issues,nan,nan,nan,E-Mail
Class II,2018-11-14,2019-10-30,372,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2018-12-26,2019-05-01,141,Terminated,LABELING,Labeling Issues,KVK-Tech, PRESCRIPTION DRUG,ORAL,Letter
Class III,2019-10-02,2023-04-10,1306,Terminated,LABELING,Labeling Issues,Greenstone , PRESCRIPTION DRUG,ORAL,Letter
Class III,2012-09-26,2013-07-10,309,Terminated,LABELING ILLEGIBLE,Labeling Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2019-04-10,2021-02-04,750,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2021-07-28,2023-05-04,666,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class I,2021-11-10,,,Ongoing,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2022-06-01,2022-08-25,118,Terminated,MISLABELING,Labeling Issues,nan,nan,nan,E-Mail
Class III,2012-07-25,2012-11-05,153,Terminated,LABELING,Labeling Issues,Par Pharmaceutical, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2018-05-23,2019-02-28,308,Terminated,LABELING,Labeling Issues,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class III,2020-03-11,2023-05-05,1176,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2021-03-24,,,Ongoing,LABELING,Labeling Issues,nan,nan,nan,E-Mail
Class II,2016-06-15,2016-06-22,37,Terminated,LABELING,Labeling Issues,nan,nan,nan,Telephone
Class III,2019-11-06,2022-01-19,825,Terminated,LABELING,Labeling Issues,Sandoz , PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class I,2022-06-01,2022-11-08,662,Terminated,LABELING,Labeling Issues,nan,nan,nan,Telephone
Class III,2012-08-22,2013-07-02,342,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2014-08-27,2014-11-04,172,Terminated,LABELING,Labeling Issues,nan,nan,nan,Telephone
Class III,2018-07-11,2021-02-02,965,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class I,2021-05-12,2023-10-16,950,Terminated,LABELING NOT ELSEWHERE CLASSIFIED,Labeling Issues,nan,nan,nan,Press Release
Class I,2023-02-01,,,Ongoing,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2012-12-12,2014-05-30,645,Terminated,LABELING,Labeling Issues,Ferring Pharmaceuticals ., PRESCRIPTION DRUG,nan,Letter
Class II,2014-01-22,2014-11-01,339,Terminated,LABELING,Labeling Issues,B. Braun Medical ., PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2020-11-04,2021-04-09,182,Terminated,MISLABELING OF SUS,Labeling Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2018-02-21,2018-09-06,213,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2022-07-20,,,Completed,LABELING,Labeling Issues,CVS Pharmacy, OTC DRUG,TOPICAL,Letter
Class III,2013-08-21,2016-05-16,1026,Terminated,LABELING,Labeling Issues,Akorn, PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2014-07-30,2015-10-07,447,Terminated,LABELING,Labeling Issues,XGen Pharmaceuticals DJB, PRESCRIPTION DRUG,EPIDURAL,E-Mail
Class III,2017-02-22,2017-12-12,330,Terminated,LABELING,Labeling Issues,LEO Pharma ., PRESCRIPTION DRUG,TOPICAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2017-11-15,2018-03-20,147,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2019-10-23,2020-06-03,280,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2020-02-05,2022-12-13,1091,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2023-07-26,,,Ongoing,LABELING,Labeling Issues,GLENMARK THERAPEUTICS INC., OTC DRUG,ORAL,nan
Class I,2019-12-18,,,Ongoing,LABELING,Labeling Issues,Aurolife Pharma , PRESCRIPTION DRUG,ORAL,Letter
Class III,2020-07-01,2022-08-22,1011,Terminated,LABELING,Labeling Issues,Rising Pharma Holdings, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class III,2020-10-07,2022-01-21,499,Terminated,LABELING,Labeling Issues,Rite Aid Corporation, OTC DRUG,ORAL,Letter
Class II,2014-06-18,2017-01-06,1003,Terminated,CORRECT LABELED PRODUCT MISCART,Labeling Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2019-08-14,2020-12-16,540,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class I,2023-01-25,,,Completed,LABELING MIXUP,Labeling Issues,nan,nan,nan,Letter
Class III,2013-06-12,2013-07-01,121,Terminated,LABELING,Labeling Issues,nan,nan,nan,FAX
Class II,2018-03-14,2020-01-09,685,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2012-07-25,2014-03-27,700,Terminated,LABELING,Labeling Issues,Bayer HealthCare ., OTC DRUG,ORAL,Letter
Class III,2014-07-23,2015-07-06,363,Terminated,LABELING,Labeling Issues,AGOURON, PRESCRIPTION DRUG,ORAL,Letter
Class III,2014-11-05,2017-07-27,1148,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2020-08-26,2022-07-22,711,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2020-10-28,2022-01-19,467,Terminated,LABELING,Labeling Issues,ANI Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class III,2016-11-23,2018-11-08,751,Terminated,LABELING NOT ELSEWHERE CLASSIFIED,Labeling Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2023-06-14,,,Completed,MISLABELING,Labeling Issues,nan,nan,nan,E-Mail
Class III,2023-11-01,,,Ongoing,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2014-11-26,2017-03-22,866,Terminated,CORRECT LABELED PRODUCT MISPACK,Labeling Issues,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2016-06-22,2017-09-12,477,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class I,2022-08-03,,,Completed,LABELING,Labeling Issues,Mylan Specialty L.P., PRESCRIPTION DRUG,SUBCUTANEOUS,Press Release
Class III,2023-04-19,,,Ongoing,LABELING,Labeling Issues,Array BioPharma ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2014-05-28,2014-12-17,217,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2018-07-11,2020-11-25,901,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2021-04-21,,,Ongoing,LABELING,Labeling Issues,Doc Rx, PRESCRIPTION DRUG,ORAL,Letter
Class III,2022-10-26,2023-07-25,287,Terminated,"BOXES MISLABELED TO READ ""DECONGESTANT FREE""",Labeling Issues,Walgreen Company, OTC DRUG,ORAL,E-Mail
Class III,2016-04-06,2016-06-22,133,Terminated,LABELING,Labeling Issues,nan,nan,nan,Telephone
Class III,2017-11-08,2020-05-13,943,Terminated,LABELING,Labeling Issues,Winthrop U.S, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2016-05-11,,,Ongoing,LABELING,Labeling Issues,Hospira, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class III,2015-03-11,2017-01-05,693,Terminated,LABELING,Labeling Issues,nan,nan,nan,E-Mail
Class II,2018-04-25,2019-08-14,539,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2022-11-30,,,Ongoing,LABELING,Labeling Issues,Acella Pharmaceuticals, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class III,2023-10-04,,,Ongoing,LABELING,Labeling Issues,RB Health (US) , OTC DRUG,TOPICAL,Letter
Class III,2012-11-21,2013-01-31,227,Terminated,LABELING,Labeling Issues,nan,nan,nan,E-Mail
Class III,2013-03-27,2014-12-18,748,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2013-05-08,2014-04-30,408,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2014-05-14,2015-04-01,362,Terminated,LABELING,Labeling Issues,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2016-07-06,2017-06-14,369,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class I,2018-12-12,2023-05-01,1628,Terminated,LABELING NOT ELSEWHERE CLASSIFIED,Labeling Issues,Fresenius Kabi USA, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class I,2018-12-26,2023-02-01,1513,Terminated,LABELING,Labeling Issues,nan,nan,nan,Press Release
Class III,2019-05-08,2021-02-11,658,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2019-12-18,2022-01-14,779,Terminated,LABELING,Labeling Issues,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2021-08-25,,,Ongoing,CORRECT LABELED PRODUCT MISPACK,Labeling Issues,nan,nan,nan,Letter
Class II,2023-09-13,,,Completed,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2016-06-22,2017-06-23,422,Terminated,LABELING,Labeling Issues,Genzyme Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2016-06-15,2016-10-06,149,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2018-01-17,2020-05-11,907,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2020-04-01,2020-09-28,318,Terminated,LABELING MIX,Labeling Issues,Energique, OTC DRUG,ORAL,Letter
Class III,2021-06-16,2022-09-29,491,Terminated,LABELING,Labeling Issues,Mckesson Corporation DBA SKY Packaginng, PRESCRIPTION DRUG,ORAL,Letter
Class III,2022-08-17,,,Completed,LABELING,Labeling Issues,AvKARE, PRESCRIPTION DRUG,ORAL,Letter
Class III,2016-07-20,2016-11-28,153,Terminated,LABELING,Labeling Issues,Golden State Medical Supply, PRESCRIPTION DRUG,ORAL,Letter
Class III,2019-07-24,2020-09-09,426,Terminated,LABELING,Labeling Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class II,2021-10-27,2022-09-07,362,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2017-09-27,2020-01-13,1012,Terminated,LABELING,Labeling Issues,nan,nan,nan,Telephone
Class III,2017-11-15,2020-03-20,872,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2021-11-24,2022-12-21,420,Terminated,LABELLING,Labeling Issues,Actavis Pharma, PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-12-25,2014-06-26,232,Terminated,LABELING,Labeling Issues,nan,nan,nan,Visit
Class III,2016-11-30,2017-07-27,281,Terminated,LABELING,Labeling Issues,Hospira, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class I,2019-02-20,2023-04-04,1621,Terminated,LABELING,Labeling Issues,"[""Dr.Reddys Laboratories ""]", PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class I,2016-07-13,2016-11-29,244,Terminated,LABELING,Labeling Issues,nan,nan,nan,E-Mail
Class III,2018-05-23,2020-01-08,635,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2012-06-27,2012-12-04,197,Terminated,LABELING,Labeling Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2014-05-07,2016-11-16,1122,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class I,2015-09-02,2018-03-09,1059,Terminated,LABELING,Labeling Issues,RB Health (US) , OTC DRUG,ORAL,Letter
Class II,2013-07-03,2013-10-28,178,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2012-07-25,2017-02-08,1941,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2013-04-24,2015-05-07,777,Terminated,LABELING,Labeling Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2015-06-10,2016-05-19,387,Terminated,LABELING,Labeling Issues,Fresenius Kabi USA, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2020-01-29,2021-09-08,603,Terminated,LABELING,Labeling Issues,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class III,2023-03-15,,,Ongoing,LABELING,Labeling Issues,Akron Pharma ., OTC DRUG,TOPICAL,Letter
Class III,2012-08-08,2013-07-16,369,Terminated,LABELING,Labeling Issues,nan,nan,nan,E-Mail
Class II,2020-06-24,2022-01-24,606,Terminated,LABELING,Labeling Issues,GlaxoSmithKline Consumer Healthcare Holdings (US) , OTC DRUG,ORAL,Letter
Class I,2013-06-19,2016-06-29,1279,Terminated,LABELING,Labeling Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2014-11-19,2016-01-05,452,Terminated,CORRECT LABELED PRODUCT MISPACKED,Labeling Issues,nan,nan,nan,Telephone
Class III,2016-02-03,2020-01-06,1449,Terminated,LABELING,Labeling Issues,Bausch & Lomb Incorporated, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class II,2017-06-07,2018-11-15,546,Terminated,LABELING,Labeling Issues,Allergan, PRESCRIPTION DRUG,SUBLINGUAL,Letter
Class III,2020-03-04,2023-04-04,1147,Terminated,LABELING,Labeling Issues,Golden State Medical Supply, PRESCRIPTION DRUG,ORAL,E-Mail
Class II,2013-04-03,2014-05-12,434,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2017-05-17,2018-02-15,532,Terminated,LABELING,Labeling Issues,sanofi-aventis U.S. , PRESCRIPTION DRUG,SUBCUTANEOUS,Letter
Class II,2017-08-09,2018-05-04,319,Terminated,LABELING,Labeling Issues,nan,nan,nan,E-Mail
Class II,2017-09-20,2017-11-21,110,Terminated,LABELING MIXUP,Labeling Issues,Medline Industries, OTC DRUG,TOPICAL,Letter
Class III,2018-08-15,2019-02-05,210,Terminated,LABELING,Labeling Issues,Oceanside Pharmaceuticals, PRESCRIPTION DRUG,RECTAL,Letter
Class II,2017-03-01,2017-10-24,264,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2018-11-28,2020-11-06,728,Terminated,LABELING,Labeling Issues,Ecolab ., OTC DRUG,TOPICAL,Letter
Class II,2022-03-09,,,Ongoing,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2013-06-05,2014-04-14,357,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class II,2015-06-17,2017-07-10,787,Terminated,LABELING,Labeling Issues,Liebel-Flarsheim Company , PRESCRIPTION DRUG,"ORAL', 'RECTAL",Letter
Class III,2015-07-01,2016-04-12,313,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2015-09-09,2015-12-02,103,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2016-09-28,2018-04-19,623,Terminated,LABELING,Labeling Issues,sanofi-aventis U.S. , PRESCRIPTION DRUG,SUBCUTANEOUS,Letter
Class II,2017-05-31,2017-10-18,238,Terminated,LABELING,Labeling Issues,nan,nan,nan,E-Mail
Class III,2017-04-12,2018-02-14,331,Terminated,LABELING,Labeling Issues,Cosette Pharmaceuticals, PRESCRIPTION DRUG,TOPICAL,E-Mail
Class III,2021-11-17,2022-08-12,311,Terminated,LABELING,Labeling Issues,A-S Medication Solutions, OTC DRUG,ORAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2021-12-15,,,Ongoing,LABELING NOT ELSEWHERE CLASSIFIED,Labeling Issues,nan,nan,nan,Press Release
Class I,2022-07-20,,,Ongoing,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2022-10-12,2023-09-28,394,Terminated,LABELING,Labeling Issues,Woodbine Products Company, OTC DRUG,TOPICAL,Telephone
Class I,2022-12-21,,,Completed,LABELING,Labeling Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2014-07-30,2014-07-31,1038,Terminated,LABELING,Labeling Issues,Amneal Pharmaceuticals of New York , PRESCRIPTION DRUG,ORAL,Telephone
Class II,2014-09-24,2015-11-17,446,Terminated,LABELING,Labeling Issues,nan,nan,nan,Press Release
Class II,2015-10-21,2018-06-06,993,Terminated,LABELING,Labeling Issues,nan,nan,nan,Telephone
Class III,2019-01-23,2020-05-11,557,Terminated,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2019-05-22,2021-04-26,728,Terminated,LABELING,Labeling Issues,ROERIG, PRESCRIPTION DRUG,ORAL,nan
Class II,2020-09-09,2022-09-17,793,Terminated,LABELING,Labeling Issues,Deseret Biologicals, OTC DRUG,ORAL,E-Mail
Class III,2022-06-01,2023-08-17,461,Terminated,LABELING,Labeling Issues,ViiV Healthcare Company, PRESCRIPTION DRUG,ORAL,Letter
Class I,2023-06-28,,,Ongoing,LABELING,Labeling Issues,Major Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class I,2018-07-11,2020-08-31,794,Terminated,LABELING,Labeling Issues,nan,nan,nan,nan
Class II,2020-07-01,2022-01-19,588,Terminated,LABELING,Labeling Issues,Alembic Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-09-16,2022-02-22,564,Terminated,LABELING NOT ELSEWHERE CLASSIFIED,Labeling Issues,nan,nan,nan,E-Mail
Class III,2017-07-12,2020-01-13,1062,Terminated,LABELING,Labeling Issues,nan,nan,nan,Telephone
Class II,2023-08-23,,,Ongoing,LABELING,Labeling Issues,nan,nan,nan,Letter
Class III,2013-06-05,2014-01-23,289,Terminated,LABELING,Labeling Issues,Aurobindo Pharma Limited, PRESCRIPTION DRUG,ORAL,Letter
Class III,2016-12-28,2017-05-16,175,Terminated,LABELING,Labeling Issues,nan,nan,nan,E-Mail
Class I,2018-10-03,,,Ongoing,LABELING,Labeling Issues,Camber Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-04-17,2022-05-23,1161,Terminated,LABELING NOT ELSEWHERE CLASSIFIED,Labeling Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class I,2022-11-02,,,Ongoing,LABEL MIX,Labeling Issues,Golden State Medical Supply, PRESCRIPTION DRUG,ORAL,Letter
Class III,2014-10-29,2015-06-01,234,Terminated,SUBPOTENT,Potency Issues,American Health Packaging, PRESCRIPTION DRUG,ORAL,Letter
Class II,2015-06-03,2016-02-19,323,Completed,SUBPOTENT DRUG,Potency Issues,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2017-08-23,2018-02-28,226,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2019-10-23,2023-04-04,1293,Terminated,SUPERPOTENT DRUG,Potency Issues,Aurolife Pharma, PRESCRIPTION DRUG,ORAL,Letter
Class III,2013-10-30,2015-04-29,602,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,Letter
Class II,2018-07-18,2019-05-01,306,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2018-09-12,2020-11-25,834,Terminated,SUPTERPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2020-04-29,2021-06-07,418,Terminated,SUBPOTENT DRUG,Potency Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-07-01,2021-11-05,513,Terminated,SUBPOTENT DRUG,Potency Issues,Crown Laboratories, PRESCRIPTION DRUG,TOPICAL,Letter
Class II,2020-08-12,,,Ongoing,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2021-02-17,2022-02-08,383,Terminated,SUPERPOTENT DRUG. LIDOCAINE   HIGHER CONCENTRATION THAN LISTED,Potency Issues,nan,nan,nan,Letter
Class III,2013-04-03,2013-09-12,206,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,Letter
Class III,2017-04-26,2021-09-29,1728,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,Telephone
Class II,2022-06-22,,,Ongoing,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,nan
Class II,2012-09-05,2012-08-28,1902,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,FAX
Class III,2016-07-13,2017-02-03,241,Terminated,SUBPOTENCY,Potency Issues,nan,nan,nan,Letter
Class III,2016-11-09,,,Ongoing,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2016-12-14,2018-04-19,518,Terminated,SUBPOTENT DRUG,Potency Issues,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2020-01-22,2021-04-07,453,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,Letter
Class III,2015-07-01,2016-03-21,291,Terminated,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2015-11-04,2017-05-08,592,Terminated,SUBPOTENT DRUG,Potency Issues,PHARMACIA & UPJOHN COMPANY , PRESCRIPTION DRUG,ORAL,Letter
Class III,2019-11-13,2020-08-18,322,Terminated,SUBPOTENT DRUG,Potency Issues,Sato Pharmaceutical Co., OTC DRUG,ORAL,Letter
Class I,2013-02-06,2021-07-20,3148,Terminated,SUPERPOTENT,Potency Issues,nan,nan,nan,Press Release
Class III,2014-10-01,2017-04-07,1085,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class I,2016-02-24,2016-02-22,405,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Telephone
Class II,2016-10-19,2019-07-31,1048,Terminated,LACK OF ASSURANCE OF STERILITY AND SUBPOTENT DRUG,Potency Issues,Hospira, PRESCRIPTION DRUG,"EPIDURAL', 'INFILTRATION', 'INTRACAUDAL', 'PERINEURAL",Letter
Class II,2018-12-26,2020-12-02,723,Terminated,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2020-04-29,,,Ongoing,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,E-Mail
Class III,2022-04-13,2023-01-04,292,Terminated,SUBPOTENT DRUG,Potency Issues,Advanced Accelerator Applications USA, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2019-11-20,2020-08-18,322,Terminated,SUBPOTENT DRUG,Potency Issues,Walgreen Co., OTC DRUG,ORAL,Letter
Class III,2013-06-26,2014-03-18,419,Terminated,SUPERPOTENT,Potency Issues,nan,nan,nan,Letter
Class III,2013-07-31,2018-05-18,1786,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2015-08-12,2016-02-11,213,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2022-04-20,,,Ongoing,SUBPOTENT DRUG,Potency Issues,AuroMedics Pharma , PRESCRIPTION DRUG,INTRAMUSCULAR,nan
Class III,2012-07-11,2013-02-26,347,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,Letter
Class II,2013-05-29,2016-06-30,1157,Terminated,SUBPOTENT DRUG,Potency Issues,Pfizer Laboratories Div Pfizer , PRESCRIPTION DRUG,ORAL,Letter
Class II,2021-07-07,,,Ongoing,SUBPOTENT,Potency Issues,nan,nan,nan,Letter
Class II,2022-01-19,2022-09-17,255,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,E-Mail
Class III,2014-10-22,2015-04-03,183,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2021-10-06,2023-06-21,657,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2022-02-02,2022-08-11,251,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2014-08-20,2015-06-30,363,Terminated,SUBPOTENT DRUG,Potency Issues,E-Z-EM Canada , PRESCRIPTION DRUG,ORAL,Letter
Class III,2018-08-22,2018-12-19,138,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2022-03-02,,,Ongoing,SUBPOTENT DRUG,Potency Issues,Dr. Reddys Laboratories , PRESCRIPTION DRUG,ORAL,Letter
Class II,2018-02-07,2023-08-28,2167,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2012-09-05,2013-02-22,191,Terminated,SUBPOTENT,Potency Issues,Galderma Laboratories, PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2020-01-08,2021-08-25,614,Terminated,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,Telephone
Class III,2020-08-05,,,Ongoing,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2022-03-30,2023-10-04,575,Terminated,SUPER POTENT,Potency Issues,nan,nan,nan,Letter
Class III,2023-08-30,,,Ongoing,SUBPOTENT,Potency Issues,Glenmark Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2013-06-26,2016-05-13,1109,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,Letter
Class II,2013-12-11,2015-06-26,693,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,Letter
Class II,2014-03-05,2014-06-02,208,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2013-03-27,2013-07-01,228,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,FAX
Class II,2013-04-10,2013-12-18,275,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2018-07-18,2019-04-03,272,Terminated,FAILED IMPURITIES AND DEGRADATION SPECIFICATIONS AND SUBPOTENT DRUG,Potency Issues,Actavis Pharma, PRESCRIPTION DRUG,TOPICAL,Letter
Class II,2019-08-07,2020-04-22,280,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2019-12-11,2020-06-03,195,Terminated,SUB POTENT DRUG,Potency Issues,Pacira Pharmaceuticals, PRESCRIPTION DRUG,INFILTRATION,Letter
Class II,2020-01-01,2023-08-17,1345,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2020-02-12,2022-12-16,1057,Terminated,SUBPOTENT DRUG,Potency Issues,Macleods Pharmaceuticals Limited, PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-08-14,2014-03-17,375,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2018-03-07,2018-11-29,288,Terminated,SUBPOTENT DRUG,Potency Issues,Leadiant Biosciences, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class III,2018-03-21,2020-06-26,840,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2023-12-13,,,Ongoing,STAQ PHARMA INC. RECEIVED CONSUMER COMPLAINTS RELATED TO LEAKING BAGS AND OTHER POTENTIAL BAG CONCERNS. UPON INVESTIGATION,Potency Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2015-03-25,2016-04-11,444,Terminated,SUBPOTENT DRUG AND FAILED IMPURITIES,Potency Issues,nan,nan,nan,Letter
Class II,2015-10-07,2015-11-30,94,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Telephone
Class III,2018-05-30,2019-03-18,318,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,Letter
Class II,2020-04-01,2023-06-02,1179,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Telephone
Class II,2022-02-02,2023-12-04,705,Terminated,SUPERPOTENT AND FAILED TABLET,Potency Issues,Rising Health, PRESCRIPTION DRUG,ORAL,Letter
Class III,2022-10-05,2023-08-11,416,Terminated,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class I,2012-11-28,2014-03-24,549,Terminated,SUPERPOTENT,Potency Issues,nan,nan,nan,Press Release
Class III,2014-03-26,2015-07-10,499,Terminated,SUBPOTENT DRUG,Potency Issues,GlaxoSmithKline Consumer Healthcare Holdings (US) , OTC DRUG,ORAL,Letter
Class II,2019-01-09,2023-03-15,1545,Terminated,SUBPOTENT DRUG,Potency Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class III,2019-07-10,2019-08-08,682,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2020-11-25,2021-06-24,225,Terminated,SUPERPOTENT DRUG,Potency Issues,Actavis Pharma, PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2022-08-17,2023-04-12,264,Terminated,SUBPOTENT DRUG,Potency Issues,BluePoint Laboratories, PRESCRIPTION DRUG,"INTRAVENOUS', 'SUBCUTANEOUS",Letter
Class II,2023-07-05,,,Completed,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,nan
Class II,2013-11-13,2016-04-05,925,Terminated,SUPERPOTENT DRUG,Potency Issues,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2017-11-01,2020-01-24,875,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Press Release
Class II,2018-06-20,2019-02-06,246,Terminated,SUPERPOTENT AND SUBPOTENT,Potency Issues,nan,nan,nan,Telephone
Class II,2021-09-01,2023-05-31,677,Terminated,SUBPOTENT,Potency Issues,Professional Disposables International, OTC DRUG,TOPICAL,Letter
Class II,2021-11-24,2022-06-09,217,Terminated,SUBPOTENT DRUG,Potency Issues,Amneal Pharmaceuticals , PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2015-09-23,2017-01-26,647,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2016-09-07,2018-06-14,758,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,E-Mail
Class II,2016-11-09,2019-05-10,931,Terminated,SUBPOTENT DRUG,Potency Issues,Akorn, OTC DRUG,OPHTHALMIC,Letter
Class II,2022-04-13,2023-02-27,332,Terminated,SUBPOTENT DRUG AND FAILED IMPURITIES,Potency Issues,Mylan Pharmaceuticals ., PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class III,2015-10-21,2016-10-28,458,Terminated,SUPERPOTENT DRUG,Potency Issues,Ohm Laboratories ., OTC DRUG,ORAL,Letter
Class I,2016-02-24,,,Ongoing,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2017-12-27,2019-04-03,663,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2020-12-23,2023-05-17,903,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2022-12-07,,,Ongoing,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2013-05-22,2015-04-30,752,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,Letter
Class III,2018-08-08,2022-03-09,1337,Terminated,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2023-10-25,,,Ongoing,SUBPOTENT,Potency Issues,nan,nan,nan,Letter
Class III,2018-02-07,2020-08-03,922,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2018-03-07,2020-04-29,804,Terminated,SUBPOTENT DRUG,Potency Issues,Medline Industries, OTC DRUG,TOPICAL,Letter
Class III,2013-04-03,2013-05-28,188,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2014-01-08,2015-03-05,510,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,Letter
Class II,2018-04-25,2019-04-15,384,Terminated,SUPERPOTENT DRUG,Potency Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2018-05-09,2021-01-20,999,Terminated,SUPERPOTENT DRUG,Potency Issues,Winthrop U.S, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2018-07-18,2020-01-16,556,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2023-11-08,,,Ongoing,SUBPOTENT DRUG,Potency Issues,Edenbridge Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2012-09-12,2017-04-11,1756,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,Letter
Class III,2018-09-05,2021-01-22,952,Terminated,SUBPOTENCY,Potency Issues,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-02-20,2023-03-29,1534,Terminated,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2018-03-14,2019-04-03,434,Terminated,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,Telephone
Class III,2014-10-01,2016-01-27,503,Terminated,SUBPOTENT,Potency Issues,Par Pharmaceutical, PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-11-05,2018-03-21,1304,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class I,2018-05-23,2023-10-03,1974,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2020-06-24,2020-09-28,136,Terminated,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2023-01-25,2023-10-23,335,Terminated,SUBPOTENT DRUG,Potency Issues,Fresenius Kabi USA, PRESCRIPTION DRUG,"INFILTRATION', 'PERINEURAL",Letter
Class III,2013-10-30,2014-04-10,199,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,Letter
Class III,2014-03-05,2014-09-05,210,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2017-03-01,2017-05-17,247,Terminated,SUPERPOTENT DRUG AND SUBPOTENT DRUG,Potency Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2018-10-17,2021-07-13,1014,Terminated,SUBPOTENT DRUG,Potency Issues,Cipla USA ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2013-07-03,2013-07-19,73,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2018-01-17,2019-06-20,563,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2023-03-01,2023-10-31,274,Terminated,SUBPOTENT DRUG,Potency Issues,IBSA Pharma ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-02-19,2015-10-14,638,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2014-06-11,2015-06-11,538,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2021-07-14,2022-02-16,355,Terminated,SUBPOTENT DRUG,Potency Issues,Alvogen ., PRESCRIPTION DRUG,"BUCCAL', 'SUBLINGUAL",Letter
Class I,2021-06-02,,,Completed,SUBPOTENT DRUG,Potency Issues,Acella Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Press Release
Class II,2021-09-15,2023-09-29,809,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,Letter
Class III,2022-05-25,,,Completed,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,E-Mail
Class II,2014-12-03,2016-09-22,693,Terminated,SUBPOTENT DRUG,Potency Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2015-07-08,2016-09-12,460,Terminated,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2021-12-08,2022-11-15,361,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2012-12-19,2013-02-22,686,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,FAX
Class I,2014-06-18,2014-07-31,127,Terminated,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,Telephone
Class III,2021-09-08,2022-04-05,228,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,Letter
Class II,2022-06-08,,,Ongoing,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2023-01-11,2023-12-05,343,Terminated,SUBPOTENT DRUG,Potency Issues,JUBILANT CADISTA PHARMACEUTICALS INC., PRESCRIPTION DRUG,ORAL,Letter
Class III,2013-05-08,2016-05-13,1159,Terminated,SUBPOTENT DRUG,Potency Issues,Akorn, PRESCRIPTION DRUG,AURICULAR (OTIC),Letter
Class III,2018-12-26,2019-06-14,189,Terminated,SUBPOTENT DRUG,Potency Issues,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class III,2013-11-27,2014-08-04,330,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2018-08-15,2020-07-16,715,Terminated,SUPERPOTENT DRUG,Potency Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2020-07-08,,,Ongoing,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,E-Mail
Class III,2023-07-19,,,Ongoing,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2020-12-30,2022-08-25,623,Terminated,SUBPOTENT DRUG,Potency Issues,Fresenius Kabi USA, PRESCRIPTION DRUG,"EPIDURAL', 'RETROBULBAR",Letter
Class II,2022-11-02,,,Ongoing,SUBPOTENT DRUG,Potency Issues,AuroMedics Pharma , PRESCRIPTION DRUG,SUBCUTANEOUS,Letter
Class III,2016-05-25,2018-06-06,828,Terminated,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2017-01-25,2017-09-14,275,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2022-03-02,,,Ongoing,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,E-Mail
Class III,2015-05-20,2017-04-07,731,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2015-05-20,2018-07-13,1171,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,E-Mail
Class III,2023-03-08,2023-06-21,117,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2014-12-31,2017-04-26,861,Terminated,SUBPOTENT DRUG,Potency Issues,Greenstone , PRESCRIPTION DRUG,ORAL,Letter
Class III,2020-10-21,2021-11-10,412,Terminated,SUBPOTENT DRUG,Potency Issues,Leadiant Biosciences, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class III,2022-04-13,2023-04-03,367,Terminated,SUBPOTENT,Potency Issues,JUBILANT CADISTA PHARMACEUTICALS INC., PRESCRIPTION DRUG,ORAL,Letter
Class II,2012-07-04,2013-07-30,543,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2013-03-06,2013-05-03,137,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2015-10-07,2015-10-02,1243,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2020-10-07,2022-02-22,524,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2012-10-03,2013-04-10,273,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,Letter
Class I,2013-02-27,2016-08-09,1334,Terminated,SUPERPOTENT,Potency Issues,nan,nan,nan,Letter
Class III,2016-11-16,2017-03-29,191,Terminated,SUPERPOTENT AND SUBPOTENT DRUGS,Potency Issues,nan,nan,nan,Telephone
Class II,2020-12-30,2021-09-23,283,Terminated,SUBPOTENT DRUG.,Potency Issues,nan,nan,nan,Letter
Class II,2018-07-18,2023-03-06,1712,Terminated,SUBPOTENT DRUG AND FAILED CONTENT UNIFORMITY.,Potency Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class III,2022-08-24,2023-09-28,428,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2017-06-07,2019-08-19,845,Terminated,SUBPOTENT DRUG,Potency Issues,Sandoz , PRESCRIPTION DRUG,ORAL,Letter
Class III,2022-05-18,,,Ongoing,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2018-02-14,2020-11-24,1030,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2021-04-21,2021-12-16,265,Terminated,SUPERPOTENT DRUG,Potency Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-04-24,2020-07-08,453,Terminated,SUBPOTENT PRODUCT,Potency Issues,nan,nan,nan,Letter
Class II,2013-08-21,2014-06-06,465,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2014-10-29,2015-09-25,375,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,E-Mail
Class II,2019-03-27,2022-08-01,1238,Terminated,SUB POTENT DRUG,Potency Issues,Akorn Operating Company , PRESCRIPTION DRUG,AURICULAR (OTIC),Letter
Class II,2020-08-05,2023-05-17,1080,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,E-Mail
Class II,2022-11-23,2023-08-23,287,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2014-06-25,2015-02-23,283,Terminated,SUBPOTENT DRUG.,Potency Issues,nan,nan,nan,Letter
Class II,2017-11-15,2020-01-24,841,Terminated,SUBPOTENT DRUG,Potency Issues,Atlantis Consumer Healthcare, OTC DRUG,TOPICAL,Letter
Class II,2022-01-05,,,Ongoing,SUPERPOTENT DRUG,Potency Issues,McKesson Corporation, PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2022-10-05,2023-09-28,401,Terminated,SUPERPOTENT DRUG,Potency Issues,Leading Pharma, PRESCRIPTION DRUG,ORAL,Letter
Class III,2017-01-25,2019-04-08,852,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2020-04-01,2021-09-22,552,Terminated,SUBPOTENT DRUG,Potency Issues,Pharmaceutical Associates, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-09-09,2021-06-14,311,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2022-12-14,2023-02-03,60,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class I,2012-07-25,2015-05-29,1137,Terminated,SUPERPOTENT,Potency Issues,nan,nan,nan,Press Release
Class I,2012-10-31,2015-05-29,1017,Terminated,SUPERPOTENT,Potency Issues,nan,nan,nan,Press Release
Class III,2015-07-15,2016-06-24,354,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class I,2012-10-31,2013-08-12,348,Terminated,SUPERPOTENT,Potency Issues,nan,nan,nan,Letter
Class III,2012-11-14,2013-03-25,161,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,Letter
Class III,2016-06-08,2018-06-06,797,Terminated,SUBPOTENT DRUG,Potency Issues,Taro Pharmaceuticals U.S.A., PRESCRIPTION DRUG,TOPICAL,Letter
Class II,2021-06-23,2022-06-09,365,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,Letter
Class II,2020-02-05,2021-06-03,506,Terminated,SUBPOTENT,Potency Issues,Pharmaceutical Associates, PRESCRIPTION DRUG,ORAL,Letter
Class III,2013-02-20,2014-05-16,494,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2021-05-26,2023-09-28,898,Terminated,SUBPOTENT DRUG,Potency Issues,Nomax ., PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class II,2013-01-02,2014-01-03,431,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,Letter
Class III,2013-12-18,2014-02-12,331,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2017-11-22,2019-04-03,575,Terminated,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class I,2012-08-15,2015-05-29,1112,Terminated,SUPERPOTENT,Potency Issues,nan,nan,nan,Press Release
Class III,2015-06-24,2016-08-15,469,Terminated,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2022-01-26,,,Ongoing,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class I,2022-07-06,2023-04-04,316,Terminated,SUPERPOTENT,Potency Issues,Akcea Therapeutics, PRESCRIPTION DRUG,SUBCUTANEOUS,E-Mail
Class III,2023-09-27,,,Ongoing,SUBPOTENT,Potency Issues,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,"OPHTHALMIC', 'TOPICAL",Letter
Class III,2015-03-11,2015-09-22,207,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2019-07-31,2021-11-02,845,Terminated,SUPERPOTENT DRUG AND FAILED STABILITY SPECIFICATIONS,Potency Issues,Tris Pharma , PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-02-19,2022-07-29,956,Terminated,SUBPOTENT DRUG,Potency Issues,Akorn Operating Company , PRESCRIPTION DRUG,AURICULAR (OTIC),Letter
Class III,2021-09-29,2023-06-21,658,Terminated,SUBPOTENCY,Potency Issues,Westminster Pharmaceuticals, PRESCRIPTION DRUG,TOPICAL,Telephone
Class II,2023-09-27,,,Ongoing,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2014-11-05,2015-08-03,305,Terminated,SUBPOTENCY,Potency Issues,nan,nan,nan,Letter
Class III,2017-12-27,2019-05-01,499,Terminated,SUBPOTENT DRUG,Potency Issues,Trigen Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class I,2020-08-26,2023-10-13,1179,Terminated,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2021-12-29,2022-11-04,323,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,Letter
Class I,2020-10-07,,,Ongoing,CHEMICAL CONTAMINATION AND SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Press Release
Class III,2022-03-02,2022-12-08,297,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2022-08-03,,,Ongoing,SUPERPOTENT DRUG,Potency Issues,Actavis Pharma, PRESCRIPTION DRUG,TOPICAL,nan
Class II,2023-09-20,,,Ongoing,SUPERPOTENT,Potency Issues,VistaPharm, PRESCRIPTION DRUG,ORAL,Letter
Class III,2018-04-04,2020-04-10,770,Terminated,SUPERPOTENT AND FAILED STABILITY SPECIFICATIONS,Potency Issues,nan,nan,nan,Letter
Class III,2018-04-04,2020-04-22,755,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2018-10-31,2022-10-18,1484,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2023-03-15,,,Ongoing,SUBPOTENT DRUG,Potency Issues,B. Braun Medical ., PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2012-06-27,2013-08-08,490,Terminated,SUPERPOTENT,Potency Issues,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2016-07-13,2017-02-03,532,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,E-Mail
Class III,2016-03-16,2017-03-24,406,Terminated,SUBPOTENT DRUG,Potency Issues,Ecolab ., OTC DRUG,TOPICAL,Letter
Class I,2018-01-31,2019-09-05,608,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,Letter
Class II,2018-07-11,2019-05-01,327,Terminated,SUPERPOTENT DRUG,Potency Issues,Ingenus Pharmaceuticals, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2013-07-31,2014-07-29,375,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2016-03-09,2016-11-22,285,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2019-02-27,2019-10-30,266,Terminated,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2013-07-24,2015-04-07,652,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2018-10-03,2020-06-26,640,Terminated,SUPERPOTENT DRUG,Potency Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2018-12-26,2021-04-01,857,Terminated,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2021-06-16,,,Ongoing,SUPERPOTENT DRUG,Potency Issues,Medline Industries, OTC DRUG,TOPICAL,Letter
Class II,2012-07-04,2013-07-30,522,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2012-06-20,2012-09-13,177,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,E-Mail
Class III,2016-03-23,2016-04-06,97,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,E-Mail
Class III,2017-01-25,2021-01-14,1549,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class I,2020-06-10,2022-01-19,607,Terminated,SUPERPOTENT DRUG.,Potency Issues,Acella Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Press Release
Class II,2021-06-09,2021-10-14,163,Terminated,SUBPOTENT DRUG,Potency Issues,Boehringer Ingelheim Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2018-01-24,2020-05-07,920,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Telephone
Class II,2020-09-02,,,Ongoing,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,E-Mail
Class II,2020-11-04,2022-03-03,598,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2017-05-10,2019-06-18,792,Terminated,SUBPOTENT,Potency Issues,Hy-Vee, OTC DRUG,ORAL,E-Mail
Class II,2019-06-19,2022-07-15,1128,Terminated,SUBPOTENT DRUG,Potency Issues,B. Braun Medical ., PRESCRIPTION DRUG,INTRAVENOUS,E-Mail
Class II,2020-08-19,2021-03-17,231,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2023-08-30,,,Ongoing,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,nan
Class II,2023-11-22,,,Ongoing,SUB POTENT AND SUPER POTENT PRODUCT,Potency Issues,nan,nan,nan,E-Mail
Class II,2016-10-26,2019-02-26,959,Terminated,SUPERPOTENT DRUG,Potency Issues,Supernus Pharmaceuticals, PRESCRIPTION DRUG,ORAL,E-Mail
Class III,2017-11-08,2018-04-23,210,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class I,2022-06-15,2022-11-07,206,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2023-07-26,,,Ongoing,SUPERPOTENT DRUG,Potency Issues,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class II,2016-08-31,2017-02-07,228,Terminated,SUPERPOTENT DRUG,Potency Issues,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class III,2012-08-22,2015-02-10,1008,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2013-05-08,2014-08-14,514,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2014-10-15,2017-09-22,1144,Terminated,SUPERPOTENT DRUG,Potency Issues,Zydus Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2015-04-22,2016-01-20,281,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2017-05-10,2017-07-27,212,Terminated,SUPERPOTENT DRUG,Potency Issues,Major Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class III,2017-08-23,2018-06-19,342,Terminated,CRYSTALLIZATION WITH SUBPOTENT OUT OF  SPECIFICATION ASSAY RESULTS FOR CHLORHEXIDINE.,Potency Issues,nan,nan,nan,Letter
Class III,2023-03-01,2023-10-31,271,Terminated,SUBPOTENT DRUG,Potency Issues,Advantice Health, OTC DRUG,TOPICAL,Letter
Class II,2012-08-01,2013-03-01,296,Terminated,SUPERPOTENT,Potency Issues,nan,nan,nan,Letter
Class I,2018-01-10,2020-06-02,956,Terminated,SUPERPOTENT,Potency Issues,Greenstone , PRESCRIPTION DRUG,ORAL,Letter
Class III,2017-01-04,,,Ongoing,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,E-Mail
Class III,2017-05-03,2017-08-24,232,Terminated,SUPOTENT,Potency Issues,nan,nan,nan,Letter
Class III,2023-05-03,2023-09-20,163,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2023-10-04,,,Ongoing,SUPERPOTENT DRUG,Potency Issues,TOLMAR ., PRESCRIPTION DRUG,SUBCUTANEOUS,Letter
Class II,2013-09-04,2014-01-07,146,Terminated,SUBPOTENT DRUG,Potency Issues,Darby Dental Supply, PRESCRIPTION DRUG,SUBCUTANEOUS,E-Mail
Class I,2017-05-31,2017-10-26,196,Terminated,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,Press Release
Class II,2021-09-29,2023-04-12,594,Terminated,SUBPOTENT DRUG,Potency Issues,Atlantis Consumer Healthcare, OTC DRUG,TOPICAL,Letter
Class II,2021-10-27,2023-02-16,512,Terminated,SUBPOTENT DRUG,Potency Issues,Teva Respiratory, PRESCRIPTION DRUG,RESPIRATORY (INHALATION),Letter
Class II,2022-12-07,2023-12-13,385,Terminated,SUBPOTENT DRUG,Potency Issues,Heritage Pharmaceuticals . d/b/a Avet Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2013-02-13,2013-07-23,188,Terminated,SUBPOTENT DRUG,Potency Issues,Actelion Pharmaceuticals US, PRESCRIPTION DRUG,RESPIRATORY (INHALATION),Letter
Class III,2021-07-21,2022-10-18,487,Terminated,SUPERPOTENT,Potency Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2016-11-16,2018-06-06,741,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2016-11-30,2020-05-01,1271,Terminated,SUPERPOTENT,Potency Issues,Pfizer Laboratories Div Pfizer , PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-06-24,2021-03-17,274,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2014-10-29,2015-08-10,390,Terminated,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,Telephone
Class II,2018-01-24,2020-05-07,954,Terminated,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,Telephone
Class III,2020-12-09,,,Ongoing,SUPERPOTENT AND SUBPOTENT,Potency Issues,nan,nan,nan,Letter
Class III,2017-04-12,2018-08-28,530,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2018-03-14,2019-05-01,427,Terminated,SUBPOTENT DRUG,Potency Issues,Trigen Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class III,2021-12-22,,,Ongoing,SUPERPOTENT,Potency Issues,nan,nan,nan,Letter
Class I,2022-08-03,2022-09-28,93,Terminated,SUBPOTENT AND SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2012-08-08,2015-04-17,1057,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,Letter
Class III,2012-12-26,2014-04-29,511,Terminated,SUPERPOTENT,Potency Issues,nan,nan,nan,Letter
Class II,2018-05-02,2019-05-16,398,Terminated,SUBPOTENT DRUG,Potency Issues,Rising Pharmaceuticals, PRESCRIPTION DRUG,AURICULAR (OTIC),Letter
Class I,2018-09-26,2019-04-02,218,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2015-10-21,2020-11-18,1897,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2017-03-22,2018-06-22,577,Terminated,SUBPOTENT DRUG,Potency Issues,Wyeth Pharmaceuticals , PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2020-12-23,2021-06-24,216,Terminated,SUBPOTENCY,Potency Issues,nan,nan,nan,Letter
Class II,2013-01-02,2013-11-14,477,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2014-04-02,2015-02-03,368,Terminated,SUBPOTENT DRUG,Potency Issues,Royal Pharmaceuticals, PRESCRIPTION DRUG,TOPICAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2021-10-20,,,Ongoing,SUBPOTENT DRUG,Potency Issues,Eli Lilly  Company, PRESCRIPTION DRUG,nan,Press Release
Class III,2022-05-04,2022-12-28,260,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2015-03-11,2015-12-04,295,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2016-01-13,2016-02-08,396,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Telephone
Class III,2021-05-26,2022-06-17,406,Terminated,SUBPOTENT AND PRESENCE OF PARTICULATES .,Potency Issues,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,"OPHTHALMIC', 'TOPICAL",Letter
Class II,2017-04-12,2017-05-12,60,Terminated,SUPERPOTENT DRUG,Potency Issues,Genentech, PRESCRIPTION DRUG,ORAL,Letter
Class III,2020-01-01,2021-02-09,421,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2021-12-22,2022-09-07,303,Terminated,SUPERPOTENT DRUG,Potency Issues,Sandoz ., PRESCRIPTION DRUG,nan,Letter
Class III,2013-12-18,2018-05-18,1675,Terminated,SUBPOTENT. DRUG,Potency Issues,Taro Pharmaceuticals U.S.A., PRESCRIPTION DRUG,TOPICAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2017-05-31,2018-05-02,359,Terminated,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2019-01-16,2020-05-07,491,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,Letter
Class II,2020-06-17,2022-01-19,601,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class I,2012-11-28,,,Ongoing,SUPERPOTENT,Potency Issues,nan,nan,nan,Press Release
Class III,2015-06-24,2016-03-31,330,Terminated,SUBPOTENT DRUG,Potency Issues,"[""Dr. Reddys Laboratories ""]", PRESCRIPTION DRUG,ORAL,Letter
Class I,2020-10-28,2022-12-08,812,Terminated,SUBPOTENT DRUG,Potency Issues,Acella Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Press Release
Class III,2022-04-13,2023-07-21,476,Terminated,SUBPOTENT DRUG AND PRESENCE OF PARTICULATE MATTER,Potency Issues,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,"OPHTHALMIC', 'TOPICAL",Letter
Class II,2014-03-12,2016-05-24,853,Terminated,SUBPOTENT,Potency Issues,Fresenius Kabi USA, PRESCRIPTION DRUG,"INTRAVENOUS', 'SUBCUTANEOUS",Letter
Class III,2014-10-15,2015-06-30,285,Terminated,SUBPOTENT DRUG,Potency Issues,E-Z-EM, OTC DRUG,ORAL,Letter
Class III,2017-07-05,2019-02-07,605,Terminated,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2017-12-27,2020-04-20,896,Terminated,SUPERPOTENT,Potency Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2019-03-27,2021-03-04,748,Terminated,SUBPOTENT DRUG.,Potency Issues,nan,nan,nan,Letter
Class III,2020-11-11,2021-08-11,289,Terminated,SUBPOTENT,Potency Issues,nan,nan,nan,Letter
Class I,2021-09-22,,,Ongoing,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2015-09-02,2016-12-15,490,Terminated,SUBPOTENT DRUG,Potency Issues,"[""Dr. Reddys Laboratories ""]", PRESCRIPTION DRUG,ORAL,Letter
Class III,2016-04-20,2017-12-04,620,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2017-12-27,2020-04-01,872,Terminated,SUPERPOTENT,Potency Issues,nan,nan,nan,Letter
Class III,2018-06-20,2019-06-20,378,Terminated,SUPERPOTENT DRUG,Potency Issues,Mylan Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-08-19,2021-09-22,414,Terminated,SUBPOTENT DRUG,Potency Issues,Pharmaceutical Associates, PRESCRIPTION DRUG,ORAL,Letter
Class III,2018-04-11,2020-06-11,813,Terminated,SUPERPOTENT DRUG,Potency Issues,Mayne Pharma, PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2021-03-10,2022-01-21,333,Terminated,SUBPOTENT,Potency Issues,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,"OPHTHALMIC', 'TOPICAL",Letter
Class III,2017-02-08,2017-09-06,278,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2017-05-24,2018-02-20,319,Terminated,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2017-11-22,2020-01-24,833,Terminated,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,Telephone
Class II,2018-07-04,2019-04-03,287,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Telephone
Class III,2019-03-27,2019-11-15,249,Terminated,SUBPOTENT DRUG.,Potency Issues,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class III,2023-10-11,,,Ongoing,SUBPOTENT,Potency Issues,nan,nan,nan,Letter
Class II,2013-12-11,2014-04-22,329,Terminated,THE FIRM RECEIVED SEVEN REPORTS OF ADVERSE REACTIONS IN THE FORM OF SKIN ABSCESSES POTENTIALLY LINKED TO COMPOUNDED PRESERVATIVE,Potency Issues,nan,nan,nan,Telephone
Class III,2013-08-28,2014-05-27,333,Terminated,SUBPOTENT,Potency Issues,Eckson Labs, PRESCRIPTION DRUG,ORAL,Letter
Class II,2017-02-01,2018-02-06,412,Terminated,SUBPOTENCY,Potency Issues,nan,nan,nan,Letter
Class II,2018-12-26,2020-10-08,672,Terminated,SUPERPOTENT DRUG.,Potency Issues,Pfizer Laboratories Div Pfizer , PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-10-23,2021-02-23,519,Terminated,SUPERPOTENT,Potency Issues,Macleods Pharmaceuticals Limited, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-07-29,2021-06-30,363,Terminated,SUPERPOTENT DRUG,Potency Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class III,2023-02-01,,,Ongoing,SUBPOTENT DRUG,Potency Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,TOPICAL,E-Mail
Class III,2017-02-15,2022-06-15,2004,Terminated,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2014-10-29,2016-02-02,545,Terminated,SUPERPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2018-04-25,2018-11-29,234,Terminated,SUBPOTENT DRUG,Potency Issues,Leadiant Biosciences, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class III,2020-12-02,,,Ongoing,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class III,2019-09-18,2021-01-28,526,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2021-05-26,2022-02-22,299,Terminated,SUBPOTENT DRUG,Potency Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-12-04,2014-08-01,486,Terminated,SUBPOTENT DRUG,Potency Issues,Cetylite Industries, PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2018-12-26,2020-01-14,400,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2023-05-24,,,Ongoing,SUBPOTENT,Potency Issues,B. Braun Medical ., PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2014-04-30,2015-03-25,345,Terminated,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2015-06-17,2017-03-14,650,Terminated,SUBPOTENT DRUG,Potency Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class I,2022-08-24,,,Completed,CHEMICAL CONTAMINATION AND SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Press Release
Class II,2023-05-10,,,Ongoing,SUBPOTENT DRUG,Potency Issues,nan,nan,nan,Letter
Class II,2018-03-14,2018-05-31,105,Terminated,STABILITY DATA DOES NOT SUPPORT EXPIRY,Stability Issues,nan,nan,nan,E-Mail
Class II,2018-03-21,2019-12-02,635,Terminated,STABILITY DATA DOES NOT SUPPORT EXPIRY,Stability Issues,nan,nan,nan,Letter
Class III,2019-02-20,2020-11-06,687,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,Akorn, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class III,2012-12-05,2014-09-11,687,Terminated,PRODUCT LACKS STABILITY,Stability Issues,GlaxoSmithKline , PRESCRIPTION DRUG,RESPIRATORY (INHALATION),Letter
Class II,2013-10-02,2014-08-25,419,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class II,2022-05-25,2023-04-13,351,Terminated,FAILED STABILITY SPECIFICATION,Stability Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2018-12-05,2020-04-06,515,Terminated,FAILED STABILITY SPECIFICATION,Stability Issues,nan,nan,nan,Letter
Class I,2023-08-09,,,Ongoing,FAILED STABILITY SPECIFICATION AND FAILED IMPURITIES,Stability Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,nan,Letter
Class III,2013-01-30,2014-10-07,781,Terminated,STABILITY DATA DOES NOT SUPPORT EXPIRATION DATE,Stability Issues,nan,nan,nan,Letter
Class II,2018-01-31,2018-06-18,180,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class II,2018-07-11,2023-03-22,1734,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class III,2015-07-01,2016-02-19,268,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class II,2018-03-14,2020-09-15,932,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class II,2018-05-23,2018-10-31,204,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2017-05-17,2017-10-24,210,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class II,2015-03-11,2017-11-30,1007,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,Akorn, PRESCRIPTION DRUG,NASAL,Letter
Class II,2016-04-13,2016-06-07,85,Terminated,STABILITY DOES NOT SUPPORT EXPIRY,Stability Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2023-07-12,,,Ongoing,FAILED STABILITY SPECIFICATIONS,Stability Issues,Preferred Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2016-11-09,2018-06-15,640,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,Taro Pharmaceuticals U.S.A., PRESCRIPTION DRUG,TOPICAL,Letter
Class II,2020-10-07,2021-08-26,356,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class III,2014-07-30,2015-11-19,531,Terminated,STABILITY DATA DOES NOT SUPPORT EXPIRY,Stability Issues,nan,nan,nan,E-Mail
Class II,2018-05-23,2018-12-10,217,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,Padagis Israel Pharmaceuticals Ltd, PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2023-07-19,,,Ongoing,FAILED STABILITY SPECIFICATIONS,Stability Issues,VIVUS , PRESCRIPTION DRUG,ORAL,nan
Class III,2021-11-03,2022-03-28,166,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class I,2015-04-15,2016-12-02,730,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2018-04-04,2018-05-31,85,Terminated,STABILITY DATA DOES NOT SUPPORT EXPIRY,Stability Issues,nan,nan,nan,E-Mail
Class I,2020-05-06,2021-10-21,551,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class II,2020-08-26,,,Ongoing,FAILED STABILITY SPECIFICATIONS,Stability Issues,Sanofi-Aventis U.S. , PRESCRIPTION DRUG,nan,Letter
Class III,2020-08-26,2021-03-16,225,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class II,2022-01-05,,,Ongoing,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class III,2022-11-23,2023-03-16,154,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,Aadi Bioscience, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2013-08-21,2013-08-28,205,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class II,2022-01-26,,,Ongoing,FAILED STABILITY SPECIFICATIONS,Stability Issues,VistaPharm, PRESCRIPTION DRUG,ORAL,Letter
Class III,2014-06-25,2015-02-12,260,Terminated,FAILED STABILITY SPECIFICATION,Stability Issues,nan,nan,nan,Letter
Class III,2013-02-13,2017-04-03,1623,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2014-11-19,2016-06-21,663,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,Fougera Pharmaceuticals ., PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2017-01-11,2017-09-18,270,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class III,2018-03-14,2020-08-31,922,Terminated,FAILED STABILITY SPECIFICATION,Stability Issues,Akorn, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class II,2018-10-10,2023-02-17,1610,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,"[""Dr. Reddys Laboratories", PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2023-01-04,,,Completed,FAILED STABILITY SPECIFICATIONS,Stability Issues,Apotex Corp, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class II,2021-04-14,2022-12-07,628,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,XGen Pharmaceuticals DJB, PRESCRIPTION DRUG,ORAL,Letter
Class II,2018-03-07,2020-04-08,847,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class II,2016-10-19,2017-06-23,707,Terminated,STABILITY DATA DOES NOT SUPPORT EXPIRY,Stability Issues,nan,nan,nan,E-Mail
Class II,2021-08-25,2022-11-14,473,Terminated,FAILED STABILITY SPECIFICATION,Stability Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class III,2018-03-21,2019-04-29,417,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,"[""Dr. Reddys Laboratories ""]", PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2019-06-19,2021-09-24,830,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,Bausch & Lomb Incorporated, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class III,2022-10-12,,,Ongoing,FAILED STABILITY SPECIFICATIONS,Stability Issues,"[""Dr.Reddys Laboratories ""]", PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS', 'SUBCUTANEOUS",Letter
Class III,2013-06-26,2014-03-28,304,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class III,2016-11-30,2017-10-20,357,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class II,2016-02-03,2017-05-09,629,Terminated,STABILITY DATA DOES NOT SUPPORT EXPIRY.,Stability Issues,nan,nan,nan,Telephone
Class II,2021-08-25,,,Ongoing,FAILED STABILITY SPECIFICATIONS,Stability Issues,Noven Therapeutics, PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class III,2018-05-30,2019-01-14,259,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,V2 Pharma, PRESCRIPTION DRUG,nan,Letter
Class II,2023-09-27,,,Ongoing,STABILITY DATA DOES NOT SUPPORT EXPIRY,Stability Issues,CareFusion 213, OTC DRUG,TOPICAL,Letter
Class III,2019-02-27,2020-11-03,648,Terminated,FAILED STABILITY SPECIFICATION,Stability Issues,nan,nan,nan,Letter
Class II,2012-12-12,2017-04-11,1602,Terminated,PRODUCT LACKS STABILITY,Stability Issues,Taro Pharmaceuticals U.S.A., PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2013-07-24,2014-02-10,242,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class II,2020-04-01,2021-05-19,426,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class III,2023-02-15,,,Ongoing,FAILED STABILITY SPECIFICATIONS,Stability Issues,Akorn, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class III,2014-02-19,2015-01-23,403,Terminated,FAILED STABILITY TESTING,Stability Issues,nan,nan,nan,Letter
Class III,2013-08-28,2015-01-29,559,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,E-Z-EM Canada , PRESCRIPTION DRUG,ORAL,Letter
Class III,2015-11-11,2016-10-23,368,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class II,2018-10-24,2019-11-07,413,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class III,2016-12-14,2019-11-20,1239,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class II,2015-09-23,2022-06-15,2494,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,nan
Class III,2022-03-02,2022-12-13,328,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,"[""Dr. Reddys Laboratories .""]", PRESCRIPTION DRUG,"INTRAVENOUS', 'SUBCUTANEOUS",Letter
Class II,2021-07-14,2022-08-11,428,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,Genentech, PRESCRIPTION DRUG,SUBCUTANEOUS,Letter
Class III,2021-04-21,,,Ongoing,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class II,2017-03-08,2019-03-15,791,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,AbbVie ., PRESCRIPTION DRUG,ENTERAL,E-Mail
Class III,2014-05-07,2014-10-15,197,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class II,2015-05-13,2016-10-25,550,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class II,2019-02-27,2022-07-29,1271,Terminated,FAILED STABILITY SPECIFICATION,Stability Issues,nan,nan,nan,Letter
Class II,2017-12-27,2018-03-29,231,Terminated,STABILITY DATE DOESN'T SUPPORT EXPIRY,Stability Issues,nan,nan,nan,Letter
Class III,2018-01-03,2020-04-03,875,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class II,2022-04-20,2022-05-10,43,Terminated,OUT OF SPECIFICATION RESULTS OBSERVED IN DISSOLUTION DURING LONG TERM STABILITY TESTING.,Stability Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2018-04-04,2019-03-01,358,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,E-Z-EM Canada , PRESCRIPTION DRUG,ORAL,Letter
Class III,2014-03-19,2015-05-22,466,Terminated,STABILITY DATA DOES NOT SUPPORT EXPIRY,Stability Issues,Pinnacle Biologics, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2014-11-05,2015-12-29,446,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,Micro Labs Limited, PRESCRIPTION DRUG,ORAL,Letter
Class III,2017-11-01,2020-01-16,855,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class III,2022-01-12,2022-09-12,264,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class II,2019-09-18,2021-10-27,791,Terminated,FAILED STABILITY SPECIFICATIONS.,Stability Issues,nan,nan,nan,Letter
Class III,2018-09-26,2019-10-08,407,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,JUBILANT CADISTA PHARMACEUTICALS INC., PRESCRIPTION DRUG,ORAL,Letter
Class III,2021-07-21,2023-02-07,594,Terminated,FAILED STABILITY SPECIFICATION,Stability Issues,Partner Therapeutics, PRESCRIPTION DRUG,"INTRAVENOUS', 'SUBCUTANEOUS",E-Mail
Class III,2018-11-21,2019-11-26,385,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,E-Mail
Class III,2014-01-29,2014-08-27,286,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class III,2017-05-31,2017-12-22,227,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,Strides Pharma Science Limited, PRESCRIPTION DRUG,ORAL,Letter
Class III,2014-01-01,2016-05-16,931,Terminated,FAILED STABILITY SPECIFICATION,Stability Issues,Akorn, PRESCRIPTION DRUG,ORAL,Letter
Class III,2014-08-06,2015-05-29,305,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class III,2018-05-02,2020-10-13,904,Terminated,FAILED DISSOLUTION SPECIFICATIONS. HIGH DISSOLUTION RESULTS WERE OBTAINED DURING STABILITY TESTING.,Stability Issues,nan,nan,nan,Letter
Class II,2019-06-19,2020-04-29,321,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,RESPIRATORY (INHALATION),Letter
Class II,2016-11-30,2019-05-10,907,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class II,2018-02-07,2018-10-17,307,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,Boehringer Ingelheim Pharmaceuticals, PRESCRIPTION DRUG,"ORAL', 'RESPIRATORY (INHALATION)",Letter
Class III,2015-06-24,2016-05-18,362,Terminated,FAILED STABILITY SPECIFICATION,Stability Issues,nan,nan,nan,Letter
Class II,2019-12-04,2023-07-16,1355,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,E-Mail
Class III,2017-11-22,2019-08-21,722,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,nan,nan,nan,Letter
Class III,2021-11-03,2022-08-23,307,Terminated,FAILED STABILITY SPECIFICATIONS,Stability Issues,Lupin Pharmaceuticals, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class I,2012-11-14,2013-02-28,2561,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2013-03-06,2015-04-24,801,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2012-09-05,2013-11-13,576,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,BRACCO DIAGNOSTICS INC, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2014-03-12,2015-03-17,399,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2016-12-28,2023-12-06,2687,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2018-09-05,2020-01-30,527,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2018-10-10,2020-06-26,646,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Pfizer Laboratories Div Pfizer , PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2019-06-05,2020-02-25,298,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2019-07-03,2021-10-26,861,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Press Release
Class II,2021-11-17,2023-10-04,722,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2012-12-26,2014-06-03,559,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Hospira, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS', 'SUBCUTANEOUS",Letter
Class II,2014-08-27,2014-12-02,124,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2014-10-08,2016-09-30,732,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2015-11-04,2016-04-13,264,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Press Release
Class II,2021-10-06,,,Completed,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2022-07-20,2023-07-25,404,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Jubilant DraxImage ., PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2013-09-18,2016-04-25,973,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2022-11-23,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2016-07-20,2017-06-16,399,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,E-Mail
Class II,2016-12-28,2017-01-17,33,Terminated,LACK OF STERILITY ASSURANCE,Sterility Issues,nan,nan,nan,E-Mail
Class II,2018-05-02,2020-09-15,888,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Press Release
Class I,2018-12-26,2021-01-29,777,Terminated,LACK OF STERILITY ASSURANCE AND INCORRECT,Sterility Issues,nan,nan,nan,Telephone
Class II,2016-10-19,2017-05-03,225,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2018-05-16,2020-06-04,770,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2021-12-08,2023-07-12,589,Terminated,LACK OF STERILITY ASSURANCE,Sterility Issues,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2014-07-30,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2019-12-04,2023-03-09,1255,Terminated,LACK OF STERILITY ASSURANCE.,Sterility Issues,nan,nan,nan,Letter
Class II,2020-04-15,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2017-07-19,2019-04-03,651,Terminated,LACK OF STERILITY ASSURANCE,Sterility Issues,nan,nan,nan,Letter
Class II,2023-05-31,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,E-Mail
Class II,2012-08-22,2014-08-13,810,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2016-09-14,2017-03-13,215,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2012-06-20,2012-09-24,446,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2015-12-02,2017-03-30,538,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,E-Mail
Class II,2016-02-03,2016-06-29,285,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,E-Mail
Class II,2017-05-24,2017-08-29,133,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2021-08-25,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Teva Parenteral Medicines, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2022-04-13,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Oryza Pharmaceuticals ., PRESCRIPTION DRUG,INTRAVENOUS,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2013-03-06,2014-10-08,636,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Hospira, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2017-11-08,2019-05-01,559,Terminated,LACK OF ASSURANCE OF STERILITY.,Sterility Issues,nan,nan,nan,Letter
Class II,2019-04-24,2020-12-15,610,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Iso-Tex Diagnostics, PRESCRIPTION DRUG,INTRAVENOUS,E-Mail
Class II,2019-10-09,2023-04-05,1351,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2022-04-27,2023-10-05,548,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2023-10-04,2023-12-04,104,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Life Molecular Imaging, PRESCRIPTION DRUG,INTRAVENOUS,Telephone
Class II,2014-07-02,2014-09-29,173,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2017-04-19,2019-07-09,844,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2018-02-21,2018-04-24,78,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2019-09-18,2023-03-25,1296,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Hospira, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS', 'SUBCUTANEOUS","Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2022-07-27,2023-11-27,501,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Cipla USA ., PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class II,2016-06-15,2017-01-13,241,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Press Release
Class II,2016-12-14,2018-06-19,594,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2017-07-12,2018-06-12,358,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2013-06-12,,,Completed,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2015-10-21,2017-02-10,539,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Nephron Pharmaceuticals Corporation, PRESCRIPTION DRUG,RESPIRATORY (INHALATION),E-Mail
Class II,2016-03-16,2016-08-09,187,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2023-02-01,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2023-05-24,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Sanofi-Aventis U.S. , PRESCRIPTION DRUG,"INTRAVENOUS', 'SUBCUTANEOUS",E-Mail
Class II,2015-01-28,2015-07-24,210,Terminated,LACK OF STERILITY ASSURANCE.,Sterility Issues,nan,nan,nan,Letter
Class II,2015-03-25,2016-12-09,645,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2016-12-28,2017-06-02,169,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Onyx Pharmaceuticals, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2018-11-14,2021-03-08,882,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2022-09-21,,,Completed,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,E-Mail
Class II,2023-09-06,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2014-03-12,2014-04-24,174,Terminated,LACK OF STERILITY ASSURANCE,Sterility Issues,nan,nan,nan,Telephone
Class II,2016-02-24,2017-04-06,447,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Press Release
Class II,2017-08-02,2019-05-01,656,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2017-09-27,2023-02-19,2007,Terminated,LACK OF STERILITY ASSURANCE,Sterility Issues,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2017-08-16,2020-09-16,1160,Terminated,LACK OF STERILITY ASSURANCE.,Sterility Issues,nan,nan,nan,Letter
Class II,2019-12-18,2021-02-04,616,Terminated,LACK OF STERILITY ASSURANCE.,Sterility Issues,nan,nan,nan,E-Mail
Class II,2022-08-17,2023-11-27,482,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Cipla USA ., PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class II,2023-04-05,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,E-Mail
Class II,2023-09-27,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,TRP Company, OTC DRUG,OPHTHALMIC,Letter
Class II,2015-09-23,2016-02-10,253,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2019-10-30,2019-12-04,77,Terminated,LACK OF STERILITY ASSURANCE.,Sterility Issues,nan,nan,nan,nan
Class II,2020-03-11,2023-12-07,1422,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Press Release
Class II,2014-01-22,2014-09-22,338,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Press Release
Class II,2015-08-26,2017-04-07,599,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2018-01-31,2018-09-14,241,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2023-07-26,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2021-05-26,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Teva Parenteral Medicines, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2015-04-08,2016-10-20,577,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2017-12-27,2020-04-29,986,Terminated,LACK OF ASSURANCE OF STERILITY .,Sterility Issues,nan,nan,nan,Press Release
Class II,2022-04-06,2023-10-05,561,Terminated,LACK OF STERILITY ASSURANCE.,Sterility Issues,nan,nan,nan,Letter
Class II,2013-05-08,2014-09-18,751,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Hospira, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2016-06-08,2016-12-23,249,Terminated,LACK OF STERILITY ASSURANCE.,Sterility Issues,nan,nan,nan,Telephone
Class I,2016-12-28,2019-05-30,1017,Terminated,NON STERILITY,Sterility Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2016-11-09,2016-11-08,27,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2019-01-16,2020-04-29,483,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAPERITONEAL,Letter
Class II,2022-01-19,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2023-09-20,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,BE Pharmaceuticals ., PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2014-07-16,2015-04-03,301,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2015-01-14,2015-07-02,192,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2015-04-01,2017-02-23,736,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Mylan Institutional , PRESCRIPTION DRUG,INTRAMUSCULAR,Letter
Class II,2016-07-06,2016-11-17,526,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2018-10-31,2022-09-17,1458,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2019-11-13,2023-04-13,1340,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2012-08-15,2012-11-15,512,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Nephron Pharmaceuticals Corporation, PRESCRIPTION DRUG,RESPIRATORY (INHALATION),"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2015-03-11,2016-06-22,485,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2021-05-05,2022-09-29,559,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,CareFusion 213, OTC DRUG,TOPICAL,Press Release
Class II,2016-08-03,2016-08-08,32,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2018-04-25,2019-01-15,299,Terminated,LACK OF ASSURANCE STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2022-10-12,2023-07-25,299,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Cipla USA ., PRESCRIPTION DRUG,RESPIRATORY (INHALATION),Letter
Class II,2013-10-30,2015-08-21,688,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Nephron Pharmaceuticals Corporation, PRESCRIPTION DRUG,RESPIRATORY (INHALATION),"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2014-11-05,2018-05-31,1373,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2021-01-20,2023-06-07,1175,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2022-06-08,,,Completed,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2023-04-26,,,Ongoing,LACK OF ASSURANCE OF STERILITY.,Sterility Issues,nan,nan,nan,Telephone
Class II,2015-06-17,2016-12-20,585,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2023-07-19,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,B. Braun Medical ., PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2014-02-12,2016-12-09,1334,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Press Release
Class II,2013-09-04,2017-02-22,1444,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2014-11-05,2016-09-22,1140,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Press Release
Class II,2013-12-25,2015-06-10,575,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2019-11-27,2021-02-04,443,Terminated,LACK OF  ASSURANCE OF STERILITY,Sterility Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,IRRIGATION,Letter
Class II,2021-03-03,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Teva Parenteral Medicines, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class I,2014-09-03,2014-09-19,114,Terminated,NON STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2017-01-11,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2018-07-25,2020-01-24,591,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2022-02-09,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2022-09-21,2022-10-19,84,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2013-12-11,2014-10-28,407,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2015-10-14,2016-01-12,111,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2013-09-25,2014-08-14,353,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2017-05-03,2017-08-30,146,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2019-04-24,2023-05-17,1527,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,E-Mail
Class II,2014-12-17,2014-12-12,806,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Fresenius Kabi USA, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'SUBCUTANEOUS",Letter
Class II,2013-07-10,2017-02-22,1435,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2014-12-03,2015-11-03,361,Terminated,LACK OF STERILITY ASSURANCE,Sterility Issues,nan,nan,nan,Letter
Class II,2015-08-12,2017-02-17,602,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2022-06-01,,,Completed,LACK OF ASSURANCE OF STERILITY.,Sterility Issues,nan,nan,nan,Letter
Class II,2015-05-20,2018-06-05,1176,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2015-09-02,2018-04-23,1043,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2016-01-27,2016-02-10,48,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2021-01-06,2023-08-23,979,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2023-06-14,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Golden State Medical Supply, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class II,2013-09-18,2014-07-18,357,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2015-09-30,2016-09-15,379,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2015-11-25,2017-12-29,848,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2019-07-24,2021-10-27,841,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2013-01-09,2016-10-07,1472,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2013-08-28,2013-11-21,178,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2015-11-18,2016-04-07,183,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2022-03-23,2023-08-15,1104,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2013-01-02,2013-08-29,358,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2017-07-19,2020-04-29,1028,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2018-11-14,2019-01-18,79,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2019-03-27,2020-12-15,645,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Iso-Tex Diagnostics, PRESCRIPTION DRUG,INTRAVENOUS,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2019-08-28,2019-10-15,60,Terminated,LACK OF ASSURANCE OF STERILITY.,Sterility Issues,nan,nan,nan,Letter
Class II,2020-04-08,2022-12-08,997,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2021-10-20,2022-12-28,462,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,E-Mail
Class II,2023-05-31,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Sagent Pharmaceuticals, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2013-06-26,2015-05-15,708,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2013-09-25,2014-07-16,327,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2023-08-02,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Sagent Pharmaceuticals, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2013-05-15,2014-11-10,622,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Hospira, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2022-10-05,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Cipla USA ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-08-30,,,Completed,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2015-04-01,2016-02-24,343,Terminated,LACK OF ASSURANCE OF STERILITY. COMPLAINTS WERE RECEIVE OF MISSING CLOSURES AND,Sterility Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2015-07-08,2017-02-16,630,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2015-09-16,2015-09-11,52,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2015-11-04,2015-11-27,52,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2016-06-01,2018-02-05,649,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2017-09-20,2018-04-23,251,Terminated,LACK OF ASSURANCE OF STERILITY.,Sterility Issues,nan,nan,nan,Telephone
Class II,2018-05-30,2018-12-06,388,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2022-06-29,2023-07-25,410,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,INTRAMUSCULAR,Letter
Class II,2017-05-31,2018-03-13,390,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Sato Pharmaceutical, OTC DRUG,OPHTHALMIC,Letter
Class II,2023-03-01,,,Ongoing,LACK OF STERILITY ASSURANCE,Sterility Issues,B. Braun Medical ., PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2014-10-08,2016-07-07,856,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Sagent Pharmaceuticals, PRESCRIPTION DRUG,INTRAVENOUS,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2018-01-17,2018-12-19,470,Terminated,LACK OF STERILITY ASSURANCE,Sterility Issues,nan,nan,nan,Letter
Class II,2021-01-13,2023-12-04,1078,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Merck Sharp & Dohme , PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2012-11-21,2016-10-07,1462,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2019-05-08,2023-05-19,1502,Terminated,LACK OF ASSURANCE OF STERILITY FOR INJECTABLES AND SOLUTIONS INTENDED TO BE STERILE.,Sterility Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2021-10-13,2023-06-27,638,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2013-07-31,2013-08-28,295,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Alkermes, PRESCRIPTION DRUG,nan,Letter
Class II,2013-07-31,2014-02-04,230,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Astellas Pharma US, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2017-11-01,2018-08-09,303,Terminated,LACK OF ASSURANCE OF STERILITY.,Sterility Issues,nan,nan,nan,Letter
Class II,2018-03-28,2019-02-14,421,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Fresenius Medical Care North America, PRESCRIPTION DRUG,INTRAPERITONEAL,Letter
Class II,2018-08-22,2022-09-01,1499,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2013-09-18,2013-10-17,55,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Press Release
Class II,2018-06-27,2020-06-04,735,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2020-01-22,2021-10-27,677,Terminated,LACK OF STERILITY ASSURANCE.,Sterility Issues,nan,nan,nan,Letter
Class II,2020-12-23,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2023-03-15,,,Ongoing,LACK OF STERILITY ASSURANCE,Sterility Issues,nan,nan,nan,Press Release
Class II,2012-08-22,2014-08-15,816,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class I,2014-02-05,2017-02-08,1395,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Press Release
Class II,2015-10-21,2016-06-08,260,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2017-07-19,2020-04-29,1028,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2019-01-16,2021-02-19,779,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2021-12-08,2022-12-02,380,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2013-09-25,2013-09-17,12,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2014-07-23,2015-04-22,678,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,CareFusion 213 , OTC DRUG,TOPICAL,Letter
Class II,2016-10-12,2018-01-25,500,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2016-12-07,2018-06-18,621,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2018-10-31,2023-03-29,1626,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Heritage Pharmaceuticals . d/b/a Avet Pharmaceuticals ., PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2013-04-10,2015-04-06,777,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2013-05-01,2017-04-19,1463,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2014-07-23,2015-09-09,439,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Hospira, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2023-06-07,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Fresenius Medical Care North America, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2017-07-26,2020-04-29,1038,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Press Release
Class II,2014-02-05,2018-06-01,1597,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Press Release
Class II,2014-09-24,2016-01-26,1014,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2017-06-14,2018-12-04,551,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2019-01-09,2023-03-28,1546,Terminated,LACK OF STERILITY ASSURANCE.,Sterility Issues,nan,nan,nan,Letter
Class II,2022-07-20,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2013-08-21,2013-08-21,149,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2013-07-10,2015-06-18,758,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2017-07-12,2019-10-30,866,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Press Release
Class II,2018-08-15,2019-03-11,278,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,INTRAVENOUS,Telephone
Class II,2014-10-29,2017-03-23,904,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Teva Parenteral Medicines, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS', 'SUBCUTANEOUS",Letter
Class II,2019-05-01,2019-10-30,201,Terminated,LACK OF STERILITY ASSURANCE.,Sterility Issues,nan,nan,nan,Letter
Class II,2021-03-24,2022-12-28,657,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Sagent Pharmaceuticals, PRESCRIPTION DRUG,INTRAVENOUS,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2013-03-13,2015-03-31,890,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2013-04-03,2015-03-31,855,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Wyeth Pharmaceuticals , PRESCRIPTION DRUG,nan,Letter
Class II,2013-08-14,2016-04-18,1028,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2014-02-05,2015-05-19,495,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2014-12-03,2015-12-28,440,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2017-05-24,2018-08-10,452,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,nan
Class II,2022-11-09,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2022-12-14,,,Ongoing,LACK OF STERILITY ASSURANCE,Sterility Issues,B. Braun Medical ., PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2013-03-27,2015-03-31,774,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2016-11-23,2017-10-17,342,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2018-08-15,2020-11-25,923,Terminated,LACK OF STERILITY ASSURANCE.,Sterility Issues,nan,nan,nan,Letter
Class II,2018-07-11,2019-02-04,235,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2023-01-18,2023-06-21,173,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2014-01-22,2014-12-18,412,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2016-02-24,2017-04-13,429,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2017-01-11,2021-07-02,1745,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Press Release
Class II,2017-10-25,2017-12-06,72,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2018-05-16,2020-01-23,639,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2023-01-18,,,Completed,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2014-08-27,2015-08-25,424,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2016-12-14,2017-03-09,163,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2016-12-21,2020-04-29,1258,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Press Release
Class II,2017-06-07,2018-03-29,315,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2023-08-02,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,E-Mail
Class II,2013-01-23,2013-03-12,196,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,E-Mail
Class II,2015-10-21,2022-06-15,2486,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2019-02-20,2021-03-30,834,Terminated,LACK OF STERILITY ASSURANCE.,Sterility Issues,nan,nan,nan,Letter
Class II,2019-10-09,2021-08-19,707,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Press Release
Class II,2022-09-14,2023-11-27,462,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Cipla USA ., PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class II,2023-05-03,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAPERITONEAL,Letter
Class II,2013-06-12,2014-10-08,526,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2013-10-02,2014-06-19,300,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2015-03-25,2016-02-26,366,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Heritage Pharmaceuticals . d/b/a Avet Pharmaceuticals ., PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Press Release
Class II,2023-02-22,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Leadiant Biosciences, PRESCRIPTION DRUG,INTRAVENOUS,E-Mail
Class II,2023-03-08,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2020-04-08,2022-10-14,945,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2017-03-22,2017-05-23,102,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2019-08-14,2022-09-16,1185,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Press Release
Class II,2019-07-31,2021-04-19,641,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2021-08-11,2021-10-22,84,Terminated,LACK OF STERILITY ASSURANCE,Sterility Issues,nan,nan,nan,E-Mail
Class II,2013-10-16,2014-10-28,418,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Hospira, PRESCRIPTION DRUG,"EPIDURAL', 'INFILTRATION', 'INTRACAUDAL', 'PERINEURAL",Letter
Class II,2014-09-17,2016-06-08,679,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2015-02-04,2016-04-21,485,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2019-06-19,2021-02-05,624,Terminated,LACK OF STERILITY ASSURANCE.,Sterility Issues,nan,nan,nan,Press Release
Class II,2019-10-30,2020-12-01,419,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2023-05-24,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Meitheal Pharmaceuticals ., PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2012-08-29,2012-10-11,80,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,FAX
Class II,2021-01-13,2021-11-02,320,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2021-10-06,2022-10-02,380,Terminated,LACK OF STERILITY ASSURANCE.,Sterility Issues,nan,nan,nan,Telephone
Class II,2013-03-13,2015-05-15,857,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2013-05-22,2016-10-19,1301,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2019-10-16,2020-12-01,426,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2022-01-19,2022-12-02,325,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2014-06-25,2014-07-02,51,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2014-12-24,2015-10-28,337,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2016-04-06,2017-05-03,426,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,"[""Dr.Reddys Laboratories Ltd""]", PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2020-04-15,,,Ongoing,FIRM IS RECALLING 46 LOTS OF VARIOUS PRODUCTS BECAUSE OF A LACK OF STERILITY ASSURANCE.,Sterility Issues,nan,nan,nan,Letter
Class II,2021-09-29,2023-10-04,768,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,GLENMARK PHARMACEUTICALS INC., PRESCRIPTION DRUG,INTRAMUSCULAR,Letter
Class II,2013-06-05,2014-08-01,466,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2015-07-22,2016-11-17,504,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2018-02-14,2019-05-01,517,Terminated,LACK OF STERILITY ASSURANCE.,Sterility Issues,nan,nan,nan,Letter
Class II,2019-04-24,2021-09-24,906,Terminated,LACK OF STERILITY ASSURANCE.,Sterility Issues,nan,nan,nan,Letter
Class II,2022-06-15,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2012-10-10,2013-09-11,506,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,CareFusion 213 , OTC DRUG,TOPICAL,Letter
Class II,2013-07-17,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2015-05-20,2017-07-20,889,Terminated,LACK OF ASSURANCE OF STERILITY AND STABILITY DATA DOES NOT SUPPORT EXPIRY,Sterility Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2017-10-25,2019-01-24,491,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Symbiopathic, OTC DRUG,OPHTHALMIC,Letter
Class II,2019-05-15,2020-09-28,517,Terminated,LACK OF STERILITY ASSURANCE,Sterility Issues,Sagent Pharmaceuticals, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2022-03-23,2023-03-16,384,Terminated,LACK OF STERILITY ASSURANCE,Sterility Issues,B. Braun Medical ., PRESCRIPTION DRUG,INTRAVENOUS,Other
Class II,2018-12-26,2020-10-13,694,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2012-09-26,2013-05-23,562,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2017-07-19,2017-12-06,167,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Press Release
Class II,2019-09-18,2020-10-08,405,Terminated,LACK OF ASSURANCE OF STERILITY.,Sterility Issues,nan,nan,nan,Press Release
Class II,2013-07-31,2018-05-11,1884,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2013-09-04,2014-10-28,438,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Hospira, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2016-07-13,2016-10-31,124,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2019-10-09,2022-08-01,1046,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Akorn, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class II,2023-10-25,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2013-11-06,2017-02-28,1272,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2014-12-17,2015-10-02,303,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Hospira, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2017-08-09,2020-07-20,1131,Terminated,LACK OF STERILITY ASSURANCE,Sterility Issues,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Press Release
Class II,2017-08-02,2019-10-30,838,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2019-03-27,2020-01-14,307,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2016-08-31,2017-03-31,255,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2023-05-24,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2023-09-06,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAPERITONEAL,Letter
Class II,2013-10-09,,,Completed,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2016-01-27,2017-01-13,374,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2017-03-01,2019-04-03,782,Terminated,LACK OF STERILITY ASSURANCE,Sterility Issues,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2017-03-15,2018-06-12,475,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Endo Pharmaceuticals ., PRESCRIPTION DRUG,INTRACAVERNOUS,Letter
Class II,2022-01-05,2023-12-06,754,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Press Release
Class II,2013-09-25,2013-10-17,38,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Press Release
Class II,2014-10-15,2016-02-24,586,Terminated,LACK OF STERILITY ASSURANCE,Sterility Issues,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2014-11-12,2015-06-30,267,Terminated,LACK OF STERILITY ASSURANCE,Sterility Issues,nan,nan,nan,Press Release
Class II,2018-01-03,2018-03-22,224,Terminated,LACK OF STERILITY ASSURANCE,Sterility Issues,nan,nan,nan,E-Mail
Class II,2023-01-11,,,Completed,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2015-06-03,2015-11-16,182,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2023-02-22,,,Completed,LACK OF STERILITY ASSURANCE,Sterility Issues,nan,nan,nan,Telephone
Class II,2014-12-31,2015-07-01,260,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2021-07-28,,,Completed,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2022-06-22,2023-08-14,465,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,NorthStar RxLLC, PRESCRIPTION DRUG,INTRAMUSCULAR,nan
Class II,2014-01-08,2014-11-10,395,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Hospira, PRESCRIPTION DRUG,"EPIDURAL', 'INFILTRATION', 'INTRACAUDAL', 'PERINEURAL",Letter
Class II,2016-01-06,2017-10-18,708,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2016-04-06,2017-01-06,329,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2018-11-07,2021-05-06,930,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2019-08-21,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2016-09-28,2017-04-19,303,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2021-11-03,2023-04-12,607,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,nan
Class II,2022-12-14,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Fresenius Medical Care North America, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2017-04-05,2020-09-18,1288,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2019-02-27,2020-01-24,360,Terminated,LACK OF ASSURANCE OF STERILITY.,Sterility Issues,nan,nan,nan,Letter
Class II,2022-07-27,,,Completed,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2023-12-13,,,Ongoing,LACK OF ASSURANCE OF STERILITY.,Sterility Issues,nan,nan,nan,Telephone
Class II,2015-11-25,2016-09-22,342,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Press Release
Class II,2019-07-17,2023-06-06,1441,Terminated,LACK OF ASSURANCE OF STERILITY.,Sterility Issues,nan,nan,nan,Telephone
Class II,2020-03-11,2022-12-28,1035,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Pfizer Laboratories Div Pfizer , PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2020-08-12,2022-12-08,871,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Hospira, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2013-09-04,2014-10-28,442,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Hospira, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2013-09-25,2014-08-18,360,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2014-01-15,2017-04-19,1279,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2015-04-29,2016-11-04,577,Terminated,LACK OF STERILITY ASSURANCE,Sterility Issues,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2022-10-26,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Fresenius Medical Care North America, PRESCRIPTION DRUG,INTRAVENOUS,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2018-05-09,2022-02-18,1424,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Eugia US , PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2014-04-16,2014-05-01,140,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,E-Mail
Class II,2016-06-08,2017-07-21,430,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2016-11-30,2018-08-28,665,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2016-12-28,2018-02-12,433,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2015-11-25,2017-03-30,565,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2015-12-09,2016-10-01,348,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2016-03-09,2016-11-17,324,Terminated,LACK OF  ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2016-07-20,2018-01-11,631,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Press Release
Class II,2016-10-05,2016-11-18,115,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2018-09-05,2022-01-18,1265,Terminated,LACK OF ASSURANCE OF STERILITY.,Sterility Issues,nan,nan,nan,Letter
Class II,2019-11-06,2022-01-14,827,Terminated,LACK OF STERILITY ASSURANCE.,Sterility Issues,nan,nan,nan,Press Release
Class II,2021-03-03,2021-03-26,37,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Massachusetts General Hospital, PRESCRIPTION DRUG,INTRAVENOUS,Telephone
Class II,2013-05-22,2014-03-21,345,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Press Release
Class II,2013-09-11,2014-08-27,379,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2014-10-08,2016-08-17,903,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2015-10-07,2016-08-30,355,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2018-11-07,2021-02-05,879,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Press Release
Class II,2018-11-14,2020-06-04,596,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2021-01-27,2023-06-07,1175,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2021-09-01,2022-08-08,374,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2022-08-17,2023-06-22,332,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2013-07-31,2014-03-05,258,Terminated,LACK OF STERILITY ASSURANCE,Sterility Issues,Astellas Pharma US, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2016-09-28,2017-07-12,322,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2019-11-20,2020-12-10,422,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Press Release
Class II,2013-06-19,2014-07-07,403,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2013-09-18,2014-01-21,137,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Press Release
Class II,2022-03-30,2023-09-28,750,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,MEDTECH PRODUCTS INC, OTC DRUG,OPHTHALMIC,Letter
Class II,2013-06-12,2014-11-10,543,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Hospira, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2013-10-09,2016-02-08,885,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2013-07-03,2015-07-17,1169,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2013-06-12,2014-12-16,580,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2018-02-28,2020-05-07,862,Terminated,LACK OF STERILITY ASSURANCE.,Sterility Issues,nan,nan,nan,Press Release
Class II,2021-09-22,2023-08-15,727,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Letter
Class II,2014-01-01,2014-08-20,287,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,GlaxoSmithKline , PRESCRIPTION DRUG,SUBCUTANEOUS,Letter
Class II,2013-09-18,2014-06-03,284,Terminated,LACK OF ASSURANCE OF STERILITY,Sterility Issues,nan,nan,nan,Telephone
Class II,2019-11-27,,,Ongoing,LACK OF ASSURANCE OF STERILITY,Sterility Issues,TRP Company, OTC DRUG,OPHTHALMIC,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2012-11-07,2015-11-30,1318,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2014-05-21,2015-06-01,445,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2019-04-24,2022-01-19,1020,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class II,2014-02-12,2017-05-02,1469,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2016-06-15,2017-08-30,737,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2014-03-19,2015-01-29,546,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class II,2017-11-08,2020-09-09,1069,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class II,2020-02-19,,,Ongoing,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2013-05-22,2013-11-14,332,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Telephone
Class I,2017-12-13,2018-12-04,445,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class III,2017-11-22,2020-02-12,835,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,JUBILANT CADISTA PHARMACEUTICALS INC., PRESCRIPTION DRUG,ORAL,Letter
Class II,2018-02-14,2018-09-13,237,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class II,2021-05-26,2021-07-16,114,Terminated,MARKETED WITHOUT APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class II,2013-03-20,2013-07-29,794,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class I,2023-03-08,,,Ongoing,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class II,2016-07-20,2018-06-14,785,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Telephone
Class I,2018-01-31,2018-12-11,387,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2012-10-03,2018-11-01,2443,Terminated,MARKETED WITHOUT AN APPROVED ANDA,Unapproved,nan,nan,nan,E-Mail
Class I,2015-07-15,2018-06-27,1286,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2016-02-24,2017-06-01,610,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class II,2017-05-03,2019-05-08,771,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2013-12-25,2021-02-10,2737,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2022-03-23,2022-12-02,296,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class I,2013-05-22,2015-08-27,1196,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2016-12-28,2017-07-27,256,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2017-12-27,2018-09-06,401,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2019-06-19,2023-10-16,1651,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2019-11-13,2021-10-27,740,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class II,2020-10-07,2022-02-25,541,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class I,2016-02-24,2017-06-01,609,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2016-12-28,2017-04-06,160,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class II,2014-06-25,2014-10-15,125,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Visit
Class I,2016-03-16,2022-05-19,2428,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class II,2016-08-10,2017-06-06,336,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class I,2017-03-08,2017-03-28,105,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2020-09-30,2022-02-08,525,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2022-04-27,,,Ongoing,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2023-05-10,,,Ongoing,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2013-09-04,2018-06-27,1842,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2014-06-18,2019-10-02,2077,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class I,2014-06-18,2016-10-07,1093,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class I,2019-05-22,2023-03-07,1414,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2022-02-23,2023-05-02,638,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2021-07-28,2022-06-09,436,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class II,2021-08-25,2023-05-04,647,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2023-12-13,,,Ongoing,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,nan
Class I,2014-04-30,2016-06-29,1136,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class I,2019-01-30,2021-10-26,1022,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class II,2021-05-26,,,Ongoing,MARKETED WITHOUT APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class II,2021-05-12,,,Ongoing,MARKETED WITHOUT APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2013-12-25,2018-05-30,1759,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2012-12-05,2013-03-18,203,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2023-09-06,,,Ongoing,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2013-12-25,2014-11-21,760,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2021-07-21,2023-07-12,792,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2013-04-24,,,Ongoing,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class I,2013-05-01,2013-11-14,339,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2017-07-19,2018-03-09,325,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class II,2020-12-02,2023-06-02,926,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2018-02-07,2018-12-06,372,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class I,2018-03-14,2019-01-28,348,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class II,2018-11-21,2022-01-18,1191,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2023-09-20,,,Ongoing,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class II,2014-12-31,2017-01-13,791,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2016-02-24,,,Ongoing,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Other
Class I,2017-08-23,2018-04-05,335,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2014-06-04,2017-05-03,1227,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class II,2014-08-13,2017-03-14,993,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class II,2016-06-08,,,Ongoing,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2016-10-26,2018-07-06,785,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2018-02-21,2019-07-16,536,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2022-01-05,,,Completed,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2014-05-28,2015-02-03,390,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2013-06-19,2019-10-01,2422,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Telephone
Class I,2022-02-16,2022-08-17,201,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2016-06-01,2019-06-21,1259,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2013-02-27,2013-03-25,96,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2014-06-18,2014-06-12,205,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class II,2017-11-29,2020-07-09,1052,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2018-05-30,2021-04-07,1091,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2021-07-07,,,Ongoing,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class II,2021-06-23,,,Ongoing,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2022-08-10,,,Ongoing,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2016-06-01,2017-03-30,666,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2017-03-08,2018-10-29,705,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2019-04-03,2023-02-27,1446,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class I,2014-09-24,2015-04-10,366,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2019-04-17,,,Completed,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2022-07-27,2023-02-08,226,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2013-05-22,2013-07-22,333,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2013-08-07,2013-08-16,158,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2019-11-13,2023-03-22,1247,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2014-12-31,2018-06-05,1533,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2012-11-07,2015-11-30,1232,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Telephone
Class I,2017-11-01,2018-04-24,306,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class II,2018-05-30,2019-05-01,349,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2016-06-01,,,Ongoing,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2021-03-31,2022-04-20,429,Terminated,MARKETED WITHOUT APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2014-03-26,2019-10-02,2288,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2018-01-10,2019-05-01,588,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class III,2014-11-05,2017-04-03,895,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,Taro Pharmaceuticals U.S.A., PRESCRIPTION DRUG,ORAL,Letter
Class I,2016-02-24,2016-03-14,161,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class I,2022-07-27,2022-11-08,166,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class I,2018-11-21,,,Ongoing,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2020-01-22,2021-10-29,682,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2013-11-27,2013-11-27,231,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2013-12-18,2015-01-23,553,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2016-06-15,2016-06-09,181,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Telephone
Class I,2016-12-28,2020-09-30,1615,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2016-06-01,2021-09-27,2119,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2020-09-30,2022-05-19,623,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2016-06-01,2017-02-07,389,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class II,2016-10-26,2021-09-30,1917,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2017-05-31,2021-11-03,1681,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Other
Class I,2021-06-30,2023-07-12,785,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2013-05-22,2018-05-10,1865,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class I,2017-02-22,2020-11-17,1439,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class II,2021-05-05,,,Ongoing,MARKETED WITHOUT APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class II,2012-10-24,2013-02-28,146,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class I,2021-09-29,,,Completed,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class I,2017-08-23,2020-10-05,1188,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class II,2016-02-24,2019-03-06,1134,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2014-04-23,2015-01-29,489,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class II,2014-05-28,2014-07-24,86,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2015-08-26,2015-12-24,195,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Telephone
Class II,2020-01-29,2023-07-12,1418,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class III,2015-05-20,2016-03-03,328,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,Insight Pharmaceuticals , OTC DRUG,nan,Letter
Class I,2014-04-23,2019-10-02,2186,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2017-08-30,2021-02-10,1357,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class II,2014-02-12,2019-07-22,2259,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Telephone
Class II,2015-04-01,2018-06-04,1263,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class II,2017-08-23,2022-08-25,1921,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2014-05-21,,,Completed,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2015-05-13,2018-04-26,1143,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2022-02-16,2022-06-09,125,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class II,2014-08-06,2017-03-14,1159,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2018-01-31,2020-09-25,1023,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class II,2021-05-05,2021-07-16,113,Terminated,MARKETED WITHOUT APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2014-04-16,2018-06-27,1884,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2013-08-14,2015-01-29,755,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2014-02-05,2014-05-09,172,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class III,2014-09-17,2015-06-16,300,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2015-05-13,2017-01-23,729,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2017-12-06,2022-04-06,1643,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2022-02-23,2022-03-29,49,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2015-11-25,2018-10-18,1169,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2017-04-12,2017-09-13,209,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class II,2019-07-31,2021-04-09,634,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2013-04-10,2013-08-07,149,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2020-03-25,2023-10-17,1439,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2021-08-11,,,Ongoing,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class II,2023-05-03,,,Ongoing,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Other
Class I,2020-04-08,2021-11-10,604,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2014-02-05,2020-10-05,2527,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2013-11-27,2017-04-13,1317,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2013-08-14,2014-09-19,501,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class II,2014-08-27,2014-10-21,119,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2016-07-13,,,Ongoing,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2014-09-24,2015-08-06,496,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2016-06-01,2022-11-16,2611,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2018-04-04,2019-07-26,505,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class I,2019-03-20,2021-01-26,704,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2020-09-09,2023-06-05,1025,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2013-04-24,2013-06-05,534,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Telephone
Class I,2016-07-13,2020-04-23,1591,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2017-09-20,2018-08-10,389,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2022-10-19,2023-08-10,335,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2016-06-01,2017-04-17,501,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class II,2014-07-23,2016-11-28,938,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2021-09-22,2023-10-16,796,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2013-12-04,2020-10-05,2611,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class II,2015-01-07,2015-03-23,123,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class I,2013-09-11,2014-04-21,355,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class III,2018-02-21,2020-05-11,893,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Not Yet Classified,2023-12-06,,,Ongoing,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Telephone
Class II,2013-11-27,2017-04-13,1317,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2019-11-06,2021-10-27,772,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2020-10-07,,,Ongoing,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Telephone
Class II,2021-05-12,2022-04-18,388,Terminated,MARKETED WITHOUT APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2022-02-23,2022-03-29,49,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2019-06-05,,,Ongoing,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2013-02-13,2019-10-02,2568,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Telephone
Class I,2014-05-28,2014-09-18,303,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2014-08-20,2015-02-10,286,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2017-09-20,2018-03-27,249,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2022-07-20,,,Ongoing,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2014-08-20,2014-09-22,160,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2018-06-06,2020-06-10,755,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2022-01-05,,,Ongoing,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class II,2019-04-17,2020-12-15,676,Terminated,UNAPPROVED NEW DRUG,Unapproved,nan,nan,nan,Press Release
Class II,2020-07-01,2020-12-03,206,Terminated,LACK OF ASSURANCE OF STERILITY AND MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class I,2015-11-18,,,Ongoing,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class I,2017-02-22,2017-06-01,183,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2014-05-28,2014-09-18,248,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2015-05-13,2015-11-04,366,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class I,2017-08-23,2020-05-07,1084,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class II,2021-09-01,,,Ongoing,MARKETED WITHOUT ANDA,Unapproved,nan,nan,nan,nan
Class I,2022-02-23,2022-03-04,24,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2022-03-02,2022-06-03,113,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2014-05-28,2015-08-21,763,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2015-05-13,2017-02-08,789,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2020-01-08,2023-02-08,1183,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2012-08-29,2015-12-07,1291,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2016-02-24,2016-03-16,169,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Visit
Class I,2013-05-22,2013-08-12,233,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2014-04-16,2017-03-14,1190,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class II,2021-05-05,,,Ongoing,MARKETED WITHOUT APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2022-08-10,2023-10-16,452,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2016-10-19,2017-01-30,404,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class I,2017-09-20,2020-06-02,1092,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2021-07-28,,,Ongoing,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class II,2016-05-25,2017-11-15,602,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2017-12-27,2021-02-10,1297,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2014-10-08,2015-04-01,331,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2016-02-24,,,Ongoing,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class I,2019-02-13,2023-02-06,1473,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,E-Mail
Class I,2021-10-13,,,Ongoing,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,nan
Class II,2013-07-03,2014-06-30,403,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Letter
Class I,2014-04-30,2015-05-29,557,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,Press Release
Class I,2013-12-25,2015-05-11,649,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2014-03-12,2014-09-15,420,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2014-05-07,2017-05-03,1273,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2015-12-09,2018-06-11,958,Terminated,MARKETED WITHOUT AN APPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2022-06-22,,,Completed,MARKETED WITHOUT AN UNAPPROVED NDA,Unapproved,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2013-02-20,2014-04-09,468,Terminated,CRYSTALLIZATION,Uncategorized,nan,nan,nan,Letter
Class III,2013-04-24,2013-09-11,223,Terminated,DISCOLORATION,Uncategorized,nan,nan,nan,Letter
Class II,2014-01-01,2014-10-07,365,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2015-05-13,2015-08-18,117,Terminated,CRYSTALLIZATION,Uncategorized,nan,nan,nan,Letter
Class II,2019-03-20,2021-07-12,868,Terminated,FAILED CONTENT UNIFORMITY SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2019-08-21,2021-02-09,573,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Macleods Pharmaceuticals Limited, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-01-15,2020-10-22,301,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,Letter
Class II,2020-12-23,2023-10-16,1043,Terminated,PRODUCT MIX,Uncategorized,AvKARE, PRESCRIPTION DRUG,ORAL,Letter
Class II,2021-01-06,2022-12-07,720,Terminated,CROSS,Uncategorized,Cipla USA ., PRESCRIPTION DRUG,ORAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2021-03-03,2022-12-21,672,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,"[""Dr.Reddys Laboratories ""]", PRESCRIPTION DRUG,ORAL,Letter
Class III,2021-12-15,2023-06-23,588,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Rite Aid Corporation, OTC DRUG,ORAL,Letter
Class II,2022-12-21,,,Completed,UNDERFILLED UNITS.,Uncategorized,nan,nan,nan,Letter
Class II,2013-07-17,2014-08-25,461,Terminated,CRYSTALLIZATION,Uncategorized,nan,nan,nan,Letter
Class II,2016-09-21,2019-08-23,1103,Terminated,DISCOLORATION,Uncategorized,nan,nan,nan,Letter
Class III,2016-10-05,2017-02-07,172,Terminated,TABLETS,Uncategorized,Unichem Pharmaceuticals (USA), PRESCRIPTION DRUG,ORAL,Letter
Class I,2016-12-28,2017-08-07,318,Terminated,NON,Uncategorized,nan,nan,nan,Telephone
Class III,2017-07-05,2020-02-06,982,Terminated,FAILED MOISTURE LIMITS,Uncategorized,nan,nan,nan,Letter
Class I,2018-02-21,2021-02-10,1125,Terminated,NON,Uncategorized,nan,nan,nan,Letter
Class I,2020-08-26,2022-09-28,827,Terminated,NON,Uncategorized,CareFusion 213 , OTC DRUG,TOPICAL,Letter
Class III,2012-09-05,2013-07-08,448,Terminated,SHORT FILL,Uncategorized,BRACCO DIAGNOSTICS INC, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2013-08-28,2015-05-12,840,Terminated,CRYSTALLIZATION,Uncategorized,nan,nan,nan,Letter
Class II,2014-02-12,2015-02-12,426,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,"[""Dr. Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class III,2014-03-26,2014-08-14,164,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,nan,nan,nan,Letter
Class III,2014-07-30,2017-07-10,1095,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Eon Labs, PRESCRIPTION DRUG,ORAL,Letter
Class III,2014-09-24,2018-05-18,1362,Terminated,FAILED CONTENT UNIFORMITY SPECIFICATIONS.,Uncategorized,Taro Pharmaceuticals U.S.A., PRESCRIPTION DRUG,ORAL,Letter
Class I,2014-12-31,2015-07-06,304,Terminated,NON,Uncategorized,nan,nan,nan,Press Release
Class II,2017-12-06,2018-07-03,236,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,Letter
Class III,2018-08-01,2019-12-04,525,Terminated,OUT,Uncategorized,nan,nan,nan,Letter
Class III,2019-02-20,2020-07-08,525,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Oceanside Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2021-04-28,2022-02-11,305,Terminated,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class II,2022-08-17,,,Ongoing,DEFECTIVE CONTAINER,Uncategorized,Glenmark Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-07-26,,,Ongoing,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Ascend Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class I,2013-05-22,2013-05-17,164,Terminated,NON,Uncategorized,nan,nan,nan,Letter
Class III,2013-02-13,2013-05-07,105,Terminated,TABLET,Uncategorized,nan,nan,nan,Letter
Class II,2014-05-14,2015-06-10,454,Terminated,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class III,2015-12-16,2017-07-26,602,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,Pfizer Laboratories Div Pfizer , PRESCRIPTION DRUG,ORAL,Letter
Class I,2017-11-01,2018-09-06,356,Terminated,TEMPERATURE ABUSE,Uncategorized,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2021-02-10,2023-09-19,993,Terminated,DISCOLORATION AND FAILED PH SPECIFICATIONS,Uncategorized,Eugia US , PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2021-11-10,2023-02-16,499,Terminated,FAILED EXCIPIENT SPECIFICATIONS,Uncategorized,Dr.Reddys Laboratories , PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-12-31,2014-12-23,888,Terminated,INCORRECT,Uncategorized,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2012-12-12,2013-12-24,460,Terminated,MISCALIBRATED AND,Uncategorized,nan,nan,nan,Letter
Class III,2012-12-26,2014-11-20,784,Terminated,SHORT FILL,Uncategorized,nan,nan,nan,Letter
Class III,2013-02-13,2013-06-07,200,Terminated,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class III,2013-06-26,2015-06-05,735,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,Pfizer Laboratories Div Pfizer , PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-08-07,2014-01-31,193,Terminated,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class I,2018-03-21,2019-08-07,546,Terminated,NON,Uncategorized,Hospira, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS', 'SUBCUTANEOUS",Letter
Class III,2018-09-19,2019-10-30,442,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,United Therapeutics Corporation, PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-05-08,2021-02-16,669,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,nan,nan,nan,Telephone
Class II,2020-09-02,2022-01-24,536,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,Letter
Class II,2021-10-27,2023-06-08,629,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,nan
Class III,2022-10-05,2023-02-08,141,Terminated,INCORRECT PRODUCT FORMULATION,Uncategorized,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2023-07-19,,,Ongoing,FAILED MOISTURE LIMITS,Uncategorized,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class I,2013-08-14,2018-01-08,1704,Terminated,CRYSTALLIZATION,Uncategorized,nan,nan,nan,Letter
Class II,2013-08-14,2014-11-04,516,Terminated,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class III,2013-12-04,2014-11-04,427,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,Letter
Class III,2017-05-31,2018-05-18,395,Terminated,FAILED TABLET,Uncategorized,Sun Pharmaceutical Industries, OTC DRUG,ORAL,Letter
Class II,2018-11-07,2023-04-03,1624,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2019-02-13,2019-09-09,220,Terminated,DEFECTIVE CONTAINER,Uncategorized,Meda Pharmaceuticals ., PRESCRIPTION DRUG,NASAL,Letter
Class II,2019-03-27,,,Ongoing,GCMP DEVIATIONS,Uncategorized,Aurobindo Pharma Limited, PRESCRIPTION DRUG,ORAL,Letter
Class I,2023-09-27,,,Ongoing,CRYSTALLIZATION,Uncategorized,Novartis Pharmaceuticals Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2015-08-26,2017-07-19,726,Terminated,FAILED DISSOLUTION TESTING,Uncategorized,nan,nan,nan,Letter
Class I,2016-06-01,2017-03-09,779,Terminated,NON,Uncategorized,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2016-08-31,2018-06-14,742,Terminated,CRYSTALLIZATION,Uncategorized,nan,nan,nan,E-Mail
Class II,2016-11-16,2017-06-07,287,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,nan,nan,nan,Letter
Class II,2021-03-10,,,Ongoing,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Noven Therapeutics, PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class II,2012-07-18,2014-05-09,778,Terminated,MISCALIBRATED,Uncategorized,Noven Therapeutics, PRESCRIPTION DRUG,TRANSDERMAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2013-01-30,2013-04-05,108,Terminated,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class III,2013-05-01,2013-12-05,282,Terminated,TABLETS,Uncategorized,nan,nan,nan,Letter
Class II,2014-06-04,2015-08-13,490,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class III,2017-04-19,2018-09-04,518,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,Letter
Class II,2017-08-09,2018-01-31,191,Terminated,FAILED TABLET,Uncategorized,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class III,2017-09-27,2019-04-11,615,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2018-11-28,2020-05-19,559,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,"[""Dr.Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class II,2021-02-24,2023-06-02,848,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Wilshire Pharmaceuticals , PRESCRIPTION DRUG,ORAL,Letter
Class I,2022-04-13,2023-02-08,324,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2022-06-08,,,Ongoing,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class I,2023-03-29,,,Ongoing,NON,Uncategorized,nan,nan,nan,Press Release
Class II,2012-08-29,2013-07-25,623,Terminated,MISBRANDED,Uncategorized,nan,nan,nan,Telephone
Class II,2014-02-05,2015-01-29,428,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2014-12-24,2017-09-25,1034,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,Letter
Class II,2017-03-01,2017-05-05,87,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class I,2019-06-19,2022-01-11,966,Terminated,NON,Uncategorized,Heritage Pharmaceuticals . d/b/a Avet Pharmaceuticals ., PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Press Release
Class III,2023-12-06,,,Ongoing,OOS FOR VISCOSITY,Uncategorized,Actavis Pharma, PRESCRIPTION DRUG,TRANSDERMAL,nan
Class II,2014-12-03,2015-06-16,263,Terminated,FAILED TABLET,Uncategorized,Actavis Pharma, PRESCRIPTION DRUG,ORAL,Letter
Class I,2019-07-10,2020-06-02,361,Terminated,INCORRECT PRODUCT FORMULATION,Uncategorized,nan,nan,nan,Letter
Class II,2020-07-15,2022-03-11,620,Terminated,DEFECTIVE CONTAINER,Uncategorized,EMD Serono, PRESCRIPTION DRUG,SUBCUTANEOUS,Letter
Class II,2022-05-18,2022-12-02,214,Terminated,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class I,2023-10-11,,,Ongoing,NON,Uncategorized,nan,nan,nan,Letter
Class II,2014-01-01,2014-09-03,328,Terminated,SHORT FILL,Uncategorized,nan,nan,nan,Telephone
Class II,2015-04-22,2019-02-26,1462,Terminated,TEMPERATURE ABUSE,Uncategorized,Noven Therapeutics, PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class III,2016-10-12,2018-07-02,657,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2019-02-06,2022-01-19,1129,Terminated,LACK OF PROCESSING CONTROLS.,Uncategorized,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2019-07-31,2021-06-07,689,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2019-08-07,2020-02-03,196,Terminated,LACK OF PROCESSING CONTROLS,Uncategorized,nan,nan,nan,Letter
Class II,2019-10-23,2020-12-01,419,Terminated,CRYSTALLIZATION,Uncategorized,nan,nan,nan,Letter
Class II,2022-10-26,,,Ongoing,OUT OF SPECIFICATION FOR RELATED SUBSTANCES,Uncategorized,Ingenus Pharmaceuticals, PRESCRIPTION DRUG,NASAL,Letter
Class II,2023-11-15,,,Ongoing,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Glenmark Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2023-11-15,,,Ongoing,INCORRECT PRODUCT FORMULATION,Uncategorized,nan,nan,nan,Telephone
Class I,2017-03-08,2017-06-19,290,Terminated,NON,Uncategorized,nan,nan,nan,Telephone
Class I,2016-12-28,2019-09-23,1116,Terminated,FAILED CONTENT UNIFORMITY SPECIFICATIONS,Uncategorized,nan,nan,nan,E-Mail
Class II,2018-03-28,2019-10-15,575,Terminated,DEFECTIVE CONTAINER,Uncategorized,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,VAGINAL,Letter
Class II,2018-06-20,2020-01-23,618,Terminated,LACK OF PROCESSING CONTROLS,Uncategorized,nan,nan,nan,Press Release
Class III,2019-07-10,2021-01-28,596,Terminated,DEFECTIVE CONTAINER,Uncategorized,Cipla USA ., PRESCRIPTION DRUG,TOPICAL,Letter
Class II,2023-11-29,,,Ongoing,FAILED VISCOSITY SPECIFICATIONS,Uncategorized,EDW PHARMA, PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-10-16,2014-07-25,305,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,Letter
Class III,2014-07-23,2014-11-03,130,Terminated,DOES NOT MEET MONOGRAPH,Uncategorized,nan,nan,nan,Letter
Class III,2014-12-31,2015-04-21,133,Terminated,FAILED PH SPECIFICATION,Uncategorized,nan,nan,nan,Letter
Class II,2021-12-15,2023-12-06,747,Terminated,PRODUCT MIX,Uncategorized,Camber Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2012-09-05,2013-02-19,211,Terminated,FAILED USP DISSOLUTION TEST REQUIREMENTS,Uncategorized,nan,nan,nan,Letter
Class II,2013-07-24,2014-01-29,222,Terminated,CONTRACEPTIVE TABLETS OUT OF SEQUENCE,Uncategorized,nan,nan,nan,Letter
Class III,2016-05-25,,,Ongoing,FAILED PH SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2017-01-04,2017-09-18,270,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,nan,nan,nan,Letter
Class II,2017-09-27,2020-01-24,877,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Noven Therapeutics, PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class II,2020-05-13,2023-09-07,1234,Terminated,DEFECTIVE CONTAINER,Uncategorized,Sandoz , PRESCRIPTION DRUG,nan,Letter
Class II,2020-11-11,2022-12-20,784,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,Zydus Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-12-24,2015-06-01,194,Terminated,FAILED USP DISSOLUTION TEST REQUIREMENTS,Uncategorized,nan,nan,nan,Letter
Class II,2015-06-24,2017-04-24,703,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,"[""Dr. Reddys Laboratories Ltd""]", PRESCRIPTION DRUG,ORAL,Letter
Class II,2015-07-08,2018-02-20,1006,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,Letter
Class III,2016-07-06,2017-01-13,253,Terminated,DISCOLORATION,Uncategorized,nan,nan,nan,Letter
Class II,2018-05-16,2020-06-04,762,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Noven Therapeutics, PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class III,2019-03-13,2020-03-05,371,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class I,2019-05-15,2019-08-14,117,Terminated,PRODUCT MIX,Uncategorized,ALVOGEN, PRESCRIPTION DRUG,TRANSDERMAL,Press Release
Class II,2020-04-22,2022-12-13,981,Terminated,LACK OF PROCESSING CONTROL,Uncategorized,nan,nan,nan,Letter
Class III,2020-07-08,2020-11-03,168,Terminated,TEMPERATURE ABUSE,Uncategorized,nan,nan,nan,Letter
Class III,2020-09-23,2022-01-14,619,Terminated,SHORT FILL,Uncategorized,Exela Pharma Sciences, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2022-02-02,2023-05-31,504,Terminated,FAILED DISSOLUTION SPECIFICATIONS.,Uncategorized,Ascend Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class I,2015-10-07,2015-12-30,135,Terminated,NON,Uncategorized,nan,nan,nan,Press Release
Class III,2017-11-01,2018-04-23,227,Terminated,TEMPERATURE ABUSE,Uncategorized,AbbVie ., PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class II,2018-01-24,2020-05-08,856,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class III,2018-10-31,2019-12-16,433,Terminated,DEFECTIVE CONTAINER,Uncategorized,Lupin Pharmaceuticals, PRESCRIPTION DRUG,TOPICAL,Letter
Class II,2019-05-08,2019-10-30,187,Terminated,SUB,Uncategorized,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2019-06-19,2020-10-15,506,Terminated,LACK OF PROCESSING CONTROLS.,Uncategorized,nan,nan,nan,Letter
Class III,2022-12-21,,,Ongoing,FAILED EXCIPIENT SPECIFICATIONS,Uncategorized,Camber Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class III,2023-01-25,,,Ongoing,MISMATCHING OF THE EMBOSSING ON THE TABLETS,Uncategorized,Macleods Pharmaceuticals Limited, PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-02-20,2013-07-12,234,Terminated,FAILED DISSOLUTION TEST REQUIREMENTS,Uncategorized,nan,nan,nan,Telephone
Class III,2014-11-12,2017-04-14,917,Terminated,CRYSTALLIZATION,Uncategorized,Wyeth Pharmaceuticals , PRESCRIPTION DRUG,nan,Letter
Class II,2014-12-24,2016-12-15,783,Terminated,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class II,2015-12-16,2016-10-25,327,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,GlaxoSmithKline , PRESCRIPTION DRUG,RESPIRATORY (INHALATION),Letter
Class II,2016-07-20,2019-03-19,1184,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Noven Therapeutics, PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class III,2017-02-01,2017-12-15,366,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,West-Ward Pharmaceuticals Corp., PRESCRIPTION DRUG,NASAL,Letter
Class II,2019-12-18,2021-03-04,465,Terminated,DISCOLORATION,Uncategorized,Eugia US , PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2020-11-04,2021-09-29,359,Terminated,AN EXTRANEOUS PEAK WAS OBSERVED FOR DISSOLUTION TESTING.,Uncategorized,nan,nan,nan,Letter
Class III,2021-08-25,2023-03-07,579,Terminated,OUT OF SPECIFICATION RESULTS FOR CONDUCTIVITY.,Uncategorized,nan,nan,nan,Letter
Class II,2021-12-29,,,Ongoing,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class II,2022-12-07,,,Ongoing,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Noven Therapeutics, PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class III,2022-12-07,,,Ongoing,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class III,2023-03-22,,,Ongoing,FAILED CONTENT UNIFORMITY SPECIFICATIONS,Uncategorized,Padagis US , PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class III,2023-12-06,,,Ongoing,FAILED EXCIPIENT SPECIFICATIONS,Uncategorized,VistaPharm, PRESCRIPTION DRUG,ORAL,nan
Class II,2014-03-12,2015-01-22,352,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Actavis Pharma, PRESCRIPTION DRUG,ORAL,Letter
Class III,2019-08-21,2020-11-09,460,Terminated,TEMPERATURE ABUSE,Uncategorized,Glenmark Pharmaceuticals . USA, PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2020-06-17,2022-07-28,783,Terminated,DISCOLORATION,Uncategorized,nan,nan,nan,Letter
Class II,2020-07-22,2020-09-14,77,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,nan,nan,nan,Letter
Class II,2022-07-06,,,Ongoing,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Noven Therapeutics, PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class III,2023-01-25,,,Ongoing,FAILED DISSOLUTION SPECIFICATION,Uncategorized,Intersect ENT, PRESCRIPTION DRUG,INTRASINAL,Letter
Class II,2016-06-22,2017-04-28,340,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class III,2016-06-29,2018-08-21,827,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,nan,nan,nan,E-Mail
Class II,2016-08-17,2017-04-07,249,Terminated,DOES NOT MEET MONOGRAPH,Uncategorized,nan,nan,nan,Letter
Class II,2021-10-20,2022-10-26,394,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Strides Pharma Science Limited, PRESCRIPTION DRUG,ORAL,Letter
Class I,2014-09-03,2016-10-07,1023,Terminated,NON,Uncategorized,nan,nan,nan,Letter
Class II,2014-07-02,2017-04-14,1100,Terminated,CRYSTALLIZATION,Uncategorized,Bausch & Lomb Incorporated, OTC DRUG,OPHTHALMIC,Letter
Class II,2014-07-09,2016-01-05,565,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2014-08-06,2015-03-16,247,Terminated,TEMPERATURE ABUSE,Uncategorized,Daiichi Sankyo, PRESCRIPTION DRUG,ORAL,Telephone
Class I,2015-04-15,2015-08-19,245,Terminated,NON,Uncategorized,nan,nan,nan,Telephone
Class II,2017-09-13,2019-01-14,570,Terminated,INCORRECT,Uncategorized,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2019-02-20,2019-11-06,299,Terminated,DEFECTIVE CONTAINER,Uncategorized,Macleods Pharmaceuticals Limited, PRESCRIPTION DRUG,TOPICAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2019-02-06,2021-02-22,760,Terminated,BROMFENAC OPHTHALMIC SOLUTION,Uncategorized,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class II,2019-04-10,2019-09-20,175,Terminated,DISCOLORATION,Uncategorized,Jubilant Cadista Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class I,2020-04-08,2022-12-22,1011,Terminated,DEFECTIVE CONTAINER,Uncategorized,"[""Dr.Reddys Laboratories ""]", PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS', 'SUBCUTANEOUS",Letter
Class II,2013-03-06,2014-03-21,472,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class III,2014-04-30,2017-01-20,1065,Terminated,FAILED LOZENGE SPECIFICATIONS,Uncategorized,GlaxoSmithKline Consumer Healthcare Holdings (US) , OTC DRUG,ORAL,Letter
Class I,2014-11-26,2016-10-07,1267,Terminated,NON,Uncategorized,nan,nan,nan,Telephone
Class II,2015-06-03,2019-03-19,1527,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Noven Therapeutics, PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class II,2015-06-24,2015-10-09,221,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class I,2016-12-28,2019-10-08,1163,Terminated,NON,Uncategorized,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2017-07-19,2018-03-29,302,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Actavis Pharma, PRESCRIPTION DRUG,ORAL,Letter
Class II,2017-09-06,2017-11-08,146,Terminated,DEFECTIVE CONTAINER,Uncategorized,Tris Pharma , PRESCRIPTION DRUG,ORAL,Letter
Class I,2020-07-08,2023-10-16,1224,Terminated,SUPER,Uncategorized,nan,nan,nan,Letter
Class II,2022-11-30,2023-09-13,415,Terminated,DISCOLORATION,Uncategorized,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,nan
Class II,2012-07-04,2013-03-22,354,Terminated,TABLET THICKNESS,Uncategorized,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class II,2012-06-20,2013-08-21,477,Terminated,SHORT FILL,Uncategorized,nan,nan,nan,Letter
Class I,2013-07-31,2013-07-29,207,Terminated,NON,Uncategorized,Mobius Therapeutics , PRESCRIPTION DRUG,nan,Telephone
Class III,2014-12-24,2015-08-13,483,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2015-06-17,2016-04-12,361,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class III,2016-10-19,2019-11-08,1166,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,"[""Dr. Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class III,2018-11-21,2019-02-05,102,Terminated,FAILED PH SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2019-02-27,2023-02-14,1475,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,"[""Dr. Reddys Laboratories Ltd""]", PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-11-27,2014-04-15,165,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Meijer Distribution , OTC DRUG,ORAL,Press Release
Class II,2020-06-10,2022-10-02,863,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,Major Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2021-04-28,,,Ongoing,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Noven Therapeutics, PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class III,2022-04-13,2023-06-29,476,Terminated,FAILED CONTENT UNIFORMITY SPECIFICATIONS,Uncategorized,Macleods Pharmaceuticals Limited, PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-06-21,,,Ongoing,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Amneal Pharmaceuticals , PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-12-13,,,Ongoing,FAILED PH SPECIFICATIONS,Uncategorized,Baxter Healthcare Corporation, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class III,2014-12-03,2016-02-26,513,Terminated,DISCOLORATION,Uncategorized,Zydus Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2015-01-14,2016-11-23,712,Terminated,INCORRECT PRODUCT FORMULATION,Uncategorized,nan,nan,nan,Telephone
Class II,2016-02-17,2016-02-25,360,Terminated,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class I,2017-08-23,2019-05-30,744,Terminated,CONTRACEPTIVE TABLETS OUT OF SEQUENCE,Uncategorized,nan,nan,nan,Letter
Class II,2022-05-11,2023-06-21,419,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Greenstone , PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-06-29,2023-08-18,441,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,Letter
Class III,2014-02-12,2014-05-07,175,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Allergan, PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-10-15,2015-05-19,246,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Genentech, PRESCRIPTION DRUG,ORAL,Letter
Class II,2016-02-10,2017-04-24,469,Terminated,FAILED TABLET,Uncategorized,Parke-Davis Div of Pfizer , PRESCRIPTION DRUG,ORAL,Letter
Class II,2018-12-26,2023-10-30,1827,Terminated,DEFECTIVE CONTAINER,Uncategorized,GE Healthcare ., PRESCRIPTION DRUG,"INTRAVASCULAR', 'INTRAVENOUS",Letter
Class II,2021-10-27,2023-03-13,521,Terminated,OUT OF SPECIFICATION RESULT OBSERVED IN A DISSOLUTION TEST AT THE 9,Uncategorized,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2021-12-15,2022-12-28,426,Terminated,CRYSTALLIZATION,Uncategorized,nan,nan,nan,Letter
Class II,2022-03-16,2023-06-08,465,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Major Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-06-29,,,Completed,DEFECTIVE CONTAINER,Uncategorized,Medline Industries, OTC DRUG,TOPICAL,Letter
Class III,2013-05-29,2015-05-07,722,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2013-11-27,2014-05-09,235,Terminated,FAILED TABLET,Uncategorized,Lannett Company, PRESCRIPTION DRUG,ORAL,nan
Class III,2015-12-30,2016-03-14,147,Terminated,FAILED PH SPECIFICATION,Uncategorized,nan,nan,nan,Letter
Class III,2017-11-01,2018-04-12,177,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2018-10-17,2020-04-13,581,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,nan,nan,nan,Letter
Class III,2014-08-13,2014-12-05,128,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,Letter
Class II,2014-12-17,2016-09-27,664,Terminated,FAILED TABLET,Uncategorized,Pfizer Laboratories Div Pfizer , PRESCRIPTION DRUG,ORAL,Letter
Class II,2016-10-19,2017-12-06,524,Terminated,FAILED CONTENT UNIFORMITY SPECIFICATIONS,Uncategorized,Allergan, PRESCRIPTION DRUG,CUTANEOUS,Letter
Class II,2017-04-12,,,Ongoing,DEFECTIVE DELIVERY SYSTEM,Uncategorized,GlaxoSmithKline , PRESCRIPTION DRUG,RESPIRATORY (INHALATION),Telephone
Class II,2018-03-14,2020-04-02,772,Terminated,DEFECTIVE CONTAINER,Uncategorized,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2019-03-20,2019-09-11,188,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,Letter
Class II,2020-07-08,2022-06-03,717,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,GlaxoSmithKline Consumer Healthcare Holdings (US) , OTC DRUG,ORAL,Press Release
Class III,2020-08-19,2023-06-20,1065,Terminated,FAILED CONTENT UNIFORMITY,Uncategorized,nan,nan,nan,Letter
Class II,2020-11-11,2020-12-16,75,Terminated,DISCOLORATION.,Uncategorized,nan,nan,nan,Letter
Class I,2022-12-21,,,Ongoing,DEFECTIVE CONTAINER,Uncategorized,Civica, PRESCRIPTION DRUG,INTRAVENOUS,Press Release
Class II,2014-10-15,2015-02-24,195,Terminated,DEFECTIVE CONTAINER,Uncategorized,VistaPharm, PRESCRIPTION DRUG,ORAL,Letter
Class III,2014-11-12,2015-02-04,511,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,Letter
Class II,2015-08-19,2017-03-24,599,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,"[""Dr. Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class II,2017-04-26,2019-06-17,811,Terminated,FAILED CONTENT UNIFORMITY SPECIFICATIONS,Uncategorized,Taro Pharmaceuticals U.S.A., PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2021-05-26,2022-09-26,525,Terminated,INCORRECT PRODUCT FORMULATION,Uncategorized,Sigmapharm Laboratories, PRESCRIPTION DRUG,SUBLINGUAL,Letter
Class II,2023-05-31,,,Ongoing,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class I,2023-06-07,,,Ongoing,PRODUCT MIX,Uncategorized,KRAMER NOVIS, OTC DRUG,ORAL,Letter
Class II,2012-08-29,2012-11-23,597,Terminated,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class III,2012-10-10,2013-04-11,378,Terminated,FAILED USP DISSOLUTION TEST REQUIREMENTS,Uncategorized,nan,nan,nan,Letter
Class II,2013-04-17,2014-01-15,323,Terminated,DEFECTIVE CONTAINER,Uncategorized,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class III,2013-04-24,2014-05-09,413,Terminated,FAILED USP DISSOLUTION TEST REQUIREMENTS,Uncategorized,nan,nan,nan,Letter
Class II,2013-09-04,2014-08-27,386,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,Letter
Class III,2014-12-17,2015-10-08,349,Terminated,DOES NOT MEET MONOGRAPH,Uncategorized,nan,nan,nan,Letter
Class III,2015-07-15,2017-01-13,570,Terminated,FAILED CONTENT UNIFORMITY SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2016-07-20,2018-08-31,799,Terminated,CRYSTALLIZATION,Uncategorized,Hospira, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class I,2017-12-27,2022-09-07,1861,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Amneal Pharmaceuticals , PRESCRIPTION DRUG,ORAL,Letter
Class II,2017-10-04,2020-01-24,875,Terminated,NON,Uncategorized,nan,nan,nan,Letter
Class II,2018-12-26,2020-07-08,572,Terminated,FAILED DISSOLUTION SPECIFICATIONS.,Uncategorized,nan,nan,nan,Letter
Class III,2020-08-19,2022-08-12,751,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,Letter
Class II,2022-08-03,2023-05-31,338,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-04-26,,,Ongoing,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,American Health Packaging, PRESCRIPTION DRUG,ORAL,Telephone
Class III,2023-05-17,,,Ongoing,PRODUCT MIXUP,Uncategorized,Major Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class III,2018-05-09,2020-05-19,763,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,Rhodes Pharmaceuticals L.P., PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-03-20,2022-05-16,1167,Terminated,DEFECTIVE CONTAINER,Uncategorized,"[""Dr. Reddys Laboratories .""]", PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2020-08-19,2020-12-10,139,Terminated,FAILED CONTENT UNIFORMITY,Uncategorized,nan,nan,nan,Letter
Class II,2022-01-19,2023-10-23,690,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Torrent Pharmaceuticals Limited, PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-05-11,2023-11-07,571,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Dr.Reddys Laboratories , PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-10-11,,,Ongoing,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Zydus Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2012-10-31,2013-12-09,424,Terminated,TABLET SEPARATION,Uncategorized,nan,nan,nan,Letter
Class II,2014-02-12,2015-01-29,412,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,nan,nan,nan,Letter
Class III,2014-07-23,2015-12-07,522,Terminated,FAILED PH SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2019-03-20,2020-11-18,622,Terminated,INCORRECT,Uncategorized,nan,nan,nan,Letter
Class II,2019-08-21,2020-11-06,455,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class III,2020-02-05,2021-04-26,462,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Macleods Pharmaceuticals Limited, PRESCRIPTION DRUG,ORAL,Letter
Class III,2020-02-12,2021-10-27,644,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Ascend Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-04-29,2021-06-07,413,Terminated,PRODUCT MIX,Uncategorized,nan,nan,nan,Letter
Class III,2021-04-07,2021-11-04,240,Terminated,TEMPERATURE ABUSE,Uncategorized,Janssen Biotech, PRESCRIPTION DRUG,SUBCUTANEOUS,Letter
Class I,2022-11-02,,,Ongoing,DEFECTIVE CONTAINER,Uncategorized,Civica, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2016-01-27,2016-09-13,273,Terminated,SUPER,Uncategorized,nan,nan,nan,Letter
Class I,2016-12-28,2018-02-27,537,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Novo Nordisk, PRESCRIPTION DRUG,nan,Press Release
Class III,2016-11-23,2017-06-29,245,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2017-03-15,2017-10-24,256,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Sandoz , PRESCRIPTION DRUG,ORAL,Letter
Class III,2017-03-08,2018-12-19,672,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,"[""Dr. Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class III,2017-04-12,2017-12-21,290,Terminated,CROSS,Uncategorized,"[""Dr. Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class II,2017-05-10,2017-08-04,211,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Major Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2018-07-18,,,Ongoing,TEMPERATURE ABUSE,Uncategorized,Sanofi-Aventis U.S. , PRESCRIPTION DRUG,"INTRAVENOUS', 'SUBCUTANEOUS",Letter
Class III,2020-03-25,2021-02-16,365,Terminated,FAILED TABLET,Uncategorized,Strides Pharma Science Limited, PRESCRIPTION DRUG,ORAL,Letter
Class III,2021-12-01,2022-10-12,352,Terminated,DISCOLORATION,Uncategorized,Unichem Pharmaceuticals (USA), PRESCRIPTION DRUG,ORAL,nan
Class II,2022-04-06,,,Ongoing,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,"[""Dr.Reddys Laboratories Ltd.""]", PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-08-03,2023-12-06,511,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Dr.Reddys Laboratories , PRESCRIPTION DRUG,ORAL,Letter
Class III,2012-06-27,2013-04-23,365,Terminated,CONTRACEPTIVE TABLETS OUT OF SEQUENCE,Uncategorized,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,nan,Letter
Class III,2012-08-22,2017-07-24,1848,Terminated,FAILED PH SPECIFICATION,Uncategorized,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2013-09-18,2013-09-16,24,Terminated,GLUTATHIONE 100 MG,Uncategorized,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2014-02-05,2014-07-25,191,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,Letter
Class II,2014-04-30,2015-05-01,448,Terminated,DEFECTIVE CONTAINER,Uncategorized,STRATEGIC SOURCING SERVICES, OTC DRUG,ORAL,Letter
Class II,2014-10-15,2017-04-17,948,Terminated,TEMPERATURE ABUSE,Uncategorized,Mylan Institutional , PRESCRIPTION DRUG,INTRAVENOUS,Telephone
Class III,2016-04-13,2017-04-12,377,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2016-12-28,2017-06-01,225,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,Telephone
Class III,2017-02-15,2020-07-29,1321,Terminated,DISCOLORATION,Uncategorized,Eugia US , PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2018-08-15,2022-09-09,1508,Terminated,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class III,2019-02-27,2019-12-17,301,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class I,2020-04-15,2022-08-23,883,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2023-07-26,,,Ongoing,FAILED DISSOLUTION SPECIFICATION,Uncategorized,"[""Dr. Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,nan
Class II,2014-11-05,2015-05-11,222,Terminated,DEFECTIVE CONTAINER,Uncategorized,Gilead Sciences, PRESCRIPTION DRUG,ORAL,Letter
Class II,2015-05-20,2017-12-27,1016,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class III,2015-08-12,2016-04-14,265,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Prasco Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-03-13,2020-02-26,372,Terminated,INCORRECT PRODUCT FORMULATION,Uncategorized,nan,nan,nan,Telephone
Class II,2019-08-21,2021-08-04,742,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Alvogen ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2021-06-16,2021-09-17,142,Terminated,TEMPERATURE ABUSE,Uncategorized,Fresenius Medical Care North America, PRESCRIPTION DRUG,INTRAPERITONEAL,Letter
Class I,2023-07-19,,,Ongoing,DEFECTIVE CONTAINER,Uncategorized,Cipla USA ., PRESCRIPTION DRUG,RESPIRATORY (INHALATION),Letter
Class II,2015-05-20,2015-12-04,227,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,Alvogen ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2015-07-29,2017-05-15,672,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2018-02-14,2018-12-12,316,Terminated,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class III,2018-02-21,2019-03-11,399,Terminated,SUN PHARMACEUTICAL IS RECALLING AZELASTINE HCL NASAL SOLUTION,Uncategorized,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,NASAL,Letter
Class II,2018-10-03,2021-11-05,1173,Terminated,DISCOLORATION,Uncategorized,Camber Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class III,2022-07-13,,,Ongoing,DEFECTIVE CONTAINER,Uncategorized,Glenmark Pharmaceuticals ., PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2013-12-18,2014-05-29,204,Terminated,FAILED MOISTURE LIMIT,Uncategorized,Eon Labs, PRESCRIPTION DRUG,ORAL,Letter
Class II,2017-02-22,2017-08-02,225,Terminated,FAILED TABLET,Uncategorized,Accord Healthcare ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2017-05-31,2017-07-12,385,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,E-Mail
Class II,2020-03-11,2020-10-06,229,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Actavis Pharma, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-03-18,2022-03-31,766,Terminated,LACK OF PROCESSING CONTROLS,Uncategorized,nan,nan,nan,Telephone
Class II,2022-02-09,2022-12-21,345,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class III,2022-05-11,2023-09-28,531,Terminated,FAILED VISCOSITY SPECIFICATION,Uncategorized,Akorn, PRESCRIPTION DRUG,"ORAL', 'TOPICAL",Letter
Class II,2023-05-31,,,Ongoing,SUB,Uncategorized,nan,nan,nan,Letter
Class II,2013-02-13,2014-07-30,589,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,Actavis Pharma, PRESCRIPTION DRUG,ORAL,E-Mail
Class III,2014-01-01,2014-08-27,266,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,nan,nan,nan,Letter
Class II,2014-07-09,2015-05-22,367,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2016-02-03,2017-01-11,359,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2017-02-01,2017-12-18,361,Terminated,FAILED TABLET,Uncategorized,West-Ward Pharmaceuticals Corp., PRESCRIPTION DRUG,ORAL,Letter
Class II,2018-04-25,2020-01-24,655,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Noven Therapeutics, PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class III,2020-10-28,2022-05-19,590,Terminated,DEFECTIVE CONTAINER,Uncategorized,Sandoz ., PRESCRIPTION DRUG,RESPIRATORY (INHALATION),Letter
Class II,2023-02-01,,,Ongoing,SHORT FILL,Uncategorized,Nephron SC, OTC DRUG,RESPIRATORY (INHALATION),Letter
Class II,2023-07-12,,,Completed,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2014-05-07,2015-02-24,341,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2014-09-03,2014-12-22,293,Terminated,CUSTOMER COMPLAINTS FOR FAILURE TO DELIVER THE DOSE.,Uncategorized,Alkermes, PRESCRIPTION DRUG,nan,Letter
Class II,2014-10-22,2015-02-20,142,Terminated,CRYSTALLIZATION,Uncategorized,nan,nan,nan,Telephone
Class I,2015-04-15,2015-11-25,323,Terminated,NON,Uncategorized,nan,nan,nan,E-Mail
Class II,2020-06-10,2021-05-25,368,Terminated,SOME BOTTLES MAY CONTAIN MIXED STRENGTHS OF THE PRODUCT.,Uncategorized,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-12-09,2023-02-19,823,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Major Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class III,2023-09-06,,,Ongoing,DEFECTIVE CONTAINER,Uncategorized,Glasshouse Pharmaceuticals Limited Canada, PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2023-12-13,,,Ongoing,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class III,2015-09-23,2017-05-10,652,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2016-06-15,2017-05-02,370,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Novo Nordisk, PRESCRIPTION DRUG,SUBCUTANEOUS,Letter
Class II,2017-02-22,2018-03-13,407,Terminated,FAILED DISSOLUTION SPECIFICATIONS. ABOVE OUT OF SPECIFICATION FOR DISSOLUTION RATE OBSERVED AT THE 10 HOUR TESTING POINT.,Uncategorized,Actavis Pharma, PRESCRIPTION DRUG,ORAL,Letter
Class II,2017-10-04,2018-01-03,134,Terminated,CRYSTALLIZATION,Uncategorized,nan,nan,nan,Letter
Class II,2020-12-09,2022-07-22,612,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2014-07-16,2014-10-24,210,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,nan,nan,nan,Letter
Class II,2014-11-12,2015-05-06,222,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2017-02-22,2019-03-19,817,Terminated,FAILED TABLET,Uncategorized,Aurobindo Pharma Limited, PRESCRIPTION DRUG,ORAL,Letter
Class III,2022-04-06,,,Ongoing,FAILED CONTENT UNIFORMITY SPECIFICATIONS,Uncategorized,Taro Pharmaceuticals U.S.A., PRESCRIPTION DRUG,TOPICAL,Letter
Class II,2022-07-13,2023-02-16,251,Terminated,LACK OF PROCESSING CONTROLS,Uncategorized,nan,nan,nan,nan
Class II,2012-10-17,2013-11-12,405,Terminated,PADDOCK LABORATORIES,Uncategorized,nan,nan,nan,Letter
Class III,2015-07-15,2017-12-04,930,Terminated,FAILED PH SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2016-10-12,2017-12-18,441,Terminated,FAILED TABLET,Uncategorized,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2019-02-20,2021-01-26,720,Terminated,DISCOLORATION,Uncategorized,"[""Dr. Reddys Laboratories ""]", PRESCRIPTION DRUG,ORAL,Letter
Class III,2023-02-01,,,Ongoing,SHORT FILL,Uncategorized,nan,nan,nan,Letter
Class II,2013-07-24,2013-08-21,315,Terminated,FAILED DISSOLUTION TEST REQUIREMENTS,Uncategorized,nan,nan,nan,Letter
Class II,2013-11-27,2014-02-11,314,Terminated,RESUSPENSION PROBLEMS,Uncategorized,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2015-03-11,2016-01-27,348,Terminated,FAILED TABLET SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class I,2016-10-26,2017-01-23,186,Terminated,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,E-Mail
Class III,2019-03-13,2020-12-10,647,Terminated,DOES NOT MEET MONOGRAPH,Uncategorized,nan,nan,nan,Letter
Class II,2019-11-27,2020-05-28,198,Terminated,LACK OF PROCESSING CONTROLS,Uncategorized,nan,nan,nan,Telephone
Class II,2022-01-12,2023-04-06,531,Terminated,FAILED TABLET,Uncategorized,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-07-13,,,Ongoing,SHORTFILL,Uncategorized,Macleods Pharmaceuticals Limited, PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-03-06,2014-01-14,406,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2013-04-03,2015-05-04,790,Terminated,FAILED TABLET,Uncategorized,Zydus Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-12-04,2014-11-03,390,Terminated,FAILED TABLET,Uncategorized,Actavis Pharma, PRESCRIPTION DRUG,ORAL,Letter
Class II,2015-10-21,2017-04-10,563,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Actavis Pharma, PRESCRIPTION DRUG,ORAL,Letter
Class II,2017-06-28,2019-09-25,846,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,Letter
Class II,2017-09-06,2019-01-14,517,Terminated,CRYSTALLIZATION,Uncategorized,nan,nan,nan,Letter
Class II,2018-02-07,2019-09-09,641,Terminated,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class III,2019-12-18,,,Ongoing,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Glenmark Pharmaceuticals ., PRESCRIPTION DRUG,TOPICAL,Letter
Class II,2020-02-19,2022-09-29,969,Terminated,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class II,2021-01-27,2022-08-03,573,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2022-02-02,2023-03-09,444,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,BluePoint Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class I,2022-02-23,,,Ongoing,NON,Uncategorized,nan,nan,nan,Letter
Class II,2022-08-31,2023-08-17,386,Terminated,FAILED DISSOLUTION SPECIFICATIONS.,Uncategorized,Amneal Pharmaceuticals , PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-04-26,,,Ongoing,OUT OF SPECIFICATION,Uncategorized,Ascend Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-02-06,2013-12-05,323,Terminated,FAILED TABLET,Uncategorized,Mylan Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2013-07-24,2013-12-24,189,Terminated,DISCOLORATION,Uncategorized,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-05-28,2015-03-09,320,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,nan,nan,nan,Letter
Class II,2014-10-29,2017-03-29,915,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,nan,nan,nan,Letter
Class III,2015-10-07,2017-02-14,599,Terminated,DEFECTIVE CONTAINER,Uncategorized,VistaPharm, PRESCRIPTION DRUG,ORAL,E-Mail
Class III,2015-08-12,2016-12-30,556,Terminated,TABLETS,Uncategorized,Actavis Pharma, PRESCRIPTION DRUG,ORAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2016-09-21,2017-07-17,347,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2019-09-18,2020-03-04,183,Terminated,LACK OF PROCESSING CONTROLS,Uncategorized,nan,nan,nan,Telephone
Class II,2020-04-29,,,Completed,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Noven Therapeutics, PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class II,2020-10-07,2022-01-11,505,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Strides Pharma Science Limited, PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-01-08,2014-08-27,274,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,Letter
Class II,2014-10-29,2018-06-04,1397,Terminated,DOES NOT MEET MONOGRAPH,Uncategorized,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2014-10-29,2015-04-24,199,Terminated,INCORRECT,Uncategorized,nan,nan,nan,Letter
Class II,2015-04-08,2015-07-23,198,Terminated,FAILED TABLET,Uncategorized,American Health Packaging, PRESCRIPTION DRUG,ORAL,Letter
Class II,2016-08-03,2017-02-16,220,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Actavis Pharma, PRESCRIPTION DRUG,ORAL,Letter
Class I,2018-06-20,2022-05-19,1456,Terminated,CONTRACEPTIVE TABLETS OUT OF SEQUENCE.,Uncategorized,Allergan, PRESCRIPTION DRUG,nan,Letter
Class II,2019-01-23,2020-08-31,621,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2019-07-31,2020-01-24,190,Terminated,FAILED DISSOLUTION SPECIFICATIONS.,Uncategorized,UCB, PRESCRIPTION DRUG,ORAL,Telephone
Class III,2020-05-06,2022-05-13,749,Terminated,DISCOLORATION,Uncategorized,"[""Dr. Reddys Laboratories ""]", PRESCRIPTION DRUG,ORAL,Letter
Class III,2023-11-01,,,Ongoing,FAILED TABLET,Uncategorized,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2013-10-09,2014-05-09,235,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,nan,nan,nan,Letter
Class II,2014-04-09,2014-11-12,253,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,Letter
Class II,2014-05-21,2016-04-11,748,Terminated,FIRST AID ONLY,Uncategorized,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2014-12-31,2017-09-22,1004,Terminated,FAILED TABLET,Uncategorized,Zydus Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2015-04-29,2018-03-30,1236,Terminated,DEFECTIVE CONTAINER,Uncategorized,RB Health (US) , OTC DRUG,ORAL,Letter
Class II,2015-07-15,2017-03-03,644,Terminated,FAILED CONTENT UNIFORMITY SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class III,2015-08-26,2016-03-22,249,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class II,2016-04-20,2017-04-11,371,Terminated,INCORRECT,Uncategorized,Fresenius Kabi USA, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2018-12-12,2022-02-01,1159,Terminated,DISCOLORATION,Uncategorized,Aurobindo Pharma Limited, PRESCRIPTION DRUG,ORAL,Letter
Class III,2019-12-25,,,Ongoing,DEFECTIVE DELIVERY SYSTEM,Uncategorized,nan,nan,nan,Letter
Class III,2021-04-14,2021-05-13,56,Terminated,AN ERROR OCCURRED WHERE THE PRODUCT WAS MANUFACTURED WITH POTASSIUM CHLORIDE INSTEAD OF POTASSIUM PHOSPHATE.,Uncategorized,nan,nan,nan,Letter
Class I,2021-08-18,,,Completed,NON,Uncategorized,nan,nan,nan,Telephone
Class II,2013-11-13,2014-07-17,334,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Amneal Pharmaceuticals , PRESCRIPTION DRUG,ORAL,Letter
Class III,2014-12-31,2016-12-15,751,Terminated,DISCOLORATION,Uncategorized,nan,nan,nan,Letter
Class III,2015-08-12,2017-02-28,609,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class III,2017-03-15,2018-02-05,353,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class III,2018-02-07,2020-09-21,1005,Terminated,FAILED CONTENT UNIFORMITY SPECIFICATIONS,Uncategorized,Taro Pharmaceuticals U.S.A., PRESCRIPTION DRUG,TOPICAL,Letter
Class II,2018-10-31,2019-04-03,166,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class III,2023-06-07,2023-07-25,64,Terminated,PRODUCT MIX UP,Uncategorized,nan,nan,nan,E-Mail
Class II,2013-05-08,2016-12-28,1427,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Noven Therapeutics, PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class III,2016-10-12,2017-02-27,173,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Biocompatibles, PRESCRIPTION DRUG,nan,Letter
Class II,2019-11-06,2020-04-10,175,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,Mylan Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-02-19,2022-08-04,974,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,American Health Packaging, PRESCRIPTION DRUG,ORAL,Letter
Class III,2022-08-24,2023-09-29,423,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Heron Therapeutics, PRESCRIPTION DRUG,INFILTRATION,Letter
Class III,2023-04-12,,,Ongoing,SUB,Uncategorized,nan,nan,nan,E-Mail
Class III,2013-08-14,2014-05-09,282,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2016-06-01,2021-03-09,1776,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,nan,nan,nan,E-Mail
Class II,2020-03-18,2021-10-28,605,Terminated,PRODUCT MIX,Uncategorized,Mayne Pharma Commercial , PRESCRIPTION DRUG,ORAL,Letter
Class III,2021-03-17,2022-03-21,384,Terminated,FAILED PH SPECIFICATIONS,Uncategorized,Ferring Pharmaceuticals ., PRESCRIPTION DRUG,nan,Letter
Class II,2023-11-15,,,Ongoing,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Zydus Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class I,2013-07-24,2018-01-08,1757,Terminated,CRYSTALLIZATION,Uncategorized,nan,nan,nan,Letter
Class III,2014-07-16,2015-02-19,518,Terminated,DISCOLORATION,Uncategorized,Ferring Pharmaceuticals ., PRESCRIPTION DRUG,VAGINAL,Letter
Class II,2013-12-18,2016-09-28,1079,Terminated,DEFECTIVE CONTAINER,Uncategorized,VistaPharm, PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-10-01,2015-04-30,245,Terminated,FAILED CONTENT UNIFORMITY SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class I,2015-05-13,2017-01-17,908,Terminated,NON,Uncategorized,nan,nan,nan,Letter
Class II,2016-08-24,2017-02-02,183,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class III,2016-12-14,2018-02-06,462,Terminated,FAILED CONTENT UNIFORMITY,Uncategorized,nan,nan,nan,Letter
Class I,2017-05-10,,,Ongoing,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Mylan Specialty L.P., PRESCRIPTION DRUG,INTRAMUSCULAR,Press Release
Class II,2017-08-09,2020-01-07,972,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Zydus Pharmaceuticals (USA) ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2018-01-17,2018-12-04,694,Terminated,DEFECTIVE CONTAINER,Uncategorized,"[""Dr. Reddys Laboratories .""]", PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2019-03-20,2020-11-06,624,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Lannett Company, PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-06-05,2020-10-22,518,Terminated,COMPLAINT RECEIVED OF METAL PIECE IDENTIFIED IN THE PRODUCT BOTTLE PRIOR TO THE RECONSTITUTION.,Uncategorized,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-10-02,2020-10-08,398,Terminated,TEMPERATURE ABUSE,Uncategorized,GlaxoSmithKline , PRESCRIPTION DRUG,SUBCUTANEOUS,Letter
Class II,2020-12-23,2022-12-20,747,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Zydus Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2021-02-24,2022-02-10,377,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2021-09-22,2023-06-06,706,Terminated,LACK OF PROCESSING CONTROLS,Uncategorized,nan,nan,nan,Telephone
Class II,2022-01-19,2023-09-28,640,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Padagis Israel Pharmaceuticals Ltd, PRESCRIPTION DRUG,ORAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2014-05-28,2016-01-05,603,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Allergan, PRESCRIPTION DRUG,ORAL,Letter
Class II,2015-05-13,2017-12-14,1008,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,Letter
Class III,2016-04-27,2016-10-20,210,Terminated,FAILED CONTENT UNIFORMITY SPECIFICATIONS,Uncategorized,AbbVie ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2018-03-21,2021-02-18,1101,Terminated,TEMPERATURE ABUSE,Uncategorized,Camber Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class III,2018-08-22,2019-11-15,463,Terminated,DEFECTIVE CONTAINER,Uncategorized,Nalpropion Pharmaceuticals , PRESCRIPTION DRUG,ORAL,Letter
Class III,2021-09-08,,,Ongoing,FAILED VISCOSITY SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class III,2022-07-27,,,Ongoing,FAILED TABLET,Uncategorized,Glenmark Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2012-06-20,2013-05-23,688,Terminated,MISCALIBRATED AND,Uncategorized,Noven Therapeutics, PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class I,2015-02-25,2015-11-23,501,Terminated,NON,Uncategorized,nan,nan,nan,Press Release
Class II,2015-01-28,2017-10-04,1008,Terminated,NON,Uncategorized,Bausch Health US, PRESCRIPTION DRUG,RESPIRATORY (INHALATION),Press Release
Class I,2017-11-01,2018-10-30,427,Terminated,INCORRECT PRODUCT FORMULATION,Uncategorized,nan,nan,nan,Letter
Class II,2019-11-06,2021-06-07,594,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Glenmark Pharmaceuticals ., PRESCRIPTION DRUG,VAGINAL,Letter
Class II,2020-07-29,,,Ongoing,INCORRECT,Uncategorized,nan,nan,nan,Letter
Class I,2021-10-13,2022-05-12,261,Terminated,PRODUCT MIX,Uncategorized,nan,nan,nan,Letter
Class II,2013-06-26,2014-07-23,421,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,Cephalon, PRESCRIPTION DRUG,"ORAL', 'TRANSMUCOSAL",Letter
Class III,2018-06-13,2020-01-08,593,Terminated,INCORRECT,Uncategorized,nan,nan,nan,Letter
Class III,2018-11-14,2019-11-15,406,Terminated,CONTAINER PACKAGING DEFECT.,Uncategorized,Nalpropion Pharmaceuticals , PRESCRIPTION DRUG,ORAL,Letter
Class I,2019-10-02,2021-03-23,558,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,nan,nan,nan,Letter
Class II,2020-12-09,2023-04-11,868,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Ascend Laboratories, PRESCRIPTION DRUG,ORAL,E-Mail
Class III,2022-08-10,,,Ongoing,DEFECTIVE CONTAINER,Uncategorized,Glenmark Pharmaceuticals ., PRESCRIPTION DRUG,TOPICAL,Letter
Class I,2023-02-01,,,Ongoing,DISCOLORATION,Uncategorized,nan,nan,nan,Letter
Class III,2013-04-17,2014-01-15,309,Terminated,FAILED TABLET,Uncategorized,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,nan,Letter
Class II,2013-05-01,2014-01-13,269,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,Letter
Class I,2014-05-07,2015-07-22,526,Terminated,NON,Uncategorized,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAPERITONEAL,Letter
Class II,2015-09-23,2017-04-03,592,Terminated,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2017-08-09,2020-01-08,1014,Terminated,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class II,2018-07-25,2018-11-28,146,Terminated,INCORRECT PRODUCT FORMULATION,Uncategorized,nan,nan,nan,Letter
Class II,2020-09-02,2021-06-10,300,Terminated,SUB,Uncategorized,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2021-07-21,2022-12-28,544,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,Major Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-08-14,2013-12-24,217,Terminated,UNIT DOSE MISPACKAGING,Uncategorized,nan,nan,nan,Letter
Class III,2013-08-28,2014-01-21,190,Terminated,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class III,2013-09-25,2014-07-25,329,Terminated,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2014-05-07,2016-06-22,835,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,AbbVie ., PRESCRIPTION DRUG,nan,Letter
Class II,2017-03-22,2018-03-01,391,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class III,2018-06-13,2020-01-13,594,Terminated,RESUSPENSION PROBLEMS,Uncategorized,Pharmaceutical Associates, PRESCRIPTION DRUG,ORAL,Letter
Class II,2021-07-14,2022-12-28,551,Terminated,LOW OUT OF SPECIFICATION RESULTS FOR EPINEPHRINE ASSAY.,Uncategorized,Fresenius Kabi USA, PRESCRIPTION DRUG,"INFILTRATION', 'PERINEURAL",Letter
Class II,2021-11-17,2022-09-01,311,Terminated,INCORRECT PRODUCT FORMULATION,Uncategorized,NorthStar RxLLC, PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-06-22,2023-02-08,243,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2022-08-10,2023-04-18,271,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Actavis Pharma, PRESCRIPTION DRUG,ORAL,nan
Class I,2013-04-24,2015-08-21,1050,Terminated,NON,Uncategorized,nan,nan,nan,Press Release
Class III,2014-02-12,2014-04-11,214,Terminated,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class I,2014-11-26,2016-10-07,1243,Terminated,NON,Uncategorized,nan,nan,nan,Telephone
Class II,2017-05-17,2018-03-29,335,Terminated,CRYSTALLIZATION,Uncategorized,Par Pharmaceutical, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2018-02-21,2020-02-05,775,Terminated,TEMPERATURE ABUSE,Uncategorized,Camber Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class III,2018-02-14,2020-02-03,745,Terminated,DISCOLORATION,Uncategorized,Cosette Pharmaceuticals, PRESCRIPTION DRUG,TOPICAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2015-07-15,2016-09-22,450,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2021-12-01,,,Completed,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class II,2023-03-15,,,Ongoing,FAILED DISSOLUTION SPECIFICATION,Uncategorized,American Health Packaging, PRESCRIPTION DRUG,ORAL,Letter
Class III,2014-04-16,2015-01-26,305,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Boehringer Ingelheim Pharmaceuticals, PRESCRIPTION DRUG,"ORAL', 'RESPIRATORY (INHALATION)",Letter
Class II,2017-01-18,2018-03-26,475,Terminated,DISCOLORATION,Uncategorized,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,nan
Class III,2017-09-13,2020-05-19,995,Terminated,FAILED MOISTURE LIMITS,Uncategorized,nan,nan,nan,Letter
Class II,2018-04-04,2020-07-16,871,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Padagis US , PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class III,2018-11-14,2022-08-12,1397,Terminated,FAILED PH SPECIFICATIONS,Uncategorized,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2021-04-07,2023-06-07,818,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,nan,nan,nan,Letter
Class II,2022-08-24,,,Ongoing,TEMPERATURE ABUSE,Uncategorized,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2016-03-09,2017-01-13,389,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class II,2016-08-24,2017-07-03,368,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2019-03-13,2020-03-18,390,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Ascend Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class I,2020-03-04,2023-12-11,1403,Terminated,RESUSPENSION PROBLEMS,Uncategorized,Taro Pharmaceuticals U.S.A., PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-02-09,2022-12-21,337,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,Actavis Pharma, PRESCRIPTION DRUG,ORAL,nan
Class II,2013-06-12,2013-07-29,845,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2014-02-12,2015-02-26,706,Terminated,FAILED TABLET,Uncategorized,Actavis Pharma, PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-10-22,2016-02-23,508,Terminated,INCORRECT OR MISSING LOT AND,Uncategorized,Sagent Pharmaceuticals, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS","Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2017-02-08,2018-06-29,533,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class II,2017-12-06,2020-05-11,914,Terminated,FAILED DISSOLUTION SPECIFICATIONS.,Uncategorized,nan,nan,nan,Letter
Class II,2019-12-18,2020-12-01,455,Terminated,LACK OF PROCESSING CONTROLS,Uncategorized,nan,nan,nan,Telephone
Class II,2020-02-19,2021-06-03,477,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-01-26,2023-06-01,540,Terminated,DEFECTIVE CONTAINER,Uncategorized,Actavis Pharma, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class III,2013-03-20,2013-07-26,196,Terminated,DOES NOT MEET MONOGRAPH,Uncategorized,AstraZeneca Pharmaceuticals LP, PRESCRIPTION DRUG,RESPIRATORY (INHALATION),Letter
Class III,2013-08-14,2014-07-07,334,Terminated,CONTRACEPTIVE TABLETS OUT OF SEQUENCE,Uncategorized,nan,nan,nan,Letter
Class III,2016-07-20,2022-06-15,2332,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,nan,nan,nan,Letter
Class III,2017-02-01,2018-07-11,568,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2019-03-13,,,Completed,CONTRACEPTIVE TABLETS OUT OF SEQUENCE,Uncategorized,nan,nan,nan,Press Release
Class II,2019-06-19,2021-03-08,647,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2019-06-19,2022-05-02,1064,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Glenmark Pharmaceuticals ., PRESCRIPTION DRUG,VAGINAL,Letter
Class II,2021-03-10,2022-02-17,356,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Dr. Reddys Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class II,2021-09-29,2023-02-19,570,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2022-05-25,,,Completed,TEMPERATURE ABUSE,Uncategorized,Eli Lilly  Company, PRESCRIPTION DRUG,SUBCUTANEOUS,Letter
Class II,2022-06-01,,,Ongoing,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Noven Therapeutics, PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class III,2022-08-03,,,Completed,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2022-07-27,,,Completed,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2023-09-27,,,Ongoing,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class I,2013-08-14,2015-05-05,722,Terminated,FAILED TABLET,Uncategorized,Zydus Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-08-13,2015-01-23,499,Terminated,NON,Uncategorized,Janssen Pharmaceuticals, PRESCRIPTION DRUG,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2014-06-11,2017-03-14,1140,Terminated,DEFECTIVE CONTAINER,Uncategorized,Greenstone , PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-11-26,2015-12-22,456,Terminated,FAILED CONTENT UNIFORMITY SPECIFICATIONS,Uncategorized,Micro Labs Limited, PRESCRIPTION DRUG,ORAL,Letter
Class I,2015-06-03,2017-01-02,663,Terminated,NON,Uncategorized,nan,nan,nan,Letter
Class II,2017-11-08,2018-05-02,189,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class III,2019-03-27,2020-06-26,471,Terminated,DEFECTIVE CONTAINER,Uncategorized,Lupin Pharmaceuticals, PRESCRIPTION DRUG,TOPICAL,Letter
Class II,2020-01-08,2022-08-09,998,Terminated,UNIT DOSE MISPACKAGING,Uncategorized,Akorn Operating Company , PRESCRIPTION DRUG,ORAL,Letter
Class III,2020-01-22,2022-11-22,1086,Terminated,DISCOLORATION,Uncategorized,Aurobindo Pharma Limited, PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class II,2012-10-10,2013-11-19,455,Terminated,CRYSTALLIZATION,Uncategorized,nan,nan,nan,Letter
Class II,2013-03-13,2014-01-14,410,Terminated,DISCOLORATION,Uncategorized,nan,nan,nan,Letter
Class II,2013-04-10,2014-01-15,342,Terminated,FAILED CONTENT UNIFORMITY SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2014-04-09,2015-04-01,425,Terminated,GOOD MANUFACTURING PRACTICES DEVIATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2015-01-14,2015-11-20,340,Terminated,FAILED CAPSULE,Uncategorized,Actavis Pharma, PRESCRIPTION DRUG,ORAL,Letter
Class II,2018-12-19,,,Ongoing,GCMP DEVIATIONS,Uncategorized,Mylan Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Press Release
Class II,2018-12-19,2020-06-25,563,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,"[""Dr.Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class III,2022-01-26,2023-10-20,654,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,RUGBY LABORATORIES, OTC DRUG,ORAL,Letter
Class II,2023-02-01,,,Ongoing,FAILED DISSOLUTION SPECIFICATION,Uncategorized,Ascend Laboratories, PRESCRIPTION DRUG,ORAL,E-Mail
Class II,2015-10-14,2019-03-20,1332,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Noven Therapeutics, PRESCRIPTION DRUG,TRANSDERMAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2016-10-19,2016-10-12,201,Terminated,NON,Uncategorized,nan,nan,nan,Letter
Class III,2016-09-14,2017-10-23,426,Terminated,STASON PHARMACEUTICALS IS RECALLING SELEGILINE HCL TABLETS,Uncategorized,nan,nan,nan,Letter
Class II,2017-01-18,2019-03-20,940,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Noven Therapeutics, PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class II,2018-09-26,2020-09-04,724,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Torrent Pharmaceuticals Limited, PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-01-16,2020-10-06,650,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Glenmark Pharmaceuticals ., PRESCRIPTION DRUG,VAGINAL,Letter
Class III,2019-04-17,2020-02-27,342,Terminated,FAILED PH SPECIFICATION,Uncategorized,nan,nan,nan,Telephone
Class I,2019-08-07,2021-05-07,668,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,E-Mail
Class II,2020-12-23,2023-07-18,953,Terminated,FAILED PH SPECIFICATIONS,Uncategorized,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS', 'SUBCUTANEOUS",E-Mail
Class II,2021-12-22,2022-01-04,32,Terminated,LACK OF PROCESSING CONTROLS,Uncategorized,nan,nan,nan,Telephone
Class II,2022-03-30,2022-08-04,143,Terminated,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class III,2023-03-29,2023-10-18,223,Terminated,FAILED CONTENT UNIFORMITY SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2012-08-29,2013-03-27,271,Terminated,FAILED USP DISSOLUTION TEST REQUIREMENTS,Uncategorized,nan,nan,nan,Letter
Class III,2017-01-25,2017-06-29,210,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2021-09-08,2022-08-22,385,Terminated,NON,Uncategorized,Akorn, OTC DRUG,OPHTHALMIC,Letter
Class II,2023-11-15,,,Completed,CRYSTALLIZATION,Uncategorized,Par Pharmaceutical, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2022-03-02,,,Ongoing,FAILED TABLET SPECIFICATIONS,Uncategorized,Rising Pharma Holdings, PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-02-22,,,Completed,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,BluePoint Laboratories, PRESCRIPTION DRUG,ORAL,Letter
Class II,2012-09-26,2016-12-15,1632,Terminated,THE AFFECTED LOTS OF CARBOPLATIN INJECTION,Uncategorized,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2014-07-09,2015-05-06,328,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class III,2014-08-06,2017-04-27,1043,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,nan,nan,nan,Letter
Class III,2015-07-08,2016-10-23,493,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2016-07-13,2017-04-10,381,Terminated,LACK OF PROCESSING CONTROLS,Uncategorized,nan,nan,nan,Press Release
Class II,2018-07-25,2019-01-18,207,Terminated,LACK OF PROCESSING CONTROLS,Uncategorized,nan,nan,nan,Letter
Class II,2022-06-29,2023-08-23,440,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Mayne Pharma ., PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class II,2023-03-29,,,Ongoing,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Noven Therapeutics, PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class II,2015-03-11,2015-08-14,185,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Actavis Pharma, PRESCRIPTION DRUG,ORAL,Letter
Class III,2015-04-29,2017-02-21,700,Terminated,FAILED CONTENT UNIFORMITY SPECIFICATIONS,Uncategorized,Nomax ., PRESCRIPTION DRUG,OPHTHALMIC,Letter
Class II,2015-05-06,2017-12-04,966,Terminated,CRYSTALLIZATION,Uncategorized,nan,nan,nan,Letter
Class II,2015-07-22,,,Ongoing,CRYSTALLIZATION,Uncategorized,Hospira, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2016-02-03,2016-05-18,131,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Strategic Sourcing Services , OTC DRUG,ORAL,Letter
Class II,2017-02-08,2017-10-19,295,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,"[""Dr. Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-03-25,2023-05-18,1172,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Noven Therapeutics, PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class III,2023-12-13,,,Ongoing,PRODUCT MIX,Uncategorized,nan,nan,nan,nan
Class II,2012-10-03,2013-11-01,470,Terminated,DEFECTIVE CONTAINER,Uncategorized,AbbVie ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2015-08-05,2017-02-01,558,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Boehringer Ingelheim Pharmaceuticals ., PRESCRIPTION DRUG,RESPIRATORY (INHALATION),Letter
Class II,2019-05-08,2020-11-06,578,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class I,2021-04-07,2022-11-23,643,Terminated,CRYSTALLIZATION,Uncategorized,Zydus Pharmaceuticals (USA) ., PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2013-08-14,2014-06-05,366,Terminated,DISCOLORATION,Uncategorized,nan,nan,nan,Letter
Class II,2013-08-07,2014-10-08,462,Terminated,UNIT DOSE MISPACKAGING,Uncategorized,nan,nan,nan,Letter
Class II,2014-06-18,2015-05-01,343,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,"[""Dr. Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class II,2015-02-18,2015-02-09,14,Terminated,GOOD MANUFACTURING PRACTICES DEVIATIONS,Uncategorized,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2016-07-27,2018-03-27,638,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class II,2021-01-20,2022-08-09,589,Terminated,DEFECTIVE CONTAINER,Uncategorized,Akorn, PRESCRIPTION DRUG,ORAL,Letter
Class II,2021-10-06,2022-09-07,380,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Parke-Davis Div of Pfizer , PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-07-06,,,Ongoing,DEFECTIVE CONTAINER,Uncategorized,Akorn, PRESCRIPTION DRUG,NASAL,Letter
Class III,2022-09-28,2023-03-02,164,Terminated,PRODUCT MIX,Uncategorized,Unichem Pharmaceuticals (USA), PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-05-14,2015-05-12,406,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2014-10-08,2016-12-23,974,Terminated,FAILED TABLET,Uncategorized,Actavis Pharma, PRESCRIPTION DRUG,ORAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2015-02-25,2016-12-15,801,Terminated,TEMPERATURE ABUSE,Uncategorized,Hospira, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Telephone
Class III,2015-09-09,2016-03-07,231,Terminated,FAILED TABLET,Uncategorized,Par Pharmaceutical, PRESCRIPTION DRUG,ORAL,Letter
Class III,2015-11-25,2017-11-29,831,Terminated,DEFECTIVE CONTAINER,Uncategorized,Akorn Operating Company , PRESCRIPTION DRUG,AURICULAR (OTIC),Letter
Class III,2019-12-04,2021-04-01,507,Terminated,CRYSTALLIZATION,Uncategorized,AuroMedics Pharma , PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2019-12-25,2021-04-29,506,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-02-19,2021-03-08,397,Terminated,DEFECTIVE CONTAINER,Uncategorized,Pfizer Laboratories Div Pfizer , PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-06-17,2021-05-04,341,Terminated,PRODUCT MIX UP,Uncategorized,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class III,2021-01-06,2022-01-26,400,Terminated,FAILED MOISTURE LIMITS,Uncategorized,Strides Pharma Science Limited, PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-03-19,2014-08-25,196,Terminated,FAILED TABLET,Uncategorized,Actavis Pharma, PRESCRIPTION DRUG,ORAL,Letter
Class II,2016-05-18,2016-10-26,257,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Mylan Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,E-Mail
Class II,2018-10-03,2020-09-09,733,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Noven Therapeutics, PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class III,2019-07-31,2020-09-14,425,Terminated,FAILED CONTENT UNIFORMITY SPECIFICATIONS,Uncategorized,Lupin Pharmaceuticals, PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2022-05-04,,,Ongoing,INCORRECT,Uncategorized,nan,nan,nan,Letter
Class III,2023-11-15,,,Ongoing,SUB,Uncategorized,Zyla Life Sciences US , PRESCRIPTION DRUG,ORAL,Letter
Class III,2015-07-22,2018-08-15,1146,Terminated,TABLETS,Uncategorized,American Health Packaging, PRESCRIPTION DRUG,ORAL,Letter
Class III,2016-08-31,,,Ongoing,CRYSTALLIZATION,Uncategorized,nan,nan,nan,Letter
Class I,2018-11-21,2023-01-24,1541,Terminated,NON,Uncategorized,nan,nan,nan,E-Mail
Class II,2018-12-26,2020-10-02,667,Terminated,SUB,Uncategorized,nan,nan,nan,Telephone
Class III,2020-10-14,2022-09-28,733,Terminated,FAILED IMPURTIES,Uncategorized,VistaPharm, PRESCRIPTION DRUG,ORAL,Letter
Class II,2015-02-18,2015-10-23,275,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2015-08-19,2016-03-08,224,Terminated,INCORRECT EXPIRATION DATE,Uncategorized,Fresenius Kabi USA, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class III,2016-08-10,2017-03-10,238,Terminated,FAILED CONTENT UNIFORMITY SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2017-06-14,2018-11-19,546,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,"[""Dr. Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class II,2018-08-15,2019-03-28,255,Terminated,API MATERIAL USED IN THE MANUFACTURING OF THE PRODUCT DID NOT RECEIVE REGULATORY APPROVAL PRIOR TO RELEASE.,Uncategorized,nan,nan,nan,Letter
Class II,2018-10-31,2020-02-13,556,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Shionogi ., PRESCRIPTION DRUG,ORAL,Letter
Class I,2021-07-21,2023-10-16,847,Terminated,HAND SANITIZER PACKAGED IN BOTTLES THAT RESEMBLE BEVERAGE CONTAINERS.,Uncategorized,nan,nan,nan,Press Release
Class II,2012-08-15,2013-09-19,532,Terminated,TABLET THICKNESS,Uncategorized,nan,nan,nan,Letter
Class III,2013-03-13,2014-03-06,386,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,Actavis Pharma, PRESCRIPTION DRUG,ORAL,Letter
Class III,2014-02-12,2015-06-24,597,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,nan,nan,nan,Letter
Class II,2014-06-04,2014-11-14,238,Terminated,NON,Uncategorized,"[""Teva Womens Health ""]", PRESCRIPTION DRUG,INTRAUTERINE,Letter
Class II,2015-04-29,2017-03-03,687,Terminated,PRODUCTS FAILED THE ANTIMICROBIAL EFFECTIVENESS TEST,Uncategorized,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2016-05-11,2018-08-03,837,Terminated,DEFECTIVE CONTAINER,Uncategorized,VistaPharm, PRESCRIPTION DRUG,ORAL,E-Mail
Class II,2019-04-17,2020-07-23,518,Terminated,LACK OF PROCESSING CONTROLS,Uncategorized,nan,nan,nan,Telephone
Class II,2020-12-02,2022-03-23,502,Terminated,FAILED TABLET,Uncategorized,JUBILANT CADISTA PHARMACEUTICALS INC., PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-05-18,2023-07-13,441,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,PHARMACIA & UPJOHN COMPANY , PRESCRIPTION DRUG,ORAL,Letter
Class III,2023-08-16,,,Ongoing,OUT OF SPECIFICATION RESULT OBSERVED IN CONTENT UNIFORMITY TESTING,Uncategorized,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class III,2023-09-13,,,Ongoing,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Esperion Therapeutics, PRESCRIPTION DRUG,ORAL,Letter
Class III,2023-10-25,,,Ongoing,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class II,2012-07-04,2013-02-07,336,Terminated,FAILED USP DISSOLUTION TEST REQUIREMENTS,Uncategorized,nan,nan,nan,Letter
Class I,2013-12-25,2014-09-30,389,Terminated,NON,Uncategorized,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2014-11-26,2016-08-03,1160,Terminated,NON,Uncategorized,nan,nan,nan,Telephone
Class III,2016-04-13,2018-08-16,973,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2017-07-05,2019-03-11,683,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Noven Therapeutics, PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class III,2017-07-26,2018-02-28,280,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class III,2018-08-29,2020-01-08,512,Terminated,INCORRECT,Uncategorized,nan,nan,nan,Letter
Class II,2020-06-17,2022-08-03,806,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,American Health Packaging, PRESCRIPTION DRUG,ORAL,Letter
Class III,2022-05-25,2023-10-05,520,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Apotex Corp, PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-03-27,2014-01-31,352,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,Letter
Class II,2014-02-19,2014-09-29,243,Terminated,FAILED TABLET SPECIFICATIONS,Uncategorized,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,E-Mail
Class III,2014-09-03,2015-01-13,147,Terminated,FAILED DISSOLUTION SPECIFICATIONS AND FAILED TABLET SPECIFICATIONS,Uncategorized,American Sales Company, OTC DRUG,ORAL,Telephone
Class II,2016-11-30,2017-12-26,449,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class I,2018-02-07,2019-06-14,829,Terminated,MARKED WITHOUT AN APPROVED NDA,Uncategorized,nan,nan,nan,Press Release
Class II,2018-08-08,2019-04-16,272,Terminated,FAILED TABLET,Uncategorized,Strides Pharma ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-07-06,2023-09-28,475,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Akorn, PRESCRIPTION DRUG,TOPICAL,Letter
Class II,2023-11-08,,,Ongoing,INCORRECT PRODUCT FORMULATION,Uncategorized,Padagis Israel Pharmaceuticals Ltd, PRESCRIPTION DRUG,VAGINAL,Letter
Class II,2023-12-13,,,Ongoing,FAILED TABLETS,Uncategorized,Padagis US , PRESCRIPTION DRUG,ORAL,Letter
Class III,2012-07-11,2013-04-11,329,Terminated,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class II,2012-08-29,2014-08-04,753,Terminated,MISCALIBRATED AND,Uncategorized,Noven Therapeutics, PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class II,2013-09-25,2014-09-18,385,Terminated,INCORRECT,Uncategorized,nan,nan,nan,Letter
Class II,2014-05-07,2014-12-15,252,Terminated,FAILED PH SPECIFICATIONS,Uncategorized,Piramal Critical Care , PRESCRIPTION DRUG,RESPIRATORY (INHALATION),Letter
Class II,2016-08-24,2020-09-21,1525,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Zydus Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2017-04-05,2020-09-10,1275,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Zydus Pharmaceuticals (USA) ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2020-07-29,2021-04-13,300,Terminated,TEMPERATURE ABUSE,Uncategorized,Fresenius Kabi USA, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class III,2021-04-14,2022-04-14,385,Terminated,FAILED MOISTURE LIMITS,Uncategorized,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class I,2021-09-01,2022-05-23,325,Terminated,TEMPERATURE ABUSE,Uncategorized,KVK-Tech, PRESCRIPTION DRUG,ORAL,Letter
Class II,2021-10-06,2022-06-21,305,Terminated,OUT,Uncategorized,nan,nan,nan,Letter
Class II,2023-08-02,,,Ongoing,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Alembic Pharmaceuticals, PRESCRIPTION DRUG,TOPICAL,Letter
Class I,2023-11-29,,,Ongoing,NON,Uncategorized,Rugby Laboratories, OTC DRUG,OPHTHALMIC,Letter
Class III,2014-02-12,2015-06-24,597,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,nan,nan,nan,Letter
Class III,2014-08-20,2017-03-22,966,Terminated,FAILED PH SPECIFICATION,Uncategorized,Pharmacia & Upjohn Company , PRESCRIPTION DRUG,"INTRA-ARTICULAR', 'INTRALESIONAL', 'INTRAMUSCULAR', 'SOFT TISSUE', 'INTRASYNOVIAL",Letter
Class II,2015-06-10,2016-10-21,520,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2017-05-31,,,Ongoing,DEFECTIVE DELIVERY SYSTEM,Uncategorized,GlaxoSmithKline , PRESCRIPTION DRUG,RESPIRATORY (INHALATION),Letter
Class II,2018-08-08,2019-12-02,490,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Major Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2019-12-11,2021-01-21,436,Terminated,DISCOLORATION,Uncategorized,nan,nan,nan,Letter
Class III,2020-03-18,2021-05-25,442,Terminated,FAILED CONTENT UNIFORMITY SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2020-11-25,2022-11-17,744,Terminated,FAILED PH SPECIFICATIONS,Uncategorized,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS', 'SUBCUTANEOUS",Letter
Class II,2023-03-08,,,Ongoing,SUB,Uncategorized,Alvogen, PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-09-10,2016-02-01,523,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,Letter
Class II,2016-06-01,2017-07-26,454,Terminated,FAILED TABLET,Uncategorized,ROERIG, PRESCRIPTION DRUG,ORAL,Letter
Class II,2017-02-01,2018-01-25,401,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,nan
Class III,2017-04-26,2019-06-14,816,Terminated,DISCOLORATION.,Uncategorized,nan,nan,nan,Letter
Class III,2017-05-17,2019-02-21,672,Terminated,PRODUCT IS BEING RECALLED DUE TO LOW PH VALUE.,Uncategorized,nan,nan,nan,Letter
Class II,2019-08-07,2020-09-30,791,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,American Health Packaging, PRESCRIPTION DRUG,ORAL,Letter
Class II,2021-09-01,,,Ongoing,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class II,2012-07-11,2013-03-22,310,Terminated,TABLET THICKNESS,Uncategorized,nan,nan,nan,Letter
Class II,2015-04-15,2015-08-18,181,Terminated,CRYSTALLIZATION,Uncategorized,nan,nan,nan,Letter
Class II,2015-11-11,2017-03-14,557,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Santarus, PRESCRIPTION DRUG,ORAL,Letter
Class III,2019-04-03,2020-03-06,354,Terminated,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class II,2019-08-28,2022-08-25,1123,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Upsher-Smith Laboratories, PRESCRIPTION DRUG,ORAL,Telephone
Class II,2020-06-24,2021-06-10,364,Terminated,DEFECTIVE CONTAINER,Uncategorized,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2021-10-06,2023-06-20,641,Terminated,DEFECTIVE CONTAINER,Uncategorized,Fresenius Kabi USA, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class III,2022-05-25,2023-06-02,414,Terminated,DOES NOT MEET USP OR OTC MONOGRAPH,Uncategorized,Westminster Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class I,2013-04-24,2015-08-21,938,Terminated,NON,Uncategorized,nan,nan,nan,Press Release
Class III,2017-02-08,2017-07-11,194,Terminated,FAILED TABLET,Uncategorized,Camber Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class III,2020-10-28,2022-01-24,479,Terminated,OUT,Uncategorized,Mylan Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2021-11-03,2023-08-31,688,Terminated,FAILED MOISTURE LIMITS,Uncategorized,Major Pharmaceuticals, OTC DRUG,ORAL,Letter
Class I,2016-02-17,2016-02-18,272,Terminated,SUB,Uncategorized,nan,nan,nan,Telephone
Class II,2017-06-14,2017-11-21,173,Terminated,DEFECTIVE CONTAINER,Uncategorized,L. Perrigo Company, OTC DRUG,ORAL,Letter
Class II,2022-03-30,2023-10-05,667,Terminated,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class II,2023-07-05,,,Ongoing,PACKAGING DEFECT,Uncategorized,Major Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class I,2012-08-08,2013-06-03,549,Terminated,A COMPLAINT WAS RECEIVED FROM A HOSPITAL PHARMACY ON 11,Uncategorized,nan,nan,nan,Letter
Class II,2012-11-28,2013-07-10,286,Terminated,FAILED USP DISSOLUTION TEST REQUIREMENTS,Uncategorized,"[""Dr.Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class II,2012-12-05,2013-09-18,317,Terminated,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class I,2014-03-19,2014-09-22,338,Terminated,NON,Uncategorized,nan,nan,nan,Press Release
Class I,2014-09-03,2014-12-03,226,Terminated,INCORRECT,Uncategorized,nan,nan,nan,Telephone
Class II,2018-01-17,2019-08-16,625,Terminated,FAILED TABLET,Uncategorized,Solco Healthcare US, PRESCRIPTION DRUG,ORAL,Letter
Class III,2018-02-07,2018-09-13,234,Terminated,DEFECTIVE CONTAINER,Uncategorized,AbbVie ., PRESCRIPTION DRUG,RESPIRATORY (INHALATION),Letter
Class II,2018-10-17,2020-02-24,510,Terminated,DISCOLORATION,Uncategorized,Jubilant Cadista Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2018-10-24,2019-09-30,360,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2020-06-03,2023-03-25,1046,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2012-12-05,2017-04-13,1749,Terminated,FAILED USP CONTENT UNIFORMITY REQUIREMENTS,Uncategorized,Mylan Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2013-03-06,2014-01-13,374,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class III,2014-02-05,2015-06-16,578,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Actavis Pharma, PRESCRIPTION DRUG,ORAL,Letter
Class II,2015-01-14,2016-05-23,584,Terminated,FAILED TABLET,Uncategorized,NorthStar Rx , PRESCRIPTION DRUG,ORAL,Letter
Class II,2015-04-15,2016-02-04,377,Terminated,CRYSTALLIZATION,Uncategorized,Hospira, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Letter
Class II,2015-06-10,2016-11-08,547,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2016-06-01,2017-01-23,264,Terminated,FAILED IMPUITIES,Uncategorized,nan,nan,nan,Letter
Class I,2014-04-30,2014-05-30,198,Terminated,NON,Uncategorized,nan,nan,nan,Telephone
Class II,2017-05-10,2019-07-09,848,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Akorn Operating Company , PRESCRIPTION DRUG,ORAL,Letter
Class I,2020-12-09,2022-12-28,763,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Torrent Pharmaceuticals Limited, PRESCRIPTION DRUG,ORAL,Letter
Class II,2023-03-08,,,Ongoing,PACKAGING DEFECT,Uncategorized,Major Pharmaceuticals, PRESCRIPTION DRUG,ORAL,nan
Class II,2012-09-05,2014-09-04,770,Terminated,DOES NOT DELIVER PROPER METERED DOSE,Uncategorized,GlaxoSmithKline , PRESCRIPTION DRUG,RESPIRATORY (INHALATION),Letter
Class II,2013-10-09,2014-10-01,383,Terminated,TEMPERATURE ABUSE,Uncategorized,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2014-05-14,2015-09-02,597,Terminated,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2014-10-01,2019-03-19,1708,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Noven Therapeutics, PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class II,2015-09-09,2016-03-29,244,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2016-09-14,2016-12-20,174,Terminated,LACK OF PROCESSING CONTROLS,Uncategorized,nan,nan,nan,Letter
Class III,2017-07-19,2019-01-17,574,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Lupin Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class III,2020-02-26,2020-11-04,327,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Major Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-06-10,2022-08-10,821,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Torrent Pharmaceuticals Limited, PRESCRIPTION DRUG,ORAL,Letter
Class I,2021-05-19,2023-06-21,792,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,CareFusion 213, OTC DRUG,TOPICAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2022-10-05,2023-07-13,300,Terminated,FAILED VISCOSITY SPECIFICATION,Uncategorized,nan,nan,nan,Letter
Class III,2023-11-15,,,Ongoing,DEFECTIVE CONTAINER,Uncategorized,VistaPharm, PRESCRIPTION DRUG,ORAL,Letter
Class I,2023-12-13,,,Ongoing,CRYSTALLIZATION,Uncategorized,Novartis Pharmaceuticals Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2014-03-26,2014-04-10,72,Terminated,CRYSTALLIZATION,Uncategorized,nan,nan,nan,Letter
Class I,2015-06-03,2016-02-01,295,Terminated,INCORRECT PRODUCT FORMULATION,Uncategorized,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2015-09-16,2015-12-18,109,Terminated,FALIED PH SPECIFICATION,Uncategorized,nan,nan,nan,Telephone
Class I,2016-06-01,,,Ongoing,DEFECTIVE DELIVERY SYSTEM,Uncategorized,nan,nan,nan,Press Release
Class III,2018-12-19,2019-05-01,161,Terminated,INCORRECT EXCIPIENT,Uncategorized,nan,nan,nan,Telephone
Class II,2021-12-22,,,Ongoing,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class I,2016-06-01,2017-05-16,460,Terminated,SUPER,Uncategorized,nan,nan,nan,Telephone
Class I,2023-11-29,,,Ongoing,NON,Uncategorized,Cardinal Health, OTC DRUG,OPHTHALMIC,Press Release
Class II,2015-12-09,2017-02-10,539,Terminated,DISCOLORATION,Uncategorized,Nephron Pharmaceuticals Corporation, OTC DRUG,RESPIRATORY (INHALATION),E-Mail
Class III,2022-01-12,2022-08-23,237,Terminated,OUT,Uncategorized,nan,nan,nan,Letter
Class II,2022-08-24,,,Ongoing,DEFECTIVE CONTAINER,Uncategorized,Akorn, PRESCRIPTION DRUG,ORAL,Letter
Class II,2012-08-08,2013-12-12,804,Terminated,DEFECTIVE CONTAINER,Uncategorized,VistaPharm, PRESCRIPTION DRUG,ORAL,Letter
Class II,2013-08-14,2014-08-27,435,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-02-19,2014-09-17,271,Terminated,FAILED TABLET,Uncategorized,Actavis Pharma, PRESCRIPTION DRUG,ORAL,E-Mail
Class II,2014-08-20,2014-12-16,194,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,Letter
Class II,2015-08-12,2016-04-29,308,Terminated,INCORRECT,Uncategorized,Sun Pharmaceutical Industries, PRESCRIPTION DRUG,ORAL,Letter
Class III,2018-04-11,2021-09-15,1280,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Cipla USA ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-06-03,2021-11-08,542,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,PD-Rx Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-09-30,2023-05-22,978,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Padagis Israel Pharmaceuticals Ltd, PRESCRIPTION DRUG,RESPIRATORY (INHALATION),Letter
Class II,2021-09-01,2022-03-09,204,Terminated,A 500 COUNT BOTTLE OF CARVEDILOL 25 MG TABLETS CONTAINED TWO PAROXETINE TABLETS,Uncategorized,nan,nan,nan,Letter
Class III,2014-01-08,2014-08-28,332,Terminated,FAILED CONTENT UNIFORMITY SPECIFICATIONS,Uncategorized,Cosette Pharmaceuticals, PRESCRIPTION DRUG,TOPICAL,Letter
Class II,2014-12-17,2016-03-08,482,Terminated,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class III,2015-07-22,2016-10-23,482,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,Letter
Class III,2016-12-28,2020-07-23,1359,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Zydus Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2019-03-20,2020-01-14,319,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,AvKARE, PRESCRIPTION DRUG,ORAL,Letter
Class III,2019-06-26,2022-09-17,1226,Terminated,INCORRECT,Uncategorized,Ecolab ., OTC DRUG,TOPICAL,Letter
Class II,2023-11-15,,,Ongoing,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Glenmark Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class III,2013-07-10,2017-04-06,1406,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2013-07-31,2014-09-25,552,Terminated,FAILED TABLET,Uncategorized,Actavis Pharma, PRESCRIPTION DRUG,ORAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class III,2013-09-04,2014-04-10,232,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2014-03-26,2019-03-19,1860,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Noven Therapeutics, PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class II,2016-07-13,2017-12-06,575,Terminated,FAILED CONTENT UNIFORMITY SPECIFICATIONS.,Uncategorized,Allergan, PRESCRIPTION DRUG,CUTANEOUS,Letter
Class II,2017-05-10,2019-04-11,850,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class I,2018-08-29,2020-06-03,670,Terminated,FAILED CONTENT UNIFORMITY SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2018-10-31,2020-05-07,636,Terminated,INCORRECT PRODUCT FORMULATION,Uncategorized,nan,nan,nan,Letter
Class III,2019-10-02,2021-08-18,723,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,E-Mail
Class II,2020-11-18,2021-08-26,302,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Actavis Pharma, PRESCRIPTION DRUG,ORAL,Letter
Class II,2022-08-03,2022-11-22,127,Terminated,FAILED DISSOLUTION SPECIFICATIONS.,Uncategorized,Jubilant Cadista Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-07-09,2015-05-22,357,Terminated,INCORRECT,Uncategorized,nan,nan,nan,Telephone
Class II,2016-05-18,2017-03-20,342,Terminated,DISCOLORATION,Uncategorized,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class I,2017-09-27,2019-01-11,493,Terminated,NON,Uncategorized,nan,nan,nan,Letter
Class I,2021-04-21,2022-12-09,627,Terminated,TEMPERATURE ABUSE,Uncategorized,Novo Nordisk, PRESCRIPTION DRUG,SUBCUTANEOUS,Letter
Class II,2022-06-29,2023-04-27,317,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class III,2013-06-19,2013-12-24,242,Terminated,DISCOLORATION,Uncategorized,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-07-16,2015-03-09,284,Terminated,FAILED TABLET,Uncategorized,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class II,2016-03-30,2017-06-20,501,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,AstraZeneca Pharmaceuticals LP, PRESCRIPTION DRUG,RESPIRATORY (INHALATION),nan
Class III,2017-04-05,2017-08-08,213,Terminated,DISCOLORATION,Uncategorized,Camber Pharmaceuticals, PRESCRIPTION DRUG,ORAL,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class I,2017-06-21,,,Ongoing,NON,Uncategorized,nan,nan,nan,E-Mail
Class II,2017-08-09,2017-12-06,131,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,E-Mail
Class II,2018-09-05,2020-05-07,639,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,PD-Rx Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-11-25,2021-08-11,273,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2020-12-23,2021-09-17,282,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class III,2021-05-05,2022-01-18,273,Terminated,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class I,2021-09-01,2022-05-19,282,Terminated,NON,Uncategorized,nan,nan,nan,Press Release
Class II,2021-10-06,2023-06-23,638,Terminated,FINISHED PRODUCT SPECIFICATION DID NOT MEET USP SPECIFICATIONS.,Uncategorized,Westminster Pharmaceuticals, PRESCRIPTION DRUG,TOPICAL,Letter
Class II,2012-06-20,2013-02-22,522,Terminated,TABLET SEPARATION,Uncategorized,nan,nan,nan,FAX
Class II,2014-11-26,2016-02-18,484,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class III,2015-10-07,2017-02-15,575,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,nan,nan,nan,Letter
Class II,2016-08-10,2017-08-01,365,Terminated,LACK OF PROCESSING CONTROLS,Uncategorized,nan,nan,nan,Letter
Class III,2017-08-16,2018-02-28,210,Terminated,FAILED MOISTURE LIMITS,Uncategorized,nan,nan,nan,Letter
Class III,2017-12-06,2019-04-15,510,Terminated,FAILED DISSOLUTION SPECIFICATION,Uncategorized,V2 Pharma, PRESCRIPTION DRUG,nan,Letter
Class II,2021-06-02,,,Ongoing,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Noven Therapeutics, PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class I,2021-12-08,,,Completed,TEMPERATURE ABUSE,Uncategorized,nan,nan,nan,Letter
Class III,2022-05-25,2023-09-28,513,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2013-08-07,2014-06-24,335,Terminated,DEFECTIVE CONTAINER,Uncategorized,Baxter Healthcare Corporation, PRESCRIPTION DRUG,INTRAPERITONEAL,Letter
Class I,2014-08-27,2016-09-19,817,Terminated,NON,Uncategorized,nan,nan,nan,Letter
Class II,2017-02-15,,,Terminated,DEFECTIVE CONTAINER,Uncategorized,VistaPharm, PRESCRIPTION DRUG,ORAL,Letter
Class II,2017-07-05,2017-10-06,123,Terminated,LACK OF PROCESSING CONTROLS,Uncategorized,nan,nan,nan,Telephone
Class I,2018-03-07,2019-08-07,636,Terminated,NON,Uncategorized,nan,nan,nan,Letter
Class II,2018-05-23,2020-09-28,871,Terminated,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Padagis Israel Pharmaceuticals Ltd, PRESCRIPTION DRUG,TRANSDERMAL,Letter
Class III,2019-04-24,,,Completed,DEFECTIVE CONTAINER,Uncategorized,nan,nan,nan,Letter
Class II,2021-04-21,2022-04-28,392,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class III,2022-11-09,,,Ongoing,DEFECTIVE DELIVERY SYSTEM,Uncategorized,Genentech, PRESCRIPTION DRUG,INTRAVITREAL,Letter
Class III,2013-10-16,2014-07-16,294,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,Letter
Class III,2016-08-03,2017-01-17,244,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,Letter
Class III,2018-12-26,2019-09-12,289,Terminated,SHORTFILL,Uncategorized,Glenmark Pharmaceuticals ., PRESCRIPTION DRUG,nan,Letter
Class III,2019-01-02,2019-12-17,362,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2021-09-29,2022-11-08,459,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Major Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class I,2022-02-23,2023-02-06,367,Terminated,NON,Uncategorized,"[""Teva Womens Health ""]", PRESCRIPTION DRUG,INTRAUTERINE,Letter
Class III,2022-08-24,2023-12-04,487,Terminated,FAILED TABLET,Uncategorized,nan,nan,nan,Letter
Class II,2017-03-15,2018-01-24,370,Terminated,INCORRECT,Uncategorized,Prasco Laboratories, PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2017-03-29,2019-05-31,815,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2018-08-08,2020-04-29,645,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Hikma Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,nan
Class III,2019-02-27,2021-09-08,938,Terminated,FAILED DEGRADATION,Uncategorized,Padagis Israel Pharmaceuticals Ltd, PRESCRIPTION DRUG,TOPICAL,Letter
Class III,2020-05-20,2022-08-19,847,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Major Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-08-05,,,Ongoing,LACK OF PROCESSING CONTROLS,Uncategorized,nan,nan,nan,Letter
Class III,2021-03-24,2021-06-10,113,Terminated,TEMPERATURE ABUSE,Uncategorized,nan,nan,nan,Letter
Class I,2021-08-18,2023-08-17,1046,Terminated,NON,Uncategorized,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2022-11-23,2023-07-13,265,Terminated,FAILED TABLET,Uncategorized,Mylan Pharmaceuticals ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-01-29,2015-08-03,600,Terminated,GOOD MANUFACTURING PRACTICES DEVIATIONS,Uncategorized,KVK-Tech, PRESCRIPTION DRUG,ORAL,Letter
Class II,2014-08-27,2015-11-20,484,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class III,2015-05-27,2015-12-18,252,Terminated,FAILED PH SPECIFICATION,Uncategorized,nan,nan,nan,Telephone
Class III,2016-02-24,2017-06-22,596,Terminated,FAILED TABLET,Uncategorized,"[""Dr. Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter
Class III,2016-03-23,2018-08-21,949,Terminated,TABLETS,Uncategorized,nan,nan,nan,"Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit"
Class II,2017-04-19,,,Completed,TEMPERATURE ABUSE,Uncategorized,Fresenius Kabi USA, PRESCRIPTION DRUG,"INTRAMUSCULAR', 'INTRAVENOUS",Telephone
Class II,2018-05-16,2020-05-07,765,Terminated,LACK OF PROCESSING CONTROLS.,Uncategorized,nan,nan,nan,Letter
Class II,2018-08-08,2021-07-15,1093,Terminated,FAILED TABLET,Uncategorized,Camber Pharmaceuticals, PRESCRIPTION DRUG,ORAL,Letter
Class II,2020-01-29,2023-07-21,1288,Terminated,DEFECTIVE CONTAINER,Uncategorized,Advanced Accelerator Applications USA, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2020-05-27,2022-01-26,631,Terminated,DISCOLORATION,Uncategorized,Mylan Institutional , PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2020-11-18,2023-06-02,945,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,AvKARE, PRESCRIPTION DRUG,ORAL,Letter
Class III,2021-11-03,,,Ongoing,OUT,Uncategorized,Macleods Pharmaceuticals Limited, PRESCRIPTION DRUG,ORAL,Letter
Class I,2013-02-13,2017-03-20,1593,Completed,CRYSTALLIZATION,Uncategorized,Hospira, PRESCRIPTION DRUG,INTRAVENOUS,Letter
Class II,2016-09-14,2017-12-18,481,Terminated,UNIT DOSE MISPACKAGING,Uncategorized,nan,nan,nan,E-Mail
Class III,2016-11-30,2018-07-12,708,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,Zydus Pharmaceuticals USA ., PRESCRIPTION DRUG,ORAL,Letter
Class I,2017-06-21,,,Ongoing,NON,Uncategorized,nan,nan,nan,E-Mail
Class II,2018-04-25,2020-06-04,797,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,AvPAK, PRESCRIPTION DRUG,ORAL,Letter
Class I,2018-09-19,2020-05-07,625,Terminated,PRODUCT MIX,Uncategorized,Accord Healthcare ., PRESCRIPTION DRUG,ORAL,Letter
Class II,2018-10-10,2019-05-01,222,Terminated,FAILED DISINTEGRATION SPECIFICATIONS,Uncategorized,Teva Pharmaceuticals USA, PRESCRIPTION DRUG,ORAL,Letter
Class III,2020-07-01,2023-06-30,1129,Terminated,FAILED DISSOLUTION SPECIFICATIONS,Uncategorized,nan,nan,nan,Letter
Class II,2021-08-25,2022-12-21,520,Terminated,FAILED TABLET,Uncategorized,"[""Dr. Reddys Laboratories Limited""]", PRESCRIPTION DRUG,ORAL,Letter